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Polyploidy and binuclearity are important features of the mammalian liver and are
associated with ageing. Alterations in the degree of polyploidy and nuclearity occur
with the administration of various chemicals and also during regenerative growth.
Contradictory hypotheses exist regarding the function and significance of
polyploidisation. Early studies suggest that polyploid cells are more resistant to the
dominant expression of mutated oncogenes and polyploidisation is therefore a
protective mechanism. More recent studies suggest that increasing ploidy is purely
associated with terminal differentiation and increased rates of apoptosis. There have
also been suggestions that extensive polyploidy could lead to organ failure and
development of carcinogenesis. This thesis has looked at various aspects of
polyploidisation in the mouse liver to obtain more information about the function of
polyploidisation: The effect of the non-genotoxic carcinogen, sodium phenobarbitone
(PB) on ploidy and proliferation was determined over 21 days in p53 wild type (+/+),
p53 +/- and p53 null (-/-) mice. PB induced a significant increase in the proportion
of 8n nuclei and this increase occurred independently of p53. Whether
polyploidisation occurs as a protective mechanism or acceleration of ageing in this
case is unknown. However, the results confirm that the p53 +/- mouse model, often
used in short-term bioassays, may not be suitable for the identification of non-
genotoxic carcinogens as the increase in polyploidy occurred equally in all mice and
there were no histological abnormalities in any genotype. The function of polyploidy
with respect to increasing cell size, receptor expression and susceptibility to
apoptosis was also studied. The first accurate measure of volume of isolated
hepatocytes differing in ploidy and nuclearity was carried out using confocal image
analysis. The increase in volume associated with increasing DNA content was found
to be proportional to intercellular adhesion molecule-1 (ICAM-1) surface expression,
measured by flow cytometry. Apoptosis induced by interferon-gamma (IFNy) in
culture did not occur preferentially in polyploid hepatocytes. This would suggest
that the susceptibility of polyploid cells to apoptosis depends on the circumstances.
Evaluation of the effect of fluorescent activated cell sorting (FACS) and Hoechst
33342 on RNA from sorted hepatocytes found that the quality was not affected by
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the procedure and the RNA was suitable for subsequent gene expression analysis.
Initial experiments using microarray and real-time PCR identified several genes that
were induced, including major urinary protein 2 (MUP2) and interferon gamma
receptor (IFNR) or repressed, including pterin-4a-carbinolamine dehydratase (PCD),
in cells containing greater amounts of DNA. Further biological studies will
hopefully determine whether these genes are important to the function or
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After the administration of various drugs and chemicals and with increasing age, the
rodent and human liver become increasingly polyploid (Brodsky and Uryvaeva,
1977; Hasmall and Roberts, 2000; Kudryavtsev et ah, 1993). The significance,
mechanism and control of this process remain largely unknown. Contradictory
hypotheses exist as to why polyploid cells occur in the liver. Early studies suggest
that polyploidisation could be a protective response (Uryvaeva, 1981; Brodsky and
Uryvaeva, 1985c), whereas more recent studies suggest that polyploid hepatocytes
are associated with tissue differentiation (Biesterfeld et ah, 1994; Sigal et ah, 1995)
and are more likely to undergo apoptosis leading to an increased risk of organ failure
or to carcinogenesis (Gupta et ah, 2000). Whatever the reason or reasons,
polyploidisation is an important feature of the liver worthy of further study.
Therefore, this thesis studies various aspects of polyploidisation in the rodent liver.
The introduction provides background information about ploidy in the mammalian
liver, as well as other polyploid cells and organisms, in order to gain a greater insight
into this subject.
1.1 What is Polyploidy?
The majority of mammalian cells are diploid (2n) i.e. they contain two sets of
chromosomes. However, many tissues such as the liver, bone marrow, myocardium
and pancreas, contain nuclei in which the chromosome number is increased in
multiples of n (the normal haploid chromosome number) and are referred to as
'polyploid'. Another phenomenon referred to under the term polyploidisation is
multinucleation where a cell contains more than one nucleus. Approximately 80% of
rodent adult hepatocytes are binuclear (contain two nuclei). Polyteny, found in a
diverse range of tissues and taxa including insects and plants is often referred to as
'polyploidy'. A well-known example is the nuclei of secretory cells in the salivary
gland of diptera (Brodsky and Uryvaeva, 1977). These cells undergo a process
called endoreduplication, which is different to the process of polyploidisation in
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other cells such as hepatocytes and megakaryocytes and will be discussed in more
detail in a later section. Aneuploidy, which is often found in malignancies, is
sometimes mistakenly referred to as 'polyploidy'. Aneuploidy is the loss or
duplication of chromosomes or chromosomal segments but not the duplication of full
chromosomal sets (Feldmann, 1992).
The term 'polyploid' is most often used to describe an increase in DNA content
within a single nucleus and in some instances has been used to describe binuclear or
multinuclear cells. In this thesis 'polyploid' will only be used to describe
mononuclear cells and polyploidisation will refer to the mechanism by which a cell
obtains a DNA content greater than 2n within the one nucleus. However, in the case
of hepatocytes where a binuclear cell contains more than the diploid DNA content,
these cells will be called polyploid binuclear cells. The abbreviations used to
describe hepatocytes with different ploidy and nuclearity are often confused in the
literature. The abbreviations used in this thesis are provided in Table 1.
Table 1. Abbreviations used to describe hepatocytes.
Abbreviation Type of hepatocyte
2n Diploid
2 x 2n Binuclear diploid cell
4n Tetraploid
2 x 4n Binuclear tetraploid cell
8n Octoploid
2 x 8n Binuclear octoploid cell
16
1.2 Occurrence of Polyploid Cells
1.2.1 Plants, invertebrates and protozoa
Polyploid cells are found widely in nature, in plants, insects, worms, molluscs and
protozoa, as well as in several mammalian tissues (Brodsky and Uryvaeva, 1985a).
In insects and higher plants, nearly all normal differentiated cells are polyploid or
polytene. In vertebrates polyploidy is much more rare, with about 50 polyploid
species within 14 families of fishes, amphibians and reptiles (Otto and Whitton,
2000). High ploidy or polytene cells can be found in the macronucleus of ciliates, in
mollusc ganglia, salivary glands, silk gland and many other insect tissues, in rodent
trophoblast giant cells and in the haustorial cells of the embryo-suspensor and
endosperm of plants (Nagl, 1995; Brodsky and Uryvaeva, 1985b). Many mutant
strains of yeast are polyploid and consequently many studies have utilised these
organisms to study the growth and control of polyploidisation (Chan and Botstein,
1993). Other organisms widely used in the study of cell growth and development are
the nematode Caernorhabditis elegans, Drosophila and Xenopus. In Drosophila,
most larval tissues become polytene and adult tissues can either be polyploid or
polytene. During larval development in C.elegans, endoreduplication cycles occur
within the intestinal and hypodermal nuclei (Hedgecock and White, 1985).
Endoreduplication is thought to be beneficial to cells as it saves time and energy
(Therman et al., 1983). In plants, polyploidy is thought to have evolutionary
implications and is thought to have contributed to their success within the
environment (Otto and Whitton, 2000; Thompson and Lumaret, 1992; Soltis and
Soltis, 1995). It is clear that polyploidisation is important in the growth and
development of various organisms and it has been suggested that polyploidisation
played an important role in vertebrate evolution (Kobel and Du Pasquier, 1986).
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1.2.2 Mammalian cells
Polyploid cells have long been discovered in several human and animal tissues
including in the uterus, salivary gland, epidermis, urinary bladder, brain, liver,
trachea, bone marrow and myocardium (Brodsky and Uryvaeva, 1985a). More
recently, aortic smooth muscle (Barrett et al., 1983; Lee et ah, 1992) as well as
mouse ovary (Keighren and West, 1993) have also been found to contain polyploid
cells. The degree of polyploidy varies greatly in different tissues. In the bone
marrow, megakaryocytes synthesise up to 64 times the normal amount of DNA
(Biesterfeld et ah, 1994). Similarly to the liver, polyploidisation ofmyocytes in the
cardiac ventricle of mice occurs mainly in the first postnatal week, with 70% of cells
becoming binuclear and 10% becoming mononuclear with a 4n DNA content
(Brodsky et ah, 1980). In human artery smooth muscle cells, cerebrum, rectus
abdominis and thyroid, approximately 6-7% of cells are 4n with higher polyploid
cells being much more rare (Barrett et ah, 1983; Bohman et ah, 1985). The
polyploid nature of megakaryocytes and some other cells is directly related to cell
and tissue function and these cells are therefore commonly referred to as obligate
polyploids (Zimmet and Ravid, 2000). In other cells including the liver, the function
or functions are unknown. However, the possibility remains that polyploidisation is
related to cell or tissue function and cell growth in such tissues, as it is usually the
tissues that synthesise considerable amounts of tissue proteins and perform vital
tissue functions that are polyploid (Brodsky and Uryvaeva, 1977). Polyploidy in
various cell types has also been associated with the development of carcinogenesis
and disease. However, the significance of polyploidy will be studied in more detail
in later sections.
1.2.2.1 Ploidy in the liver
In rats and mice, the formation of polyploid hepatocytes begins shortly after birth
with the appearance of binuclear cells (2x2n) and the formation of 4n cells at
weaning (Brodsky and Uryvaeva, 1977; Carriere, 1967; Nadal and Zajdela, 1966).
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The onset of polyploidy is also associated with independent feeding as prior to
weaning there is little diurnal variation in DNA synthesis. However, after weaning,
DNA synthesis shows a diurnal pattern, which is affected by a protein deficient diet
(Dallman et al., 1974). Interestingly, excess glucose feeding to mice results in
polyploidisation of pancreatic P cells (White et al., 1985). In rat liver, the 4n nuclei
increase dramatically between 3 to 8 weeks after birth and seem to remain constant
thereafter (Bohman et al., 1985). In mice, the level of ploidy continually increases
with age and can reach up to 64n in some strains (Epstein, 1967; Severin et al.,
1984). The order of polyploid cell formation in the liver is shown in Figure 1.
Formation of binuclear cells in the liver is preceded by a burst in mitotic activity
(Wheatley, 1972). The mechanism of polyploidisation is described in more detail in
a later section but binucleation is thought to be an intermediary stage in the
formation ofmononuclear polyploid cells (Alfert and Geschwind, 1958; Brodsky and
Uryvaeva, 1977). In agreement with this theory is the finding that the formation of
binuclear cells in human liver precedes the formation ofmononuclear polyploid cells
of the next ploidy class (Watanabe and Tanaka, 1982). A study by Carriere, 1967,
found that in normal growing rat liver, the majority of cells engaging in DNA
synthesis were polyploid. As with mononuclear polyploid cells, binuclear cells
increase with age but in some cases have been found to decline at maturity (Gerlyng
et al., 1993). The level of binucleation is also species and strain specific. The level
is highest in the mouse and can range from 60-80% (Severin et al., 1984), whereas in
the rat and in humans the level ranges from 10-30% (Gerlyng et al., 1993;
Kudryavtsev et al., 1993; Seglen, 1997; Watanabe and Tanaka, 1982). In human
liver, binuclear hepatocytes are present in the embryonic liver and mononuclear
polyploid hepatocytes appear between 1 and 5 years of age. Up to 50 years of age
further polyploidisation occurs slowly and subsequently intensifies up until 86 to 92
years where the proportion of polyploid cells reaches approximately 27%. As in rats,
human 2n hepatocytes can pass several times through the normal mitotic cycles











2n 2x2n 4n 2x4n 8n 2x8n
Figure 1. Formation of mononuclear and binuclear hepatocytes. 2n cells
become 4n and 4n cells become 8n through the formation of binuclear cells.
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The majority of studies on liver ploidy have been carried out in mice, rats and
humans. The degree of polyploidy varies from species to species with the degree of
polyploidy decreasing in the order of mouse > rat > human > guinea pig >
woodchuck (Seglen, 1997). The cellular and nuclear DNA contents of various
mammalian liver cells are summarised in Table 2. In the liver of the woodchuck,
polyploid cells are absent indicating that polyploidy is not obligatory to liver
function (Seglen, 1997). The liver is composed of parenchymal cells (hepatocytes)
involved in the detoxification of drugs and toxins, and non-parenchymal cells such as
biliary epithelial cells, fenestrated endothelial cells, kupffer cells and Ito cells
(Severin et al., 1984) involved in immune responses. Polyploidy in the liver is a
feature of the parenchymal population only (Bohman et al., 1985). The parenchymal
cell population accounts for 70% of the total cell population in the liver with the
remaining 30% made up of non-parenchymal cells. In C3H male mice of 16 weeks
of age, the majority of parenchymal cells are 4n (70%) and 80% are binuclear.
Diploid and 8n cells make up 20% and 9.5% of the parenchymal population
respectively. Some studies have found that polyploidy varies between the sexes,
with adult female mice showing higher levels of ploidy than male mice of the same
age (Epstein, 1967; Steele et al., 1981a). There is also a variation between different
strains ofmice (Severin et al., 1984), see Table 2.
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Table 2. Ploidy in the mammalian liver: Age, sex and strain variations
Species Strain Sex Age % Cells* % % Nuclei* Ref.
2n 4n 8n 16n BN 2n 4n 8n 16n (et al.,)
Mouse C3H Mi 6 M 15 50 30 5 80 40 50 8 1 Severin
1984
u a 24 M 15 25 55 5 50 35 50 10 3 a
DBA u 9 M 15 35 42 8 50 38 50 12 0 a
NZB it 6 M 22 40 35 8 65 50 38 12 1 a
Balb/c F 10W 58 38 4 Steele
1981a
CBA F 32 W - - - - - 32 47 21 - a












14 71 15 1 35 Mossin
1994
u ((
50g 47 52 2 39 Gerlyng
1993
Human N/A Mi PrN,
4.5M





95 5 0 2 u
a it 51-
55y
73 24 3 19 a
a (C 86-
92y
56 34 10 21 a
*Values given are averages from several observations and therefore do not always add up to
100%. BN = Binuclear cells, Mi = Mixed, M = Male or Months, F = Female, W = Weeks, y
= years, D = day, g = grams, PrN = Prenatal, PoN = Postnatal
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The first observations of liver ploidy were described in fixed tissue sections or cells
of rodent and human liver several decades ago by several authors using quantitative
microspectrophometry (Alfert and Geschwind, 1958; Brodsky and Uryvaeva, 1977;
Carriere, 1967; Epstein, 1967; Nadal and Zajdela, 1966). More recent work has
utilised newer techniques such as flow cytometry, which allows the accurate and
quick determination of ploidy of large numbers of isolated hepatocytes and nuclei
(Bohman et al., 1985; Steele et al., 1981a; Steele et al., 1981b; Severin et ah, 1984).
Other studies have utilised the measurement of cell size and volume as these have
been found to be proportional to DNA content (Deschenes et al., 1981; Sigal et al.,
1999; Watanabe and Tanaka, 1982; Williams et al., 1997). In mouse tissue section,
2n nuclei ranged from 6.0 to 7.5 jam and 4n nuclei ranged between 7.5 and 9.0 jam
(Danielsen et al., 1986). Watanabe and Tanaka, 1982, demonstrated that in human
liver, 4n cells were roughly twice the volume of 2n cells and that the volume of
binuclear cells was the same as that of mononuclear cells of the same ploidy class
e.g. 2x2n and 4n.
1.2.2.1.1 Ploidy of cultured hepatocytes
Many of the studies described above have been carried out on isolated hepatocytes or
tissue sections. Studies of hepatocytes in culture can also provide important
information about polyploid cells. A study by Gomez-Lechon et al., 1981, showed
that the proportion of polyploid nuclei decrease and the proportion of multinucleate
cells increase over a period of days in non-proliferating cultures. They suggested
that the depletion of 4n and 8n nuclei were due to their instability in culture rather
than a transition between ploidy levels. Time-lapse photography demonstrated that
multinuclear cells occurred through cell fusion, which is not thought to occur in vivo
and may therefore be an artefact of culture. The mechanism of polyploidisation is
covered in more detail in section 1.4.
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1.2.2.1.2 Ploidy in different zones of the liver
The proposed lineage model in the liver involving the maturation of stem cells and
precursors in the periportal region and ending with maturing hepatocytes near the
central vein (Sigal et al., 1992), suggests that different regions of the liver will
contain hepatocytes of different ploidy. As mentioned previously, the DNA content
of hepatocytes is proportional to cell size and studies have examined either cell size
or ploidy when comparing cells from different regions with conflicting findings.
Cells from the different regions can be characterised by their function. The cells
within the periportal region (zone I) are involved in gluconeogenesis, ureagenesis
and amino acid uptake and degradation, whereas the cells in the perivenous area or
centrilobular region (zone 3) are involved in glycolysis and glutamine synthesis
(Feldmann, 1992; Jungermann and Kietzmann, 1996; Sigal et al., 1992). Cells from
each region also differentially express other genes that are summarised in Figure 2,










Figure 2. Diagrammatic representation of gene expression in hepatocytes
from different zones. Certain genes are expressed in all hepatocytes whereas
others are specifically found in the periportal or perivenous region. Adapted from
Bilir et al., 19931. Other information taken from Sancho-Tello et al., 19872,
Rajvanshi et al., 19983 and Yamauchi et al., 19884.
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Vargas et al., 1987, found that cells showing enzymatic properties of the periportal
and perivenous areas showed much heterogeneity in regard to ploidy, although the
perivenous region was enriched in 2n nuclei whereas the periportal region contained
an increased proportion of 4n nuclei. Similarly, Sancho-Tello et al., 1987,
demonstrated that the larger neonatal rat hepatocytes showed biochemical and
sereological characteristics of the periportal region whereas the smaller, low density
cells showed characteristics of the perivenous region. The smaller cells in this study
were also found to have higher alcohol-metabolising enzyme activities. Conversely,
other studies have demonstrated that cell size was greater in the perivenous region
compared to cells from the periportal region (Rajvanshi et al., 1998; Schmucker,
1990). Smaller cells from the periportal region were found to have higher serum
albumin or ceruloplasmin biosynthetic rates (Rajvanshi et al., 1998) whereas various
studies have shown that the larger cells from the perivenous region have higher
cytochrome p450 activity (Ingelman-Sundberg et al., 1988; Rajvanshi et al., 1998;
Sweeney et al., 1978b). From these studies, it is obvious that cells in each region
express different enzymes and carry out different functions in the liver. However, it
is unclear exactly which ploidy populations are found in each region and whether
differential gene expression is related to the degree ofploidy in the liver.
1.2.2.1.3 Ploidy during regenerative, non-binucleating growth
The degree of ploidy and nuclearity in the liver has been found to change in many
circumstances including after a 2/3 partial hepatectomy (PH). After a PH, the liver
has a remarkable capacity to completely regenerate. The response of the liver to
such a stimulus is proliferation of all cells types and complete replacement of the
removed area (Columbano and Shinozuka, 1996; Michalopoulos and DeFrances,
1997). Early studies of hepatocellular carcinogenesis and more recent studies of
regeneration following toxic injury indicated the presence of small, 2n cells, termed
oval cells, that could act as progenitor cells. It was suggested that these cells were
ultimately responsible for hepatocyte renewal following injury (Sigal et al., 1992;
Thorgeirsson, 1993). However, it is now generally accepted that liver regeneration
occurs by the division of fully differentiated hepatocytes and that progenitor cells are
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only involved in this process when the division of differentiated cells is impaired
(Thorgeirsson, 1996; Michalopoulos and DeFrances, 1997). Removal of the liver
tissue by PH results in the almost complete disappearance of binuclear cells from the
liver (Wheatley, 1972; Melchiorri et ah, 1993; Gerlyng et al., 1993). Gerlyng et al.,
1993, demonstrated that in rats, the binucleation rate decreased from 27% before PH
to 5% 45 h after PH. This study also demonstrated that all (97%) hepatocytes
replicated at least once, irrespective of ploidy and nuclearity and therefore all ploidy
classes were involved in the regeneration process. The disappearance of binuclear
cells does not occur until mitotic activity becomes prominent, indicating that
binuclear cells proliferate and form mononuclear progeny (Wheatley, 1972). The 2n
hepatocytes exhibit a more sustained proliferative activity during the later phase of
liver regeneration (Gerlyng et al., 1993). The growth of the liver after a PH seems to
occur in two phases: The first week is where the regenerative growth occurs with an
initial loss of binuclear cells and increase in mononuclear cells of all ploidy classes.
Subsequently, developmental growth occurs with a high rate of binucleation that
eventually restores the fraction of binuclear cells that were initially lost (Saeter et al.,
1988). After the first week there is a depletion of 2n cells and an increase in the
proportion of polyploid hepatocytes (Brodsky and Uryvaeva, 1977; Melchiorri et al.,
1993; Sigal et al., 1999). The significance of alterations in ploidy and nuclearity
during regeneration is unclear. The induction of polyploidisation after a PH was
suggested to be due to an activation of cell-ageing events such as decreasing the
proliferative rate of hepatocytes and advancing the cells through the terminal
differentiation process (Sigal et al., 1999). However, it has also been suggested that
the switch to non-binucleating growth during regeneration could enable the liver to
recover its size without exhausting its growth potential (Gerlyng et al., 1993).
1.2.2.1.4 Drug-induced polyploidisation
Various drugs and chemicals induce DNA synthesis and also alter hepatocyte ploidy
and nuclearity. The changes in ploidy after administration of different hepatic
mitogens vary. Many studies suggest that the increase in the 2n population is
frequently associated with chemical hepatocarcinogenesis. Indeed, administration of
thioacetamide to rats increases the 2n population and decreases the polyploid
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population as well as increasing S-phase. Long-term administration of thioacetamide
produces a high degree of nodule development (Sanz et ah, 1995). Other drugs such
as carbon tetrachloride (CCI4) (Steele et ah, 1981b) and the liver carcinogens, 2- and
4-acetylaminofluorene (2-AAF, 4-AAF) (Gerlyng et ah, 1994; Saeter et ah, 1988)
and 3'-methyl-4-dimethylaminobenzene (3'M) (Styles et ah, 1985) also result in an
increase in the proportion of 2n hepatocytes in rodents, although low-doses of 2-AAF
were associated with a shift from 2n to 4n (Clawson et ah, 1992). Other changes in
ploidy occur with the administration of non-genotoxic carcinogens such as
phenobarbitone (PB) and the peroxisome proliferators, diethylhexylphthalate
(DEHP) and WY-14, 643. Administration of these drugs result in increases in 8n
nuclei or cells (Bohm and Noltemeyer, 1981; Hasmall and Roberts, 1997; Hasmall
and Roberts, 2000; Miller et ah, 1996). A study by Cascales et ah, 1994,
demonstrated that 7 days administration of cocaine results in an increase in 4n and 8n
nuclei and a decrease in 2n nuclei. This effect was even more dramatic when mice
were pre-treated with PB. Administration of various drugs also alters the proportion
of binuclear cells. After administration of lead nitrate there is an increase in the
proportion of binuclear cells, specifically within the 2x4n and 2x8n compartments,
with a decrease in 2x2n cells (Melchiorri et ah, 1993). However, administration of
2-AAF, 4-AAF, MCP and cyproterone acetate (CPA) induces a pattern of non-
binucleating growth similar to the pattern seen during regeneration after a PH
(Gerlyng et ah, 1994; Saeter et ah, 1988). Interestingly, long-term treatment of rats
with the antibiotic, rifabutin, induces 'giant' multinuclear cells with some cells
containing up to 25 nuclei. The nuclei within these cells appeared to be normal and
did not induce any pathological abnormalities (Scampini et ah, 1993).
Both the induction of proliferation and alterations in ploidy and nuclearity have been
proposed as indicators of the carcinogenic potential of a drug. This hypothesis has
been tested by the comparison of the non-genotoxic hepatocarcinogens
diethylhexylphthalate (DEHP), chlorendic acid (CEA), MCP and PB with the non-
carcinogenic hepatic mitogens 1,4-dichlorobenzene (DCB) and ethylene thiourea
(ETU). The studies revealed that all chemicals increased the labelling index (LI) in
the mononuclear 8n population. However, it was only the carcinogens that
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significantly increased the LI in the binuclear octoploid (2 x 4n) cells. It was
therefore suggested that increased DNA synthesis in specific ploidy populations may
be significant for subsequent hepatocarcinogenesis (Hasmall and Roberts, 1997;
Hasmall and Roberts, 2000).
Various drugs have been found to alter ploidy and injure hepatocytes in particular
zones of the liver. Thioacetamide has been shown to induce necrosis in the
perivenous region and mainly within the 4n population (Diez-Fernandez et al., 1993).
Cocaine and ethanol also preferentially injure cells in the perivenous region as well
as altering ploidy (Cascales et al., 1994; Sancho-Tello et al., 1987). Increasing
polyploidy associated with high concentrations of the mitotic hepatocarcinogen,
dieldrin, occurs only in centrilobular hepatocytes with the periportal region
remaining unchanged from controls (Kamendulis et al., 2001). Accumulation of iron
in the liver, also associated with an increased risk of cancer, resulted in an increase in
8n nuclei and a decrease in binucleate cells within the centrilobular region of the
liver even though the deposition of iron occurred mainly in the periportal region
(Madra et al., 1995). Whether injury to certain areas of the liver is directly related to
differences in ploidy or whether it is due to different functions of cells within these
different regions is unknown.
Clearly studies of regeneration and drug-induced polyploidisation provide vital
information about polyploidy in the liver and may help establish the mechanisms and
controls involved in the process.
1.2.2.2 Ploidy in cancer and disease
Aneuploid cells are sometimes mistakenly referred to as polyploid. However,
aneuploidy is the loss or duplication of chromosomes or chromosomal segments and
not the duplicaton of whole chromosomal sets (Feldmann, 1992). The majority of
malignant tumours and early stage carcinomas are aneuploid (reviewed by Pihan and
Doxsey, 1999). However, hepatocellular carcinomas (HCC), as well as other types
of disease, are also associated with changes in the degree of ploidy and nuclearity
(Anti et al., 1994; Attallah et al., 1999; Feldmann, 1992), although the findings are
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often contradictory. One point to remember is that in the literature, polyploidy is
sometimes referred to as aneuploidy and vice versa. However, in this section, care
has been taken to ensure that these terms are used separately.
Much work in rodents has used chemically induced carcinogenesis to study ploidy
within foci, neoplastic nodules and hepatocellular carcinomas (HCC). The
development of HCC requires an inducer such as a PH, an initiating event such as
diethylnitrosamine (DEN) and a promoter of growth such as 2-AAF. Several studies
in rodents and humans indicate that as well as aneuploidy, a predominance of diploid
cells and a decrease in binuclearity are associated with nodular lesions and
hepatocarcinogenesis (Anti et al., 1994; Gerlyng et ah, 1992; Goolsby and Rao,
1996; Schwarze et ah, 1984; Schwarze et ah, 1991). Analysis of BrdU incorporation
has shown that the 2n cells have a higher proliferative activity than other cells and it
has been suggested that this could play a role in the development and progression of
the disease (Gerlyng et ah, 1992). Schwarze et ah, 1984, suggested that the selective
outgrowth of 2n cells is an early stage in the development of cancer. The increased
diploidy has also been suggested to predispose cells to more severe alterations such
as aneuploidy (Anti et ah, 1994). Indeed, the hepatocarcinogenic action of the
antiestrogen, tamoxifen, is thought to be due to a increase in the proportion of 2n
cells in the rat (Dragan et a., 1998).
A predominance of 2n cells in disease is not however the rule. Extensive copper
accumulation in the liver in Long Evans Cinnamon (LEC) rats, similar to that seen in
patients with Wilson's disease, and an accumulation of iron, results in increasing
polyploidy associated with impaired mitotic progression. This can lead to chronic
liver injury and to HCC in older rats (Kato et ah, 1996; Yamada et ah, 1998).
Sarafoff et ah, 1986, demonstrated that although the majority of foci induced by N-
methyl-n-nitrosourea and subsequent feeding with PB consisted of almost
exclusively diploid cells, other foci showed an increase in 4n cells and a few large
foci contained a mixture of 2n, 4n and 8n hepatocytes. The authors suggest that both
2n and 4n cells are capable of expanding as a homogenous clone. However, the
clonal homogeneity is lost when the foci expand. Similarly, Gramantieri et ah, 1996,
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found that in patients with actual or previous hepatitis B virus (HBV) infection,
higher ploidy values and a reduction in binuclearity was associated with the
development of HCC. Schwarze et al., 1991, found that long-term treatment of rats
with deoxycholic acid resulted in the development of benign neoplastic nodules
containing a majority of polyploid cells. However, these nodules failed to progress
to the carcinoma stage. Goolsby and Rao, 1996, found that ciprofibrate-induced
HCC was associated with the development of aneuploidy and 8n cells. One study of
experimental carcinogenesis in mice found no correlation between ploidy and liver
carcinogenesis (Danielsen et al., 1988).
The association ofploidy and cancer may be something to do with some alteration in
the normal ploidy status in the liver. The nuclei of binuclear cells from normal
human liver contain exactly the same amount of DNA (Watanabe and Tanaka, 1982).
However, one study of human hepatomas found that binuclear cells obtained from
non-cancerous regions and from hepatomas contained nuclei with different DNA
contents (Koike et al., 1982). Another study found increases in nuclear deformity as
well as increasing DNA content in cases of liver cell dysplasia (Henmi et al., 1985).
Changes in ploidy and nuclearity are also associated with cancer and disease in
tissues other than the liver. In atherosclerotic plaques, the degree of tetraploidy was
found to be lower than in normal smooth muscle cells (Barrett et al., 1983).
However, in spontaneously hypertensive rats, the incidence of polyploidy and
multinucleated smooth muscle cells was higher than in normal rats (Lee et al., 1992).
In chronic myelocytic leukaemia, there is a marked shift towards lower ploidy in
megakaryocytes. However, in patients who have suffered a myocardial infarction,
megakaryocyte ploidy is increased (Zimmet and Ravid, 2000). In cervical cancer,
both polyploid and aneuploid lesions exist. However, most polyploid lesions regress
whereas the aneuploid lesions persist (Reid et al., 1984). High ploidy cells are also
found in tumour cell lines and are thought to play a role in the progression of cancer
(de la Hoz and Baroja, 1993).
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There is a possibility that a change in ploidy is not the sole factor required for disease
and that S-phase may also play a role. In a study into chronic viral hepatitis C
infection, it was suggested that the suppression of S-phase and the degree of
inflammation led to the development of aneuploidy and malignant transformation
(Werling et al., 2000). In embryonic tumours, aneuploidy was associated with high
levels of S-phase (Rugge et ah, 1998).
The significance of ploidy in cancer and disease is unclear and in many cases the
hypotheses are contradictory. Development and progression of liver disease may be
related to differences in species, strain, age and the agents used in the initiation of
cancer (Lin et ah, 1989). Other factors such as proliferation and apoptosis are also
likely to play a role in the development of disease and alterations in all these
processes, not just ploidy, may affect the onset and outcome of disease.
1.3 Significance of Polyploidy
For many cell types such as megakaryocytes and bladder epithelial cells, polyploid
cells play a role in tissue function. However, the function and significance of
polyploidy in hepatocytes is unclear and as mentioed above, hypotheses are
contradictory. Early studies suggest that polyploidisation in hepatocytes is a
protective mechanism, whereas more recent work suggests that increased polyploidy
is associated with terminal differentiation and could lead to an increased risk of
carcinogenesis. This section will examine the function of various polyploid cells and
will examine the evidence leading to each of the hypotheses regarding polyploidy in
the liver.
1.3.1 A protective mechanism or a 'cheaper' alternative to mitosis?
Brodsky and Uryvaeva, 1977, suggested that when hepatocytes are forced to grow
whilst carrying out their tissue function, the cells are incapable of adequate
preparative action and as a result replace proliferation with polyploidisation. Studies
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of polyteny suggest that by avoiding mitosis, organisms undergoing
endoreduplication cycles save a considerable amount of time and energy and suggest
that polyploidisation could be an economical alternative to proliferation (Therman et
al., 1983). Similarly, non-binucleating growth associated with regeneration after a
PH may enable the liver to grow faster whilst retaining its normal function.
Therefore there is a possibility that polyploidisation in hepatocytes is an economical
alternative to mitosis.
Over the past few decades there have been other suggestions that polyploidisation in
the liver could in fact be a protective response. The role of the liver is to absorb and
detoxify various toxic substances on a daily basis and therefore, the chance of DNA
damage is higher for hepatocytes than for other cells in the body. Polyploidisation
avoiding mitosis was therefore proposed as a method that would limit the
development of chromosomal abnormalities and reduce the probability of cell death,
malignant transformation and other deleterious consequences (Medvedev, 1986;
Uryvaeva, 1981). The fact that short-term administration of various chemicals
induces polyploidisation in the liver may indicate that polyploidisation is indeed a
protective response. Cascales et al., 1994, suggested that the shift to higher ploidy
during drug-induced injury occurs as a method of increasing the function of the liver
whilst coping with intensive stress injury. Similarly, Sanz et al., 1996, suggested that
increasing ploidy associated with ageing results in higher levels of antioxidant
enzymes and thereby enhances the defence mechanisms of the cell against oxidative
damage. Interestingly, the majority of tumours in the liver are predominantly diploid
or aneuploid (Goolsby and Rao, 1996; Saeter et al., 1988; Sargent et al., 1996;
Schwarze et al., 1984; Schwarze et al., 1991) (see section 1.2.3.5), which supports
the suggestion that cells containing more than the normal number of chromosomes
might be protected from the dominant expression ofmutated oncogenes (Schwarze et
al., 1984). A recent study into the significance of polyploidy in the liver suggested
that ifpolyploidy is a protective response, carnivores, being less exposed to alkaloids
and vegatative toxins, may have a lower degree of hepatocyte ploidy than herbivores.
Correlation analyses found that there were no significant differences in the ploidy
levels between such animals. The results did however suggest that the significant
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differences between the levels of mononuclear and binuclear cells could play some
role in the detoxification function (Vinogradov et al., 2001).
One obvious question that arises from these hypotheses is 'if beneficial, why has
polyploidisation not evolved in the liver of all mammals?' This could be related to
longevity of the species, as generally it is the shorter-lived species that have higher
levels of polyploid cells. Uryvaeva, 1981, suggested that longer-lived species have
better DNA repair mechanisms and because hepatocytes in these species rarely
divide, there is sufficient time for chromosomal aberrations to be repaired. Since
then, statistical analyses have been carried out on various species to test whether
longevity, body weight, rate of development and basal metabolism could be
correlated with ploidy. The results indicated that only the basal metabolism and
developmental rate correlated significantly. The authors therefore suggested that
polyploidisation evolved in relatively short-lived species with rapid development, as
a 'cheap' way to cope with toxic insult (Anatskaya et al., 1994). More recently, a
comparison ofmore than 50 mammalian species demonstrated that post-natal growth
rate had the strongest effect on ploidy. The authors concluded that somatic
polyploidy was therefore a 'cheap' solution to growth problems that appear when an
organ is working at the limit of its capabilities (Vinogradov et al., 2001).
1.3.2 Terminal differentiation, senescence and apoptosis
A recent review suggested that advanced polyploidy in mammalian cells is
considered to indicate terminal differentiation and cellular senescence and may lead
to the loss of replicative activity and eventually to apoptosis (Gupta et al., 2000).
Replicative senescence and terminal differentiation are associated with changes in
the morphology, biochemistry and genetics of a cell (Smith and Pereira-Smith,
1996). Changes in proliferation, autofluorescence, rate of regeneration and healing
have all been studied in ageing animals and have provided evidence that hepatocytes
undergo terminal differentiation and senescence. Several studies have shown that
cell proliferation is inversely proportional to ploidy and age (Barbason et al., 1974;
Brodsky and Uryvaeva, 1977; Mossin et al., 1994). This decrease in proliferative
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potential and the finding that polyploid cells show an increase in autofluorescence
(from products of lipid peroxidation such as lipofuscin, which represent increased
oxidative activity) have indicated that the liver is indeed undergoing a process of
terminal differentiation associated with ageing (Sigal et al., 1995). Beyer et al.,
1991, demonstrated that regeneration capacity is reduced with age. A reduction in
the proliferative response after a PH in older animals was also confirmed by the
finding that the induction of p34cdc2 and proliferating cell nuclear antigen (PCNA) is
reduced (Timchenko et al., 1998). Post et al., 1960, previously showed that there
was a decreased rate of healing associated with age after administration of CCI4.
Another study demonstrated that the accumulation of polyploid cells after a PH was
associated with an increase in senescence-associated P-galactosidase and p21
expression (Sigal et al., 1999).
Terminal differentiation and senescence have not been properly defined and there is
some debate as to whether or not hepatocytes are terminally differentiated.
Michalopoulos and DeFrances, 1997, suggested that mature hepatocytes are not
terminally differentiated as they are capable of undergoing multiple rounds of DNA
synthesis and de-differentiate under the influence of hepatocyte growth factor (HGF)
or epidermal growth factor (EGF). Overturf et al., 1997, demonstrated that
hepatocytes isolated from adult mouse livers are capable of multiple rounds of
division and can undergo greater than 80 rounds following serial transplantation of
cells into diseased livers. Separation of cells by centrifugal elutriation also
demonstrated that it was in fact the larger, denser cells that had a higher repopulation
capacity than smaller cells (Overturf et al., 1999). Similarly, the transplantation of
sorted hepatocytes into diseased mouse liver demonstrated that 4n and 8n
hepatocytes participate in subsequent repopulation (Weglarz et al., 2000). Therefore,
it seems that although polyploid hepatocytes show characteristics of terminal
differentiation and senescence with age, these cells are capable of proliferation to
compensate for any loss of tissue.
There is some evidence to support the suggestion that polyploid cells are more
susceptible to apoptosis. Oren et al., 1999, found that the rate of apoptosis was
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increased in polyploid cells after administration of the potent hepatic mitogen,
triiodothyronine (T3) to rats pre-treated with the cell cycle inhibitor, retrorsine. Sigal
et al., 1999, suggested that apoptosis accounted for the decrease in the proportion of
8n cells 5 days after a partial hepatectomy. Increased rates of apoptosis have also
been found in the livers of Long-Evans Cinnamon (LEC) rats where the liver has
become populated with megalocytes, containing enormous nuclei (Gupta et al.,
2000). Multinucleated giant cells induced in HeLa cells by down regulation of the
zinc finger protein, KRC, ultimately died. The authors suggested however that cell
death occurred through 'mitotic cell death' due to the unsupportable nature of
multiple rounds ofDNA synthesis in the absence of complete mitosis (Allen and Wu,
2000). In other studies, apoptosis induced in hepatocytes by the administration of the
mitogen, lead nitrate, was not found to occur preferentially in the polyploid
population (Melchiorri et al., 1993). Similarly, liver injury induced by
aminoguanidine results in a delay in polyploidy, increase in DNA synthesis and is
accompanied by the appearance of a hypodiploid population (Diez-Fernandez et al.,
1998) suggesting some link between lower levels of ploidy and cell death. Therefore
further study is required to determine exactly what circumstances are required to
induce apoptosis in polyploid cells.
1.3.3 Other functions of polyploid cells
1.3.3.1 Increasing cell size
In megakaryocytes, polyploidisation is directly related to cell function, resulting in
an increase in platelet production (Japa, 1943; Baatout et al., 1998a). Another
example of polyploidy relating to cell function is in the development of the butterfly
wing. The wing is made up of three different types of scales (cells) that differ in size
and position. The actual function of these scales in the construction of the wing
depends on their level of ploidy; 8n, 16n or 32n (Brodsky and Uryvaeva, 1985c).
Polyploid cells are also important to the function of the urinary bladder. The thick
membrane surrounding the bladder is made up entirely of polyploid cells and
functions as a barrier between the tissue fluid and the urine (Hicks, 1975). Polyploid
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cells are more efficient in this case as they are bigger than 2n cells. The function of
polyploidy in cardiomyocytes is unclear. However, the most common consequence
of polyploidisation is cell enlargement. Brodsky et al., 1980, suggest that there is a
possibility that a small number of polyploid cardiomyocytes has some advantage
over a large number of smaller diploid cells.
As mentioned previously, cell size and volume are proportional to DNA content in
the rodent and human liver (Danielsen et al., 1986; Deschenes et al., 1981; Watanabe
and Tanaka, 1982). The role of increasing size in polyploid hepatocytes has not been
investigated. Increasing cell size and volume have been shown to be important in the
regulation of many processes including cell proliferation and apoptosis (Lang et al.,
1998) and cell size has been implicated in the regulation of the transcription factor,
DBP (Schmidt and Schibler, 1995). Therefore, there is a possibility that cell size
may play a role in the function of hepatocytes and requires investigation.
1.3.3.2 Increasing RNA and protein synthesis
Increasing RNA transcription and protein synthesis has been associated with
increasing DNA content in various polyploid tissues. The 4n cells in the locust testis
contain twice the amount of RNA than the 2n cells and the amount of collagen
produced by a 4n fibroblast was found to be twice that of a 2n fibroblast in vitro
(Brodsky and Uryvaeva, 1985a). Differential expression of various genes in
different regions or zones of the liver has already been mentioned (see section
1.2.3.2) and as yet, it is unknown whether gene expression in these zones is related to
size or ploidy. Studies which have looked specifically at gene and protein expression
within hepatocytes containing different amounts of DNA have found conflicting
results. Several studies, using radio-labelling and cytophotometry, have shown that
the amount of RNA transcription doubles with increasing ploidy. Therefore, a 4n
cell would produce twice as much RNA as a 2n cell and an 8n cell would produce
twice that of a 4n cell (Brodsky and Uryvaeva, 1985c). A more recent study found
that the levels of catalase and glutathione peroxidase mRNA levels also correlated
with the degree of polyploidy (Fogt and Nanji, 1996). However, a study of the level
of RNA transcription within a 15 min period in rat hepatocytes found cells
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containing double the amount of DNA did not produce significantly more RNA
(Collins, 1978). Conflicting findings are also associated with protein synthesis. The
amount of albumin produced by 4n rat hepatocytes was found to be approximately
twice that produced by 2n hepatocytes (Le Rumeur et al., 1981). The activity of
succinate dehydrogenase, NADPH cytochrome c and lactate dehydrogenase was
found to increase with DNA content (Tulp et al., 1976). However, the activity of
glucose-6-phosphate reductase in 2n and 4n rat hepatocytes (Bernaert et al., 1979)
was found to be the same. Different techniques and animals were used in these
experiments which could, in part, explain some of these contradictory findings.
However, it is possible that the expression of only certain genes is increased in
proportion to DNA content and as yet it is unknown whether differential gene
expression is related to the position and function in the liver and not just ploidy.
Further experiments are needed to determine if this is the case.
1.4 Mechanisms of Polyploidisation
Polyploidisation can occur through different mechanisms and most often occurs
through a block in mitosis or cell division or through the omission of mitosis. The
different mechanisms are often mixed up in the literature. Therefore to avoid
confusion, table 3 provides clear definitions of each process. This section will not
examine all the mechanisms listed in table 3 but will discuss the mechanisms of
polyploidisation which are encountered most frequently including 1) endomitosis, 2)
polyploidising mitosis and 3) endoreduplication.
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Table 3*. Definitions of the various methods of polyploidisation.




Cells complete M-phase but do not go through
cytokinesis, forming binuclear cells.
Hepatocytes
Cardiomyocytes
Endomitosis Cells enter M-phase but are blocked at prophase,
without dissolution of the nuclear membrane.
Megakaryocyte
cell lines, originally
thought to occur in
primary
megakaryocytes
Endomitosis-A Cells enter M-phase but do not complete anaphase




Cells do not enter mitosis but proceed from a gap
phase to S-phase. Polyteny is a special case where
the duplicated chromosomes line up, side by side,





Cells enter mitosis and proceed to telophase where
there is fusion of chromosomal complexes.
C-mitosis Cells enter M-phase but are blocked at metaphase
following chromosome condensation and spindle





*Adapted from Zimmet and Ravid, 2000. 'Definition from Brodsky and Uryvaeva,
1985b. +Therman et al., 1983.
1.4.1 Endomitosis
There appear to be at least two types of endomitosis, see Table 3. The first definition
of endomitosis suggests that cells enter mitosis and are blocked at prophase. Cells
then proceed through to the next gap phase without dissolution of the nuclear
membrane. Endomitosis is now more commonly used to describe cells that proceed
through anaphase but lack nuclear division and cytokinesis as in endomitosis-A
(Edgar and Orr-Weaver, 2001; Therman et al., 1983; Zimmet and Ravid, 2000).
Endomitosis occurs in insects, some other invertebrates, plants (Brodsky and
Uryvaeva, 1985b) and some mammalian cells (Therman et al., 1983). In mammals,
megakaryocytes are perhaps the most widely studied. These cells can reach 128n
before fragmenting to form platelets (Baatout et al., 1998a). In primary
megakaryocytes it has been shown that the nuclear membrane breaks down during
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mitosis and anaphase B, telophase and cytokinesis do not occur (Nagata et al., 1997),
see Figure 3. The process of endomitosis in primary megakaryocytes and
megakaryocye cell lines (Datta et al., 1996; Kikuchi et al., 1997; Zhang et al., 1996)
is different, suggesting that different regulatory mechanisms are involved in each cell
type.
Prometaphase



















Figure 3. Diagrammatic representation of the process of endomitosis in
megakaryocytes. A 2n cell enters mitosis after G2 and continues to anaphase
where there is a block. The nuclear membrane reforms at a stage equivalent to




Several decades ago, it was noted that some cells contained more than the normal
amount of DNA but had not undergone endoreduplication or endomitosis (Brodsky
and Uryvaeva, 1985b). These cells were found to undergo variant mitotic cycles or
incomplete mitosis referred to as 'polyploidising mitosis.' Two distinct mechanisms
of polyploidising mitoses were subsequently found. The first process was termed
'nuclear restitution' and involved the formation ofpolyploid cells through the fusion
of the chromosomal complexes during telophase. The second process involved the
formation of polyploid cells through acytokinetic mitosis and binucleation (Brodsky
and Uryvaeva, 1985b). The binuclear cell is thought to be a common intermediate
step in the formation of polyploid cells in many mammalian cells including
hepatocytes, the myocardium, pigment epithelium of the retina, sympathetic ganglia,
fibroblasts of loose connective tissue and in mesothelium. Acytokinesis and
binucleation have also been described in the gastric epithelium of starfish, in the
intestine of ascarids and in some of the tissues in plants (Brodsky et al., 1980;
Brodsky and Uryvaeva, 1985b). In the case of hepatocytes, although it has been
accepted that the formation of binuclear cells occurs through acytokinesis, it is
unclear exactly how mononuclear polyploid cells arise from these binuclear cells. In
vitro studies suggest that S-phase and entry into mitosis occur simultaneously in both
nuclei. During mitosis there is fusion of the two spindles and the formation of a
single metaphase plate. Anaphase, telophase and cytokinesis follow, resulting in the
formation of two mononuclear polyploid cells (Carriere, 1967). Alternatively, time-
lapse experiments and electron microscopy studies suggest both nuclei enter S-phase
simultaneously then enter mitosis where there is the formation of a common mitotic
spindle. Chromosomal segregation and cytokinesis then occur forming mononuclear
cells of a higher ploidy class (James, 1977). The proposed mechanisms for the
formation of binuclear and polyploid hepatocytes are illustrated in Figure 4. As
previously mentioned, the mode of growth in hepatocytes after a liver has undergone
a PH or after administration of various drugs, does not involve the formation of
intermediary binuclear cells (Wheatley, 1972; Melchiorri et al., 1993). Therefore,
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the method of polyploidisation in hepatocytes may differ depending on the
circumstances.
Prometaphase




Figure 4. Schematic representation of the proposed mechanisms of
polyploidisation in hepatocytes. 1. Formation of binuclear tetraploid cell through
acytokinesis, a 2n cell becomes 2x2n; 2. Formation of mononuclear tetraploid cells
through either a fusion in the two spindles or formation of a common mitotic spindle
at anaphase and the subsequent production of two daughter cells, the 2x2n cell
becomes two 4n cells.
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1.4.3 Endoreduplication
Endoreduplication or endoreplication is different to the processes occurring in
megakaryocytes and hepatocytes. Endoreduplication occurs through repeated DNA
synthesis in the absence of any mitotic process. In many organisms the chromatids
remain closely associated forming polytene chromosomes (Edgar and Orr-Weaver,
2001; Leitch, 2000). Much of the early work on endoreduplication or polyteny, was
published in the 1970's due to the discovery of long banded chromosomes in the
larval tissues of Drosophila, Chironomidae and some other diptera, reviewed by
(Brodsky and Uryvaeval985b). Other examples are given in section 1.2.1.
1.4.4 Other mechanisms
Fusion of cells is an important mechanism in the formation of multinucleate cells in
vivo and in vitro. This process occurs naturally in vivo, during the formation of
skeletal muscles and fertilisation of the ovum and is seen in vitro in a variety of cell
types (Brodsky and Uryvaeva, 1985b). There seems to be two distinct types of cell
fusion: fusion occurring during differentiation when two adjacent cells fuse together
and 'refusion' which is more likely to be due to defect in mitosis (Martin, 1972;
Wheatley, 1972). Refusion is thought to occur when the two daughter cells reunite
after cytokinesis or when a cell undergoes incomplete cytokinesis. As mentioned
earlier, adult rat hepatocytes have been shown to undergo spontaneous cell fusion in
culture, resulting in the formation ofmultinuclear cells (Gomez-Lechon et al., 1981).
However, it is thought that fusion is an artefact of culture and does not occur in vivo.
Monopolar, multipolar and c-mitoses can result in the formation of polyploid cells or
cells containing a reduction in the amount of DNA (Brodsky and Uryvaeva, 1985b).
These processes are very rare and will therefore not be discussed in this thesis.
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1.5 Control and Regulation of Ploidy
Polyploidisation in the liver is under complex hormonal control. However, the actual
molecular mechanisms involved in this process have not been elucidated. Genetic
analysis of yeast, Xenopus, Drosophila and the nematode, Caenorhabditis elegans
now provide insights into the molecular control of the cell cycle and could provide
vital information regarding the molecular mechanisms of polyploidisation. This
section will therefore examine the hormonal regulation of this process and try to
elucidate some of the factors controlling polyploidisation by examining the
regulation ofploidy in the liver and other eukaryotic cells.
1.5.1 Regulation of ploidy and proliferation by hormones, growth
factors and cytokines
There is much evidence to suggest that hormonal regulation plays an important role
in both polyploidisation and proliferation. In the rat, the ontogeny of 4n cells
resembles that of the liver thyroid hormone receptor beta (TR-P) (Rodd et al., 1992).
The liver proteins a2U-globulin (Chatterjee et al., 1983), major urinary protein (MUP)
(Held et al., 1989) and the liver microsomal protein, LAGS (low affinity
glucocorticoid binding site), which are under complex multi-hormone regulation,
also appear at this time (Chirino et al., 1991). Several studies have demonstrated that
thyroid hormones, growth hormone (GH) and sex steroids modulate polyploidisation
and proliferation to varying degrees (Alfert and Geschwind, 1958; Carriere, 1967;
Torres et al., 1999). Originally it was thought that the action of thyroid hormone was
mediated through the release of growth hormone (Carriere, 1967). However, more
recently it was found that GH, unlike thyroid hormone, was not essential for
polyploidisation. Torres et al., 1999, demonstrated that the decrease in 4n nuclei
induced by a hypophysectomy in rats was reversed by treatment with T3 but not with
GH. Similarly, T3 significantly increased S-phase and restored the normal adult level
of 4n nuclei in the hypothyroid rat but S-phase and level of 4n nuclei were unaffected
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by GH. The differences in the degree of ploidy in humans, with males showing a
higher proportion of 4n nuclei than females, was found to be due to the effects of
gonadal steroids. Oestrogen was said to delay while testosterone promoted the
polyploidisation process. The authors therefore suggest that thyroid hormones play
an essential regulatory role whereas GH, together with the sex steroids modulate
polyploidisation to variable degrees depending on age and gender of the animals.
Other evidence for the importance of hormones in polyploidisation comes from
studies on dietary restricted rats. Compared with rats fed ad libitum, dietary
restricted rats were found to attain the adult level ofploidy 6 months later (Enesco et
al., 1991). Dietary restriction is known to inhibit growth and growth is dependent on
levels of thyroid hormone, GH (Carriere, 1967) and the thymus (Pieri et ah, 1980;
Pieri et ah, 1982). Therefore it is possible that modulation of these hormones affects
the rate ofpolyploidisation. However, another possible mechanism of control of this
process could be through alterations in thyroid hormone receptor (TR) expression.
There are at least three isoforms of the TR, which are present in different tissues at
different concentrations (Glass and Holloway, 1990; Mitsuhashi and Nikodem, 1989;
Schwartz et ah, 1992). During fasting, the levels of the TR a2 isoform mRNA
increased in the liver. The TR a2 isoform is unable to bind to T3 and may act as a
competitive inhibitor regulating the effect of T3 on liver growth (Bakker et ah, 1998).
The exact mechanisms by which thyroid hormones exert their effect have not yet
been elucidated. In rats, it has been demonstrated that administration of insulin-like
growth factor-1 (IGF-1) diminishes the metabolic thyroid hormone action in the liver
by at least in part reducing the number to thyroid hormone receptors and their level
of expression (Pellizas et ah, 1998). T3 has also been shown to regulate IGF-1 by
stimulating hepatic growth hormone receptor gene expression in the chicken
(Tsukada et ah, 1998). The effect of T3 was also found to affect the kinetics of
thymidine kinase, an enzyme important in DNA synthesis (Maliekal et ah, 1997). In
replicating hepatocytes, poly (ADP-ribose) polymerase, a nuclear enzyme involved
in DNA synthesis, DNA repair, cell replication and transformation is modulated by
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thyroid hormones and could be another mechanism of action of thyroid hromones
(Cesarone et al., 2000).
Thyroid hormones also influence DNA synthesis during liver regeneration after a PH
(Maliekal et al., 1997). Cytokines and growth factors are also involved, including
transforming growth factor alpha (TGFa) (Scotte et al., 1997) and interleukin-6 (IL-
6) (Cressman et al., 1996). Modulation of DNA synthesis is also achieved in
cultured hepatocytes by administration of insulin, EGF (Mossin et al., 1994),
dexamethasone, glucagon, norepinephrine (De Juan et al., 1992) and IGF-1 and IGF-
2 (Kimura and Ogihara, 1998). Interestingly, administration of IL-6 in mice and IL-
11 in rats resulted in increasing megakaryocyte cell size and ploidy (Ishibashi et al.,
1989; Yonemura et al., 1993). The importance of cytokines and growth factors in
liver growth and in megakaryocytopoiesis may therefore suggest a role for them in
the regulation of polyploidisation. Polyploidisation is likely to involve complex
interactions with various different molecules and receptors.
1.5.2 Cell cycle
The cell cycle is tightly regulated with many checkpoints ensuring that S-phase does
not occur until mitosis is completed and vice versa. In order for polyploidisation to
occur, be it endomitosis, endoreduplication of acytokinesis, these checkpoints must
somehow be overcome. Some of the main molecules involved in these checkpoints
are illustrated in Figure 5. Alterations in several regulatory molecules such as
cyclin/cyclin dependent kinase (CDK) complexes and cyclin dependent kinase
inhibitors (CDKIs) have been associated with polyploidisation in various cell types.
A detailed study of all genes involved in the cell cycle is outwith the scope of this
thesis and there are several comprehensive reviews on this subject (Coffman and
Studzinski, 1999; Gao andZelenka, 1997; Nasmyth, 1996b; Pines, 1999). Therefore,












Figure 5. Simplified diagram of the cell cycle representing the main molecules
involved in checkpoint controls and polyploidisation. 1. Prevention of SCF
activity results in the accumulation of cyclin E and p27 and endoreduplication
(Nakayama et al., 2000). 2. Decreasing levels of cyclin B and/or Cdk1 are
associated with endoreduplication (Hall et al., 1996; Grafi and Larkins, 1995; Zhang
et al., 1998). 3. Overexpression of cyclin A induces multiple rounds of DNA
synthesis and the formation of multinuclear cells (Bortner and Rosenberg, 1995;
Datta et al., 1998). 4. Overexpression of p21 leads to prevention of mitosis and re-
replication of DNA (Kikuchi et al., 1997). 5. Overexpression of APC activators results
in reduced levels of cyclin B and endoreduplication (Cebolla et al., 1999).
1.5.2.1 Cyclin/CDK complexes
In mammalian cells, the G1 phase of the cycle is characterised by the presence of G1
cyclins (Cyclin Dl, D2, D3) and the CDKs 2, 4, (5) and 6. The cyclin E/CDK 2
complex, sometimes called 'replication promoting factor' (RPF), is required for the
Gl/S transition and cyclin A/CDK 2 is necessary for the progression through S-
phase. Cyclin B and cyclin A bind to CDK 1 (p34cdc2) and are involved in the
initiation and progression of mitosis. The cyclin B/CDK1 complex is also known as
mitosis promoting factor (MPF). Activation of MPF occurs through
dephosphorylation of phosphate groups on the tyrosine 15 and threonine 14 residues.
Exit from mitosis occurs through ubiquitin-dependent cyclin proteolysis. Changes in
the phosphorylation status or expression through increased translation or degradation
of any of the above cyclins or CDKs could lead to repeated S-phases without mitosis
or mitosis without DNA synthesis resulting in the formation of polyploid or aploid
(no DNA) cells, respectively.
Studies in Xenopus and yeast have shown that p34cdc2 is one of the key regulators of
the cell cycle (Dasso and Newport, 1990; Enoch and Nurse, 1990). Mutants of the
cdc2 gene in the fission yeast have been shown to undergo DNA synthesis without an
intervening mitosis resulting in the formation of polyploid cells (Broek et al., 1991).
Inhibition of p34cdt2 by staurosporine in metaphase-arrested mouse cells and the
staurosporine analogue, K-252a in rat fibroblasts resulted in the formation of
polyploid cells (Hall et al., 1996; Usui et al., 1991). Endoreduplication in maize
endosperm has been shown to involve the inhibition of the cyclin B/Cdc2 complex
(MPF) (Grafi and Larkins, 1995). Reduction in the levels or activity ofMPF is also
associated with endoreduplication in budding yeast (Dahmann et al., 1995) and
Drosophila (Sigrist and Lehner, 1997). Polyploidisation induced by 1,25-
dihydroxyvitamin D3 in HL60 cells was associated with a block in G2/M due to
decreased levels of p34cdc2 protein and kinase activities. Interestingly, some cells
increased other G2 regulators and were able to overcome this block, suggesting that
cells have the capability to compensate for decreased p34cdc2 activity (Harrison et al.,
1999).
47
Studies using megakaryocyte-derived cell lines have established the importance of
cyclin/CDK complexes in endomitosis. A study using the human erythroleukemia
(HEL) cell line stimulated with phorbol esters found that elevated and sustained
levels of cyclin B1 were found in the nucleus of endomitotic cells and that CDK1
protein levels were reduced. Overexpression of CDK1 did not lead to a normal
mitosis and the authors suggested that this was due to a failure in the formation of
MPF. This study also demonstrated that cyclin Bl, normally localised in the
cytoplasm, translocates to the nucleus of polyploid cells (Datta et al., 1996).
Conversely, other studies using the MegT (murine megakaryocyte) cell line have
found reduced levels of cyclin Bl with apparently normal levels of CDK1. The
decrease in cyclin Bl was due to accelerated ubiquitin-dependent degradation
(Zhang et al., 1996; Zhang et al., 1998). These studies suggest that endomitotic cells
cannot undergo mitosis due to a failure to form MPF either by reduced levels of
CDK1 or cyclin Bl, resulting in further rounds of DNA synthesis without a complete
mitosis. A study into the kinetics of cyclin Bl in primary murine megakaryocytes
found that in Gl, cyclin B was increased in polyploid cells and in G2/M, levels of
cyclin B increased linearly with ploidy. However, there was no definitive change in
the polyploid cells and it was therefore suggested that endomitosis in primary
megakaryocytes involves alterations of other cell cycle regulators (Carow et al.,
2001). Similarly, a study in human megakaryocytes found that endomitosis occurred
independently from cyclin Bl regulation and that the ubiquitin-dependent
degradation of cyclin Bl occurred normally at anaphase (Roy et al., 2001). The
hearts and livers of embryonic or newborn mice, deficient in the winged helix
transcription factor, Trident (also known as HFH-11, FKL16 and WIN), show
extensive polyploidy, with cardiomyocytes gaining up to 50 times the amount of
DNA. Disruption of Trident results in post-natal death. The authors suggest that
Trident could play a role in the upregulation of M-phase cyclins or CDKs (Korver et
al., 1998). Interestingly, the Trident gene is involved in regulating proliferation
induced by a PH (Ye et al., 1999).
Cyclin D3/CDK2 and cyclin E/CDK2 activity have been found to increase during
endomitosis in the HEL cell line, as has the specific kinase activity of the cyclin
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A/CDK2 complex. This increase in cyclin/CDK complex activity was found to be
augmented by reductions in the CDK inhibitory proteins, p21CIP1 an(t p27Klpl (Datta
et al., 1998). Antisense experiments in primary megakaryocyte cell cultures have
found that although low levels of cyclin B1 are associated with megakaryocyte
polyploidy, progression of the polyploidisation process was dependent on the
presence of cyclin D3 (Wang et al., 1995). In transgenic mice, overexpression of
cyclin D3 increased the level of megakaryocyte ploidy (Zimmet et al., 1997).
Therefore, it was suggested that endomitosis involves the upregulation of CDK
complexes involved in G1 and S phase progression. Drosophila is a particularly
interesting model to study as both mitotic and endoreduplication cycles occur during
normal development. The endoreduplication cycles are characterised by the absence
of cyclins A and B and the periodic expression of cyclin E (Knoblich et al., 1994;
Sauer et al., 1995). The switch from mitotic cycles to endoreduplication cycles
seems to be regulated by a conserved eukaryotic gene, fizzy-related (fzr), which
negatively regulates the levels of cyclins A, B and B3 (Sigrist and Lehner, 1997).
Loss of the gene encoding a zinc finger transcription factor, escargot, is also
associated with initiation of an endocycle in Drosophila. Escargot was found to
interact with Dmcdc2 (the Drosophila form of Cdc2 or CDK1) and was therefore
proposed to inhibit entry into S-phase by maintaining high level of the cyclin/CDK
complex in G2 (Hayashi, 1996).
Cyclin A is critical in the control ofDNA replication (Girard et al., 1991; Resnitzky
et al., 1995; Rosenberg et al., 1995) and the G2 to M transition (Lehner and
O'Farrell, 1990; Ravnik and Wolgemuth, 1996; Pagano et al., 1992) and therefore is
another candidate in the control of polyploid cell formation. A comparison of
haploid and tetraploid strains of Saccharomyces cerevisiae using microarray
technology found several genes that were either induced or repressed. One gene that
was repressed was CLN1, a G1 cyclin with homology to human cyclin A. The
authors suggest that lower expression of G1 cyclins allows cells to pass through
START at a larger size and remain polyploid (Galitski et al., 1999). Recently it was
found that overexpression of the transcription factor, B-myb, a direct physiological
target for cyclin A/CDK2, enables various G1 checkpoints to be overcome,
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promoting entry into S-phase in certain cell lines (Saville and Watson, 1998).
Overexpression of cyclin A in mammary glands of transgenic mice results in the
formation of multinucleate cells, suggested to occur through the failure of
cytokinesis (Bortner and Rosenberg, 1995). Overexpression of the oncogene, c-myc
in colcemid-treated cells is thought to induce DNA re-replication and polyploidy
through the activation of CDK2 activity (Kao et al., 1996; Li and Dang, 1999).
Therefore, polyploidy seems to occur through alterations in various cyclins, either
through overexpression or ubiquitin-dependent degradation and also through altering
CDK activity, with different mechanisms occurring in different cells.
The ubiquitin proteasome pathway does in fact play a role in the control of
polyploidisation in various cells. Accumulation of cyclin E and p27K,pl in mice
lacking the Skp2 protein (an F-box protein and substrate recognition component of a
Skp-l-Cullin-F-box protein (SCF) ubiquitin ligase), results in the formation of cells
with enlarged nuclei, polyploidy and multiple centrosomes. These enlarged cells
show reduced growth rates and increased apoptosis (Nakayama et ah, 2000). In
S.cerevisiae, mutation of the DOA4 gene, which codes for a ubiquitin hydrolase,
results in the overreplication of parts of the genome (Singer et ah, 1996). In fission
yeast, polyploid popl mutants accumulate high levels of the CDK inhibitor, Ruml
and the S-phase regulator Cdcl8. These proteins are not ubiquitinated in the absence
of popl, suggesting that popl, may be a recognition factor for Ruml and Cdcl8,
targeting these proteins for ubiquitination and degradation through the 26S
proteasome pathway (Kominami and Toda, 1997).
In yeast, formation of pre-replication complexes before the initiation of S-phase
requires several proteins including an origin recognition complex (ORC), licensing
factors such as MCM proteins and Cdc6. Phosphorylation of these proteins by
cyclin/CDK complexes has been implicated in the control of S-phase and ensures
DNA replication occurs 'once per cycle'. Cyclin B/CDK complexes have been
found to inhibit the transition of replication origins to a pre-replicative state in
S.cerevisiae (Dahmann et al., 1995). The ability of Cyclin A/CDK2 to phosphorylate
CDC6 is proposed to be a negative regulatory event, preventing the re-replication of
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DNA during S-phase and G2 (Petersen et al., 1999). Experiments on the embryonic
cell cycle of frogs indicate that there is a licensing factor that binds DNA during
mitosis and is consumed during S-phase, controlling DNA replication (Blow and
Laskey, 1988; Leno et al., 1992). In budding yeast, the licensing factor, Swi5, is
made in G2 but stays in the cytoplasm due to phosphorylation by Cdc28 (equivalent
to Cdc2 in fission yeast). At the end ofmitosis, Cdc28 is inactivated, resulting in the
dephosphorylation of Swi5 which can then enter the nucleus and bind DNA,
allowing replication to occur (Moll et al., 1991). Licensing factors are also thought
to be involved in the control of DNA replication in mammalian cells. In
megakaryocytes, the licensing factor, MCM3, is found only in polyploidising cells
and not in the fully differentiated cells (Nagata et al., 1997). Kinases responsible for
the regulation of cyclin/CDK activity through phosphorylation and
dephosphorylation determine the timing of G2 and mitosis. One such kinase, Weel,
is responsible for the phosphorylation ofCDKs at tyrosine-15 and high levels of this
kinase are found during endoreduplication in maize endosperm (Sun et al., 1999).
Cyclin/CDK2 acitivity is important for centrosome duplication during the Gl/S
transition. Failure to coordinate duplication and mitosis results in abnormal numbers
of centrosomes and aberrant mitoses (Lacey et al., 1999). Therefore, polyploidy
could occur through the modulation of cyclin/CDK complexes at several points in
the cell cycle and it is possible that different processes occur in different cells.
1.5.2.2 CDKIs
The gene products, p21CIP1 and p27KIPI are structurally related proteins which
respond to a diverse set of signals including growth factor depletion, contact
inhibition and DNA damage, thus regulating the progression through G1 and S-phase
(Polyak et al., 1994; Reynisdottir et al., 1995). Other CDKIs, pl5INK4b and pl6INK4a
respond to exogenous growth factor levels and associate with CDK4 or CDK6
complexes (Serrano et al., 1993; Hannon and Beach, 1994). The ruml gene product,
p25 (fission yeast) and the SICJ gene product, p40 (budding yeast) inhibit B-type
cyclins preventing the activation of mitosis during G1 (Benito et al., 1998;
Correabordes and Nurse, 1995; Martin-Castellanos et al., 1996; Moreno and Nurse,
1994; Murray, 1994b; Nasmyth, 1996a; Schwob et al., 1994). The actions of these
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inhibitors have not been fully established. However, several studies have suggested
that they could play a role in polyploidisation by inhibiting CDK complexes involved
in Gl/S and G2/M progression. Indeed the universal CDKI, p21 has been shown to
act on CDK2 and Cdc2 (Pines, 1994; Reynisdottir et al., 1995). Expression of p21 in
U20S-derived cell lines results in an accumulation of 2n and 4n cells, indicating that
p21 regulates both G1 and G2 progression in these cells (Medema et ah, 1998). In
hepatocytes, p21 is of particular interest as increased expression of this CDKI is
associated with increasing age and senescence (Sigal et ah, 1999). Polyploidisation
in the UT-7 megakaryocyte cell line (Kikuchi et ah, 1997), HEL cell line (Datta et
ah, 1998) and in mouse hepatocytes (Wu et ah, 1996) is associated with changes in
p21 expression. In the UT-7 cell line, overexpression of p21 resulted in an increase
in ploidy and it was suggested that p21 acted through the suppression of Cdc2
activity at mitosis. This study also demonstrated that p21 mRNA was induced before
polyploidisation in normal human megakaryocytes (Kikuchi et ah, 1997). In the
liver of p21 transgenic mice, large polyploid nuclei appeared in some of the
hepatocytes, indicating the role of p21 in polyploidisation, in vivo (Wu et ah, 1996).
Transfection of p21 in the human breast carcinoma cell line, MCF-7, resulted in the
formation of 'giant' polyploid and multinuclear cells (Sheikh et ah, 1995). However,
overexpression of p21 in other human cell lines was found to induce
endoreduplication only in cells lacking pRB (Niculescu III et ah, 1998), suggesting
that functional pRB is necessary to prevent DNA replication in p21 G2-arrested cells.
Interestingly, in human cell lines treated with microtubule inhibitors, the absence of
p21 induces endoreduplication suggesting that p21 is involved in a checkpoint
ensuring S-phase does not occur after an aberrant mitosis. In these cell lines the
formation of polyploid cells was associated with gross nuclear abnormalities and
apoptosis (Mantel et ah, 1999; Stewart et ah, 1999; Waldman et ah, 1996).
Ruml ('replication uncoupled from mitosis') has recently been identified in fission
yeast as a regulator of G1 progression (Labib and Moreno, 1996). This gene has
been shown to play a role in the length of Gl, the prevention of DNA replication
until the completion ofmitosis and in the prevention ofmitosis until the completion
of Gl. Overexpression of this gene in yeast was found to induce several rounds of
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DNA synthesis without mitosis, resulting in the occurrence of 4n and 8n cells and
deletion of Ruml resulted in mitosis with no intervening S-phase (Moreno and
Nurse, 1994). The Ruml gene product, p25 specifically inhibits the B-type cyclins
preventing the activation ofmitotic complexes in G1 (Correabordes and Nurse, 1995;
Martin-Castellanos et al., 1996). p25Ruml accumulates in anaphase and persists until
the end of Gl. During S-phase, p25Ruml is degraded allowing the activation of
mitotic cyclin/Cdc2 complexes and initiation of mitosis. Inhibition of p25Ruml
degradation by mutations in phosphorylation sites required for targeted ubiquitin-
dependent degradation causes protein stabilisation and polyploidisation (Benito et al.,
1998). A similar protein, p40SIC1, is found in budding yeast which specifically
inhibits Clb (B-Type cyclins)/Cdc28 complexes preventing the initiation of S-phase
and mitosis during Gl (Schwob et al., 1994; Nasmyth, 1996a). So far, no CDK
inhibitors described have been found to have specificity for the cyclin B/Cdc2
complex in animals (Sherr and Roberts, 1995; Elledge et al., 1996) and it is possible
that animal cells use other mechanisms already described to control the proper
progression from Gl to S phase.
1.5.2.3 Regulators of mitosis and cytokinesis
Mitosis can be separated into five different stages: Prophase, prometaphase,
metaphase, anaphase and telophase. During these stages the chromosomes condense,
the nuclear membrane breaks up, the chromosomes are aligned and separated and a
nuclear membrane forms around each group of daughter chromosomes. Cytokinesis
then ensures that the cytoplasm divides equally, forming two daughter cells (Alberts
et al., 1994a). As described previously, polyploidisation can occur if any of these
stages are absent or disrupted. Binuclear hepatocytes are thought to result from an
absence of cytokinesis (Nadal and Zajdela, 1966) and polyploid megakaryocytes
result from a failure to complete anaphase (Nagata et al., 1997). Therefore, the
factors controlling mitosis and cytokinesis may be critical in the development or
control of polyploidisation in these cells.
Cyclin/CDK complexes such as cyclin B/Cdc2 (MPF) are involved in the
progression of mitosis as well as its initiation. MPF kinase activity is directed to
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MAPs, among other proteins, and hence plays a role in spindle formation.
Dephosphorylation of p34cdc2 and cyclin B degradation are required for entry into
anaphase and telophase, respectively (Holloway et al., 1993; Jacobs, 1992; Lehner
and O'Farrell, 1990). Changes in the normal distribution of these molecules could
prevent entry into mitosis and could be involved in polyploidisation where certain
phases of mitosis such as anaphase and cytokinesis do not occur. The anaphase
promoting complex (APC) is involved in controlling the activity of CDKs by
destroying G2 cyclins such as cyclin B during late metaphase. Association of the
APC with specific activators seems partially responsible for specific substrate
targeting and timing. One APC activator, the human hCDHl (yeast CDH1) gene
shows sequence and functional similarities to the plant homologue, ccs52.
Overexpression of ccs52 in yeast triggers mitotic cyclin degradation and induces
endoreduplication and cell enlargement, suggesting a role for the APC in the control
of endoreduplication (Cebolla et al., 1999). In vascular smooth muscle cells,
polyploidisation is associated with overexpression of Cksl, a cdc2 adapter protein
that promotes degradation of cyclin B, suggesting that regulation of polyploidisation
by the APC may also occur in mammalian cells (Hixon et al., 2000).
Proper chromosome segregation in eukaryotes depends upon the mitotic spindles that
assemble at the time of cell division and disassemble upon its completion (Barton
and Goldstein, 1996). These spindles are composed largely of microtubules (made
up of tubulin subunits) which can attach to the chromosomes through interactions
with specialised protein complexes known as kinetochores (Alberts et al., 1994b).
Disruption of microtubule assembly or disruption of associated proteins is likely to
prevent the completion of mitosis. Inhibition of microtubule assembly by
administration of colchicine, which inhibits tubulin polymerisation, results in
increasing polyploidisation in megakaryocyte cell lines (Baatout et al., 1998b).
Members of the kinesin family play critical roles in cell division. Mitosis kinesin-
like protein 1 (MKLP1), a member of this family, causes plus end-directed sliding of
microtubules over one another and may mediate anaphase B spindle elongation
(Nislow et al., 1992). The mechanism ofpolyploidisation in thrombopoietin-induced
primary megakaryocytes involves a lack of outward movement of the spindle poles
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during anaphase B and it has been suggested that this process could result from
alterations in the regulation ofMKLP1 (Nagata et al., 1997).
Deletions or mutations of various genes involved in duplication of the spindle pole
body (mitotic spindle in mammalian cells) in yeast result in a polyploid phenotype
including CDC3 (Schild et al., 1981), MPS1 and MPS2 (Winey et al., 1991), MOB1
(Luca and Winey, 1998), Karl (Rose and Fink, 1987; Vallen et al., 1992). Other
mutations preventing the proper separation of chromosomes or cell division are also
implicated in polyploidisation. Mutations in ESP1 result in accumulation of extra
spindle pole bodies and asymmetrical segregation of chromosomes (McGrew et al.,
1992). Mutational analysis of SPA1 found that the gene is required for cell growth,
spindle segregation and other cellular processes (Snyder and Davies, 1988).
Asymmetrical cell division results from mutations in NDC1 resulting in one daughter
cell that doubles in ploidy and a cell that inherits no chromosomes. This gene is
required for the attachment of chromosomes to the spindle pole (Thomas and
Botstein, 1986). The Sep 160p is also required for the proper segregation of
chromosomes (Weber et al., 1997). In fission yeast, Bubl is essential in maintenance
of the spindle checkpoint, ensuring that chromosomes are properly segregated.
However, loss of this gene results in loss of chromosomes often associated with
aneuploidy (Bernard et al., 1998). Some of the genes and gene products studied
above have been found to be homologous with genes in other eukaryotes. The ESP1
gene of S. cerevisiae is similar to the cutl gene of Schizosaccharomyces pombe and
the bimB gene of Aspergillus nidulans (McGrew et al., 1992) and Scpl60p of S.
cerevisiae shows some homology with chicken and human vigilin and the product of
C08H9.2 of Caenorhabditis elegans (Weber et al., 1997). Therefore, it is possible
that homologues of some of these genes may be found to play a role in the
polyploidisation ofmammalian cells. Other genes involved in the spindle checkpoint
in Drosophila and in humans are Rod and ZwlO (hRod and hZwlO in humans). The
proteins encoded by these genes associate with the kinetochores and ensure anaphase
does not occur until all chromosomes are properly orientated on the spindle. Cells
lacking these genes are often aneuploid (Basto et al., 2000; Chan et al., 2000).
Obviously, genes and gene products involved in the spindle checkpoint are essential
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in maintenance of ploidy. However, it should be noted that deletion or mutations in
several of the genes mentioned, results in aneuploidy and not polyploidy and may
therefore have no role in the process ofpolyploidisation in mammalian cells.
The Aurora/Ipllp kinase family is important in the regulation of chromosome
segregation and cytokinesis and is therefore important in the maintenance of ploidy
and the prevention of aneuploidy (Bischoff and Plowman, 1999). In S.cerevisiae,
Ipll (increase in ploidy) mutants are defective in chromosome segregation resulting
in aneuploidy (Biggins et al., 1999). In Drosophila, mutations of aurora cause
mitotic arrest with chromosomes arranged on a single spindle (Glover et al., 1995).
In C.elegans, disruption of the aurora homologue, AIR2 results in the production of a
single polyploid cell after multiple rounds of DNA replication without cytokinesis
(Schumacher et al., 1998). Xenopus oocyte and egg extracts contain pEg2, a protein
with sequence homology to aurora and Ipll enzymes, which is important in the
assembly of the mitotic spindle (Roghi et al., 1998). AIM-1 and STK15, also
members of the aurora kinase family are continually repressed after the induction of
polyploidisation in normal human megakaryocytes and cell lines. The authors
suggest that downregulation ofAIM-1 at M-phase may therefore be involved in the
abortive mitosis associated with polyploidisation in megakaryocytes (Kawasaki et
al., 2001).
Inhibitor of apoptosis proteins (IAPs) suppress apoptotic cell death in several model
systems and are highly conserved between insects and mammals. All IAPs contain a
baculovirus IAP repeat (BIR) which is essential for the anti-apoptotic activity of
IAPs (Fraser er al., 1999). In cultured cells, inhibition of the human BIRP, survivin,
results in apoptosis, hyperploidy, multinucleation, multipolar mitotic spindles and
supernumerary centrosomes. Interestingly, polyploidy induced by survivin
antagonists is accentuated in p21-deficient cells (Li et al., 1999). In C.elegans, the
survivin homologue, BIR1, is important in maintenance of ploidy. Ablation of BIR1
expression resulted in a defect in cytokinesis and the formation ofmultinuclear cells
(Fraser et al., 1999). AIR2 was subsequently found to be absent from chromosomes
in the absence of BIR1 and it is proposed that BIR1 localises AIR2 to the
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chromosomes where AIR2 phosphorylates proteins and affects chromosome
behaviour and spindle organisation (Speliotes et ah, 2000). In fission yeast lacking
BIR1, there is a defect at the metaphase to anaphase transition and a failure to
elongate the mitotic spindle (Uren et ah, 1999). Downregulation of KRC, a large
zinc finger protein that regulates transcription of target genes via the kB gene
enhancer element, has recently been found to result in growth without cytokinesis
forming giant multinuclear cells in mammalian cell lines. However, it is not known
whether KRC acts directly as a growth mediator or indirectly through target genes
(Allen and Wu, 2000). Mutations in the IPL2 (Chan and Botstein, 1993) and SPA1
(Snyder and Davies, 1988) genes of S. cerevisiae also give rise to multinucleate cells,
possibly through some failure in bud growth, chromosome segregation or nuclear
migration. Recently, there has been a suggestion that cytokinesis is also regulated by
centrosomes. Removal of centrosomes from cells results in aborted cytokinesis and
the formation of binuclear cells (Hinchcliffe et ah, 2001; Piel et ah, 2001). However,
Hinchcliffe et ah, 2001 demonstrated that these cells were blocked in Gl. Another
protein involved in spindle assembly, chromosome segregation and cytokinesis is the
Drosophila fumble (fbl) protein. Mutations in this gene also result in the formation
of multinuclear cells possibly through alterations in membrane synthesis (Afshar et
ah, 2001). Mutants in the microtubule binding yeast protein, Biml (homologous to
human EB1) undergo cytokinesis before the spindle is in the correct position and
results in a lethal multinucleate phenotype (Muhua et ah, 1998).
Separation of daughter cells at cytokinesis is dependent on the formation of a
contractile ring, which is composed of actin and myosin-II filaments. Cleavage
occurs through the contraction of this ring and results in the formation of two
daughter cells with identical copies of the genetic material (Alberts et ah, 1994a).
The formation of binuclear cells in the liver is thought to occur through a failure in
cell division (Nadal and Zajdela, 1966). Therefore, it is possible that factors
controlling the formation of the contractile ring during cytokinesis could be disrupted
and play a role in this process. Indeed, inhibition of actin polymerisation by
cytochalasin B prevents cytoplasmic separation without interfering with DNA
replication and induces polyploidisation in megakaryocyte cell lines (Baatout et ah,
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1998c), Pacific oyster eggs (Longo et al., 1993) and cells in yeast (Kanbe et al.,
1993). Further evidence that deregulation of actin could play a role in
polyploidisation comes from an experiment involving cytotoxic necrotizing factor 2
(CNF2). This bacterial exotoxin has been found to induce multinucleation in
megakaryocyte cell lines and is thought to act through a modification of rhoA,
leading to a dysregulation of actin and disruption of the contractile ring at mitosis
(Denko et al., 1997; Hudson et al., 1996).
1.5.2.4 Genes involved in DNA damage and repair
Other proteins involved in the cell cycle checkpoints include those that can sense
damage, arrest the cell cycle, initiate repair and cause apoptosis (Murray, 1994a).
One of the main proteins involved in this control is p53 (Prost et al., 1998; Bellamy
et al., 1997). The p53 onco-suppressor gene is mutated in over half of all human
cancers allowing affected cells to avoid death through apoptosis (Hollstein et al.,
1991). p53 is involved in several cell cycle checkpoints including at the Gl/S and
G2/M transitions (Stewart et al., 1995) and has been recently shown to associate with
centrosomes and participate in the mitotic spindle checkpoint (Ciciarello et al.,
2001). There is conflicting evidence regarding the role of p53 in the control of
polyploidisation in normal ageing hepatocytes. Bellamy et al., 1997 found that
polyploidisation associated with age in mice was not dependent on p53. Conversely,
Yin et al., 1998 found that heterozygous and homozygous p53-knockout mice did not
show normal polyploidisation with age and found an increase in the proportion of
diploid cells. There is however, general agreement on the role of p53 in
polyploidisation after mitotic spindle damage. In experiments involving mouse and
human cell lines and mouse fibroblasts, p53-deficient cells become polyploid in
response to spindle damaging agents such as nocodazole and colcemid (Casenghi et
al., 1999; Minn et al., 1996; Notterman et al., 1998). Administration of mitotic
spindle inhibitors to mouse cell lines deficient in p53 and expressing the apoptosis-
inhibiting protein, Bcl-xL also reinitiate DNA replication and become polyploid
(Minn et al., 1996). In HeLa cells treated with etoposide, overexpression of Bcl-2
results in multiple rounds of DNA replication and the formation of multinuclear
cells, which are inhibited from undergoing apoptosis. The HeLa cell line lacks
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functional p53 and pRb checkpoints due to human papillomavirus infection and it
therefore suggested that the induction ofmultinucleation might be due to the loss of
the p53 mitotic spindle checkpoint (Elliott et al., 1999). Interestingly,
polyploidisation also occurs in human fibroblasts overexpressing a dominant gain of
function p53 mutation (p53RSC, relaxed spindle checkpoint) when treated with
colcemid (Gualberto et al., 1998). Polyploidisation also occurs after DNA damage
by irradiation or chemotherapy in p53 mutated lymphoma cells (Illidge et al., 2000).
The excision repair cross complementing gene (ERCC-1) is involved in nucleotide
excision repair (NER) after DNA damage. ERCC-1 knockout mice are runted at
birth and die before weaning with liver failure. Hepatocytes from these mice
demonstrate increasing polyploidy, abnormal nuclei, elevated levels of p53 and p21
and a reduction in DNA synthesis and binucleation suggesting that polyploid cells
form due to a block in the cell cycle (McWhir et al., 1993; Nunez et al., 2000; Weeda
et al., 1997). The accelerated polyploidisation in ERCC-1 deficient mice was not
rescued by p53 deficiency but it was demonstrated that p53 was responsible for the
reduction in DNA synthesis and binucleation. However, in mice capable of DNA
repair, p53 did not affect binucleation (Nunez et al., 2000).
1.5.2.5 Other molecules associated with polyploidisation
At nonpermissive temperatures, Chinese hamster cells bearing the ts41 mutation
accumulate up to 16n. This process of polyploidisation differs from that induced by
other mutations discussed above as DNA re-replication occurs without G2, M-phase
and Gi. Therefore, it is suggested that the ts41 gene product participates in the
control of entry into mitosis and inhibition of entry into S-phase (Handeli and
Weintraub, 1992).
Induction of polyploidisation through inhibition of protein kinases by the
staurosporine analogue, K252a, is potentiated by exogenous cyclic AMP.
Exogenous cyclic AMP is usually unable to cross the cell membrane. The induction
of polyploidisation by K252a, changes the membrane structure, somehow allowing
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exogenous cyclic AMP to enter the cell and increase polyploidisation (Zong et al.,
2000).
The role of reactive oxygen species (ROS) and antioxidant enzymes in the control of
mammalian cell growth and proliferation is well known. One study demonstrated
that ROS are capable of inducing proliferation in various cell types, whereas
antioxidants reduce this effect (Burdon, 1995). In the liver, ROS and antioxidant
enzymes have been shown to modulate cell proliferation (Tsai et al., 1992; Liotti et
al., 1987). More recently, it has been suggested that antioxidant enzymes may
influence the rate of hepatocyte polyploidisation as PH-induced polyploidy is
reduced in transgenic mice overexpressing various antioxidant enzymes (Nakatani et
al., 1997).
1.5.3 A gene involved in regulation of cell size
The human tumour suppressor gene PTEN (phosphatase and tensin homologue
deleted from chromosome 10) encodes a cytoskeleton-associated molecule with both
protein phosphatase and phosphatidylinositol 3,4,5-triphosphate (PIP3) 3-
phosphatase activities. This gene is particularly interesting due to its role in the
regulation of cell size and is thought to inhibit growth through modulating the
responses of cells to insulin. In mammalian cell cultures, the lipid phosphatase
activity of this protein is involved in regulating cell proliferation, cell survival and
cell migration (Huang et al., 1999). During Drosophila eye development,
inactivation and overexpression of the highly conserved PTEN homologue, DPTEN,
affects cell size, while overexpression also inhibits cell cycle progression at early
mitosis and promotes cell death in a context-dependent manner (Huang et al., 1999).
So far, no studies have been carried out to determine whether PTEN plays a role in
polyploidisation. Analysis of PTEN expression in hepatocytes of different ploidy
would therefore be particularly interesting.
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1.6 Summary and Aims
Polyploidisation in the liver occurs naturally with age and after the administration of
various drugs and chemicals (Alfert and Geschwind, 1958; Brodsky and Uryvaeva,
1977; Hasmall and Roberts, 1997; Hasmall and Roberts, 2000). The significance of
this process is unclear and hypotheses suggest that it is either a protective response or
that it is associated with terminal differentiation and senescence, leading to increased
rates of apoptosis and possibly to carcinogenesis (Medvedev, 1986; Uryvaeva, 1981;
Gupta et ah, 2000). By studying polyploidisation induced by PB in hepatocytes
differing in p53 expression, the relationship between cell size and receptor
expression, the susceptibility of hepatocytes to IFNy-induced apoptosis and gene
expression within different ploidy populations, this thesis hoped to determine
possible controls and functions of polyploidisation in mouse hepatocytes.
The mechanisms controlling polyploidisation in hepatocytes are not known.
However, there is considerable evidence that p53 is involved in the control of
polyploidisation in various cells treated with mitotic spindle inhibitors (Casenghi et
al., 1999; Minn et al., 1996; Notterman et al., 1998). There is also evidence to
suggest that p53 may be involved in regulation of polyploidisation associated with
ageing, although findings are contradictory (Yin et al., 1998; Bellamy et al., 1997).
PB is a hepatic mitogen that induces polyploidisation in mice (Bohm and
Noltemeyer, 1981). Therefore, the first aim of this thesis was:
• To determine if changes in ploidy and proliferation induced by PB were
dependent on p53.
As mentioned above, the function or functions of polyploidisation are unclear and
hypotheses are contradictory. Cell size and volume are known to regulate various
cell functions including proliferation and apoptosis (Lang et al., 1998). Gene
expression in some cells is also influenced by cell size (Schmidt and Schibler, 1995).
In hepatocytes, cell size increases in proportion to DNA content (Danielsen et al.,
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1986; Deschenes et al., 1981; Epstein, 1967; Sweeney et al., 1978a; Watanabe and
Tanaka, 1982). Therefore, the second and third aims were:
• To determine if the increasing size of polyploid hepatocytes played any role in
the function of these cells, specifically by determining whether increasing size
altered surface receptor expression.
• To determine whether polyploid hepatocytes are more susceptible to apoptosis
induced by IFNy.
The recent development of microarray technology enables thousands of genes to be
screened and is particularly useful in cases where there is little information available.
This technique has been used to compare haploid and tetraploid strains of yeast and
provides new insights into gene expression in different ploidy populations (Galitski
et al., 1999). In order to study gene expression within mouse hepatocytes, cells
differing only in DNA content must be separated, which has previously been possible
using FACS and the DNA dye, Hoechst 33342 (Weglarz et al., 2000). This
technique has not been well characterised, but in combination with microarray
technology, would provide much information regarding gene expression within
different hepatocyte populations. Therefore, the fourth and fifth aims were:
• To sort highly viable and pure populations of hepatocytes differing only in DNA
content.
• To ensure that the RNA obtained from these cells was suitable for microarray
analysis.
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2 Materials and Methods
Unless stated, manufacturers and suppliers are given in Appendix 1. Details of
buffers and other solutions are provided in Appendix 2.
2.1 Animals and Animal Procedures
2.1.1 Administration of PB and Brdll
The animal work for the PB study was carried out by AstraZeneca Pharmaceuticals
(Alderley Edge). Briefly, 5-6 week old male C57BL/6 p53 +/+, +/- and -/- mice
were purchased from Taconic Farms, Germantown, New York and acclimatised for
two weeks prior to dosing. Animals were housed five per cage under appropriate
conditions of temperature and humidity and with a 12-hour artificial light cycle.
Mice were fed powdered irradiated R and M Nol (modified) diet (Special Diet
Services) containing PB (1000 ppm) for 21 days; this regimen was chosen based on
previous data (not shown). Control groups were fed a similar diet without PB. Food
and water were available ad libitum. BrdU (0.8mg/ml) was administered
continuously in drinking water for 72 h before termination.
2.1.2 Preparation of FNAs for flow cytometry
Mice were euthanased by inhalation of halothane (FLUOTHANE™, AstraZeneca
Pharmaceuticals). The mouse body and liver weights were noted. A representative
portion of liver tissue was removed from the right lobe, fixed in methacarn overnight
and processed to paraffin for histological examination. Fine needle aspirates (FNAs)
were then taken using a 20 g needle and making at least 6 passes to include each lobe
of the liver; cells were aspirated into citrate buffer. This technique yielded similar
numbers of cells from each case. FNAs were stored at -70°C prior to use for the
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Primary hepatocytes from C3H male, 6-12 weeks old (unless otherwise noted), were
isolated using a two-step retrograde liver perfusion procedure adapted from the
technique described by Bellamy et al., 1997. All perfusion equipment was sterilised
with 70% ethanol before use and rinsed with sterile H2O. Animals were killed by
cervical dislocation, mice were dissected and the ribcage was removed. A cannula
(OD 1mm, ID 0.5mm) was inserted into the right chamber of the heart and down the
thoracic inferior vena cava. All media was heated to and kept at 39.7°C throughout
the perfusion. This temperature ensured that the medium entering the liver was
37°C. Perfusion medium was run through at a low flow rate until the liver inflated.
The pump was stopped and the portal vein was cut. The flow rate was increased to
9.5 ml/min and the liver was perfused for a further 5 min. The liver was then
perfused with digestion medium containing collagenase type 4 (0.5 mg/ml) and
DNase type 1 (0.1 mg/ml) for 7 min. HBSS (digestion medium) and collagenase
type IV were chosen, as the cell yield was greater than that obtained using other
media and collagenase type I. The digested liver held intact by its capsule was
removed to a petri dish and the gall bladder was removed. Hepatocytes were
dissaggregated by gently scraping cells from the fibrous supporting tissue.
2.1.3.2 Purification of cell suspension
The cell suspension was pipetted a few times with a wide bore pipette to break up
clumps and filtered through a 100 pm sieve onto a fresh petri dish. The sieve was
washed twice with cold plating medium to collect the rest of the dissaggregated cells.
The cell suspension was placed in a falcon tube and made up to 50 ml with ice cold
plating medium. The cells were centrifuged at 50 g for 5 min at 4°C and the
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supernatant (containing debris and non-parenchymal cells) was removed. The cells
were then spun over Percoll for 10 min at 50 g to purify the hepatocyte population
further. The live cell pellet was resuspended in 5 ml cold plating medium and the
cell yield and viability was calculated.
2.1.3.3 Assessment of yield and viability
Cell viability was assessed using a trypan blue exclusion assay (Hay, 1992). Cells
with damaged membranes take up trypan blue and can be differentiated by light
microscopy from live cells that are unstained.
Cell yield and viability were calculated by adding an aliquot of the cell suspension
(20 pi) to 50 pi trypan blue and 30 pi phosphate buffered saline (PBS). A drop of
this mixture was added to each side of a coverslipped Neubauer haemocytometer
(chamber depth 0.1 cm). The number of live and dead (blue) cells in five 1mm
squares on each side of the haemocytometer was counted and the average taken.
Cell Yield (xl04/ml) = cell number in 5 squares x dilution factor (5)
% Viability = number of live cells/total count x 100
Only isolated cells with greater than 90% viability were used in these studies.
2.2 Cell Culture
Hepatocytes isolated by the collagenase perfusion technique were plated onto
collagen-coated 8-well glass slides and 6-well culture plates in Dulbecco's Modified
Eagle's Medium/Nutrient Mixture F12 Ham (DMEM F12) containing 2% FCS at a
density of 0.3 - 0.4 x 105 cells per cm2. FCS was added to help cell attachment.
Slides were agitated to evenly distribute the cells. After 24 h, cells were washed
twice with PBS and the media was replaced with serum-free Chee's modified
medium. Cultures were incubated at 37°C in a humid atmosphere containing 5%
65
CCVair. The media was kept less than 2mm deep to maintain optimum oxygen
tension and was replaced every 48 h.
2.2.1 Administration of IFNy
Hepatocytes cultured on 6-well plates or 8-well slides were given IFNy (lOOU/ml) in
Chee's medium for 1-4 days. This concentration of IFNy was chosen, as this is the
lowest dose that induces maximum apoptosis based on dose response studies carried
out in the laboratory (Christian McCullough, personal communication) and studies
published in the literature (Kano et al., 1997; Kano et al., 1999; Morita et al., 1995).
Controls were set up without IFNy. Each condition was carried out in 5 wells and
the experiment was repeated 3 times. Values are given as mean ± SD.
2.3 Flow Cytometry
2.3.1 Analysis of nuclear DNA content using the Vindelov technique
The Vindelov technique is a robust and reliable method of measuring DNA content
of isolated nuclei rather than intact cells; distinguishing mononuclear or binuclear
cells is therefore not possible (Vindelov et al., 1983a, b and c). The nuclei from
FNA samples (100 pi) taken from PB-treated mice (section 2.1.2) were prepared and
the DNA was stained with propidium iodide (PI) by first adding a typsin solution
(solution A, 450 pi) for 10 min at room temperature to digest the outer cell
membrane. A solution containing trypsin inhibitor and RNase A (solution B, 325 pi)
was then added for a further 10 min to prevent excess digestion and to degrade the
RNA; samples were mixed by inversion. To stain the DNA, a solution containing PI
and spermine tetrahydrachloride (solution C, 250 pi) was added for 10 min at 4°C.
Details of all the solutions are in appendix 2. Samples were analysed by flow
cytometry (section 2.3.5).
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2.3.2 PI staining of whole cells
Another method of analysing DNA content is to stain whole cells rather than nuclei
by staining fixed hepatocytes with PI. Fixing permeates the cell membrane allowing
PI to enter and bind to DNA. This technique provides a measure of the DNA content
of both mononuclear and binuclear cells and therefore, distinguishing these two cell
populations is not possible. To analyse the effects of IFNy on hepatocyte ploidy in
vitro, hepatocytes were removed from culture plates before treatment and after 4
days treatment by incubating cells at 37°C for 10-20 min in a trypsin (0.12%)/ EDTA
(0.02%) solution and removing the rest of the cells with a cell scraper. Freshly
isolated hepatocytes were included as controls and cells were fixed in cold 70%
ethanol overnight at 4°C and stained with PI (20pg/ml), RNase (0.2mg/ml) and triton
X-100 (0.1%) in PBS for 15 min at 37°C. Flow cytometric analysis was carried out
as in Section 2.3.5.
2.3.3 Analysis of proliferation in different ploidy classes
To determine if all nuclei undergo proliferation in response to PB, nuclei were
double-labelled with PI and FITC-labelled anti-BrdU antibody using the following
method: Fine needle aspirates were centrifuged at 300 g for 5 min and the
supernatant was removed. Absolute ethanol was added for 20 min and samples were
centrifuged, as before. The samples were washed twice with PBS. Pepsin (0.2
mg/ml in 2N Hydrochloric acid) was added for 20 min and samples were washed
twice with PBS and centrifuged at 1000 g for 10 min. Samples were transferred to a
round-bottomed 96 well plate, washed in PBS and spun at 1200 g for 10 min. Rat
monoclonal anti-BrdU antibody (diluted 1:100 in PBS, 0.5% Tween 20 and 0.5%
normal rabbit serum [NRS]) was added and the sample incubated overnight at 4°C.
Samples were washed twice as above and resuspended in FITC-labelled rabbit anti-
rat antibody (diluted 1 in 100 with PBS, Tween 20 and NRS) for 30 min at room
temperature. After a further two washes with PBS, PI (100 pg/ml) and RNase
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(0.04%) were added to samples on ice for 15 min and analysed by flow cytometry
(Section 2.3.5)
2.3.4 Receptor expression
The expression of ICAM-1 and IFNyR on the surface of cells of different ploidy was
studied using a double-labelling technique: Isolated hepatocytes were stained with
an FITC-conjugated, hamster a-mouse CD54 (ICAM-1) antibody diluted 1 in 10 in
PBS with 0.1% sodium azide and 1% BSA for 1 h at 4°C. Ten-fold dilutions of the
antibody were used to determine which dilution gave the optimum staining. The
addition of sodium azide prevented the internalisation of surface receptors. Isotype
controls were included in the analysis (FITC hamster a-IgG, group 1). IFNyR
expression was determined using an indirect method. Isolated hepatocytes were
stained with purified rat a-mouse CD119 (IFNyR a chain, 0.5 mg/ml) or rabbit a-
mouse IFNyR p chain (200 pg/ml) after blocking with appropriate serum in PBS
containing 0.1% sodium azide and 1 % BSA for 10 min. Cells were incubated for 1
h at 4°C. Isotype controls were also included (purified rat IgG2a, k and normal
rabbit IgG). Undiluted FITC conjugated secondary antibodies (FITC-a rat IgG2a
and FITC-a rabbit IgG) were incubated with cells for 30 min at 4°C. To determine
the DNA content, cells were fixed in 70% ethanol and stained with PI, RNase and
Triton X-100, as in section 2.3.2. Receptor expression and DNA content was
measured by flow cytometry using a BD FACS Calibur (Becton Dickinson, Oxford,
UK). PI and FITC were detected as in section 2.3.5. A minimum of 5000 cells was
counted and each experiment was carried out in triplicate. The data was normalised
by making the intensity of fluorescence of 2n cells equal to 1 and calculating the
intensity for 4n and 8n cells accordingly. Values of fluorescence intensity for 2n, 4n
and 8n cells were plotted against average cell volume determined by confocal image
analysis.
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2.3.5 Flow cytometry of DNA content and proliferation
DNA content and proliferation were evaluated using a COULTER®EPICS@XL Flow
Cytometer (Beckman-Coulter Electronics, Luton, UK). PI and FITC were both
excited at 488nm; the red fluorescence emitted by PI was detected at 620nm and the
green fluorescence emitted by FITC was detected at 525nm. Doublet gating was
included to ensure only single events were counted. A minimum of 10,000 nuclei
was counted to determine nuclear ploidy and BrdU profiles. For whole cells, a
minimum of 5000 cells was counted. Mononuclear and binuclear cells with the same
DNA content fell within the same gate and were not distinguished in this study.
Since PI binds to DNA stochiometrically, the integral red fluorescence recorded by
the flow cytometer for each nucleus or cell is proportional to DNA content.
Therefore, histograms of FL3 (red fluorescence) are histograms of DNA content.
The proportions of 2n, 4n or 8n nuclei or cells were determined by placing gates over
the main area of each peak. Gates were set on the first sample analysed and were not
changed thereafter.
2.4 Separation of Hepatocytes Based on Size and DNA
content
2.4.1 Separation based on cell size using Percoll gradients
Percoll was diluted in PBS containing 11% HBSS to 90, 80, 30 and 20% Percoll
solutions. The gradients were made in 15 ml polystyrene centrifuge tubes by first
layering 1 ml 90% Percoll followed by 3 ml 80%, 4 ml 30% and 5 ml 20%Percoll
from below upwards, respectively. Hepatocytes (~5 x 106 cells/ml) suspended in
PBS were loaded onto the top of the gradients and the tubes were centrifuged at 300
g for 10 min at 4°C. Cell fractions in discrete bands were isolated by pipetting and
fixed in 70% ethanol, stained with PI and analysed by flow cytometry as in section
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2.3.5. Aliquots of each fraction were taken for cytospins to determine the nuclearity
of cells, see section 2.4.2.2.
2.4.2 Sorting of cells based on DNA content
The bis-benzimidazole dye, Hoechst 33342 is a DNA-specific vital cell stain that can
be used to separate live cells based on their DNA content. The staining of cells
varies dramatically with cell-type, temperature, dye concentration and incubation
time. At the time this study was carried out, there was no literature regarding the
sorting of live mouse hepatocytes using Hoechst 33342. Therefore, the technique
was adapted from methods used to sort other cell types (Arndt-Jovin and Jovin,
1977; Davies et al., 1990; Visser,1980). Cells were obtained by a retrograde
perfusion technique (section 2.1.3). Isolated cells were placed in DMEM F12 at a
concentration of <1 x 106 cells/ml. Hoechst 33342 (10 pg/ml) was added for 30 min
at 37°C, in the dark. Cells were centrifuged at 50 g for 5 min and 4/5 supernatant
was removed to bring the cell concentration to 5 x 106 cells/ml. To reduce clumping,
DNase type 1 (0.1 mg/ml) was added and left for 45 min at room temperature. Cells
were filtered through a 40 pm filter to remove larger clumps and reduce the size of
cells going through the 100 pm nozzle. Cells larger than 40 pm disturb the stream
through the nozzle and affect the purity of the sort. Filtering did not remove any of
the cell populations of interest. PI (2 pg/ml) was added to help discriminate between
live and dead cells.
Hepatocytes were sorted on a BD FACS Vantage (Becton Dickinson) using a dual
laser set up. Calibration and alignment of the FACS was carried out by Catherine
Simpson (Edinburgh MRC, Centre for Inflammation Research). Hoechst
fluorescence was analysed using an Enterprise II Coherent laser (Coherent Inc, CA).
The laser power was regulated at 60 mW on the UV line. The cells were sorted
using a lOOum nozzle at 9PSI at a rate of approximately 2000 event/s. PI
fluorescence was collected on the 488 nm line using a 576/26 nm BP filter while
Hoechst 33342 emission was collected using a 424/44 nm filter. Cells were gated on
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a FSC/SSC bivariate dot plot and dead PI positive cells were removed by subsequent
gating. Doublets were removed using pulse processing on the Hoechst signal and the
DNA profiles were displayed on a linear histogram using Hoechst area. Sort gates
representing 2n, 4n and 8n were applied and sorted using a 2-drop envelope in sort
mode Normal R. Collection tubes were lined with FCS and cells were kept on ice
after sorting.
2.4.2.1 Determination of sample purity
The purity of each sort was confirmed by fixing an aliquot of cells in 70% ethanol
overnight at 4°C and staining with PI (20pg/ml), RNase (0.2 mg/ml) and triton X-
100 (0.1%) in PBS for 15 min at 37°C. Cells were analysed by flow cytometry as in
section 2.3.5.
2.4.2.2 Proportion of mononuclear and binuclear cells in sorted populations
The proportion ofmononuclear and binuclear cells within each sorted population was
determined by making cytospins of 1 x 103 cells per sample. Slides were fixed in
Bourn's fixative, stained with Schiff s reagent and light green, as in section 2.7.
2.4.2.3 Cell growth and survival of sorted populations
The number of sorted hepatocytes available for plating was low, as the majority of
cells were required for gene expression analysis. However, two initial experiments
were carried out to determine if sorting affected hepatocyte growth and survival.
After sorting, cells were washed twice in sterile PBS to remove the Hoechst 33342.
To assess the growth potential of cells, hepatocytes were first plated on collagen
coated 8-well slides at a density of 0.3 - 0.4 x 105 per cm2 in DMEM F12 containing
2% serum (section 2.2). After the cells had adhered, the medium was replaced with
Chee's medium and left for 24 or 48 h. Hepatocytes were given BrdU and
immunohistochemistry was carried as in section 2.6. On the second occasion, cell
growth was examined using time-lapse videomicroscopy.
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2.4.2.3.1 Time-lapse videomicroscopy
Sorted cells were plated onto small tissue culture flaskettes (10cm2) at the same
density as above. BrdU experiments revealed that proliferation occurred in the 2n
population between 24 and 48 h. Therefore, to study cells that were actively
dividing, cultures were incubated for 24 h prior to the experiment. Cultures were
then gassed with 5% C02/Air prior to their insertion onto the videomicroscope
moveable platform (Leica DM IRBE; Leica Microsystems, Cambridge, UK). The
cultures were maintained at 37°C throughout the analysis. Using the lOx objective,
digital images were taken from 6 fields on each flaskette every 30 min for a further
24 h with the videomicroscope and associated software (QUIPS, Leica). Video
analysis of the resultant succession of TIFF files (Microsoft) was carried out using
Adobe Premiere and was saved as a QuickTime movie.
2.5 Histological Assessment of PB-Treated Samples
Sections (4pm) of liver from PB-treated samples were stained with haematoxylin and
eosin and examined to detect any histopathological abnormalities. The number of
cells was calculated, counting the total number of hepatocytes and non-parenchymal
cells in 10 high power fields (0.5mm2 per field). The number of hepatocytes was
then multiplied by the liver weight to obtain the total number of hepatocytes for each
liver (expressed in arbitrary units = hepatocytes per 5mm2 x liver weight/mouse
weight).
2.6 BrdU Immunohistochemistry
Hepatocytes cultured on 8-well slides were given BrdU (1 pl/ml) for 3 h prior to
fixation in 80% ethanol. Slides were incubated in 5M hydrochloric acid (HC1) for 45
min at room temperature. Rat a-BrdU diluted 1 in 100 in blocking solution (PBS,
NRS (20%), Tween 20 (0.05%)) was added for 1 h. Negative controls omitted this
antibody. Peroxidase-conjugated rabbit a-rat, pre-absorbed with normal mouse
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serum (50%) and diluted 1 in 100 in blocking solution, was added for 30 min.
Positive cells were visualised using DAB chromagen. Cells were counterstained
with haematoxylin and light green. The results are expressed as the percentage of
BrdU positive cells. A minimum of 500 cells was counted.
2.7 Analysis of Apoptosis by Feulgen Staining
Apoptotic cells can be distinguished from necrotic cells by their distinct morphology
(Bellamy et al., 1997). To determine the amount of apoptosis at each time-point,
slides were fixed in Bourn's fixative overnight at 4°C and stained according to
Feulgen technique (Stevens and Bancroft, 1982) with the following modification:
Slides were denatured with 5M HC1 for 45 min at room temperature before being
stained in Schiff s reagent (diluted 1:3 with water) for lh and counterstained in light
green (0.1%). Schiff s reagent stains DNA a red-purple colour. A minimum of 500
cells was counted and the results were expressed as the percentage of apoptosis.
2.8 Confocal Microscopy
2.8.1 Confocal imaging to measure cell volume
Isolated hepatocytes were plated on collagen-coated glass coverslips (in 6-well
plates) in Chees's medium containing 2% FCS for Vi h at 37°C. To distinguish
nuclei and cytoplasm, hepatocytes were stained with the nucleic acid stain, SYTO 16
(5 pM) and protein-binding stain CellTracker Orange (CTO; 5 pM) in fresh media
for Zi h at 37°C. Glass coverslips were transferred to small petri dishes and covered
in fresh media for confocal imaging. Confocal microscopy and calibration of the
system for volume determination was carried out as previously described (Bush and
Hall, 2001). Confocal images were acquired with the Leica TCS NT confocal
system (Leica Microsystems, Heidelberg GmbH, Germany). Linda Sharp (Dept. of
Biomedical Sciences, University of Edinburgh) provided the necessary technical
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assistance. A x63 water immersion lens, fitted to the upright Leica DMRE
microscope was used to collect quantitative fluorescent images of hepatocytes in
optical Z-steps of ~lpm. SYTO 16 was excited at 488 nm and CTO at 568nm. A
minimum of 300 measurements was taken for nuclear diameter analysis and 70
measurements for cell volume analysis. Measurements were taken from 3 different
mice. For the calibration of diameter, images of Fluoresbrite Microspheres (Mean 10
pm ±0.1) were taken using the same procedure.
2.8.2 Measurement of nuclear diameter and cell volume
Image analysis was performed on a Silicon Graphics 02 workstation (Silicon
Graphics Inc., Mountain View, CA) running Bitplane (Bitplane Inc., Zurich,
Switzerland), Imaris and VoxelShopPro Software. Volume measurements were
carried out as previously described using an intensity threshold technique (Bush and
Hall, 2001). The study utilised Calcein AM as the cytoplasmic fluorosphere. Due to
the similar spectral response of Syto 16 to Calcein AM, our study utilised the red
shifted dye, CTO. To check the validity of CTO, hepatocytes were co-loaded with
CTO and Calcein AM and volume analysis was performed. Cell volumes obtained
were consistent (r2 = 0.78, p<0.05). However, CTO derived volumes were an order
ofmagnitude smaller (xl.7 ± 0.25). Hence, volume measurements were amended to
account for this. Nuclear diameter was measured using the same confocal images
and software. Measurements were taken at the central plane of each image. Using
this technique, the diameter of the 10 pm beads was 9.41 pm ± 0.65. Therefore,




Sorted cells with the same DNA content were pooled together to obtain larger
quantities of RNA that were required for microarray analysis. These sorted samples
and cells isolated from whole liver (from young and old mice) were washed twice in
sterile PBS and resuspended in RNA extraction buffer (600 pi). Samples were stored
at -70°C until required. Total RNA was extracted using a standard
phenol/chloroform extraction protocol. Sodium acetate (2M, 60 pi), phenol (300 pi)
and chloroform (300 pi) were added to each sample, vortexed and left on ice for 15
min. Protein and other contaminants were removed by micro-centrifugation at
13,000 g for 15 min at 4°C. The aqueous phase (top layer) was transferred to fresh
eppendorf tubes and an equal volume of 100% ethanol and glycogen (1 pi) was
added to precipitate the RNA. The samples were left at -70°C overnight and the
RNA was pelleted by centrifugation at 13,000 g for 10 min. The pellet was washed
twice in ethanol and left to air-dry for 15 min at room temperature. RNA was then
resuspended in 30 pi DEPC-treated water and DNase-treated with DNA-free,
according to the manufacturers instructions. The RNA was re-precipitated to
increase the concentration of RNA by adding 100% ethanol (2 v), 2M Sodium
acetate (0.1 v) and glycogen (1 pi) and precipitating as above. RNA was then
resuspended in 10 pi TE buffer (pH 7.5). The quantity ofRNA was determined by
the absorbance reading at 260 nm on a spectrophotometer (Amersham Pharmacia
Biotech). The quality of RNA was determined by electrophoresis on a 1% (w/v)
agarose gel in TBE buffer. The gel was stained with ethidium bromide and the
ribosomal bands were visualised under ultra violet light.
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2.9.2 Microarray
2.9.2.1 Spotting of arrays and preparation of cDNA probes labelled with 33P.
cDNA clones from the Incyte mouse GEM™1 set (Incyte Genomics Ltd.,
Cambridge, UK) were spotted onto nylon membranes at AstraZeneca, Alderley
Edge, UK. The GEM™1 set contains known mouse genes from The Institute for
Genomic Research Mus.ET database as well as ESTs from GenBank's mouse
database. The arrays consist of 8734 genes and each one was spotted in duplicate.
Clones contained partial sequences of around 500 bp on average. Sequence
verification by AstraZeneca found approximately 96% of sequences were of a good
quality. I carried out all microarray and real-time PCR in the Safety Assessment
Dept., AstraZeneca, Alderley Edge in collaboration with Dr Jonathan Tugwood.
Probes were prepared from total RNA (15pg where possible) extracted from 2n, 4n
and 8n sorted cells and from RNA extracted from whole livers (young and old mice).
Details of all sorted and pooled samples are given in Appendix 3. Total RNA was
added to lpl of oligo (dT) primer (0.5pg/pl), the volume was made up to 9.5pl with
DEPC-treated water and incubated at 70°C for 10 min then placed on ice. A reaction
mixture consisting of first strand buffer, DTT (0.1M), 0.5pl dNTP mix (20mM
dATP, dGTP, dTTP and 200pM dCTP) and 3pl alpha 33P dCTP was added and
incubated at 42°C for 5 min. Superscript II (200U) was added in a total volume of
20pl and incubated at 42°C for 2 h. Heating at 70°C for 15 min terminated the
reaction. RNase H was added and incubated at 37°C for 20 min to degrade template
RNA. The solution was made up to a final volume of 50pl with TE buffer and the
unincorporated nucleotides were removed using ProbeQuant G-50 Micro columns.




The arrays were incubated in Church and Gilbert hybridisation buffer for 2 h at 62°C.
Mouse COT1 DNA (75pl) (suppresses the hybridisation of rodent repetitive DNA
sequences) and the required amount of probe (6 x 106 or 1 x 107 cpm) were mixed
and boiled at 100°C for 5 min, then placed on ice. The COT1 DNA and probe were
added to 10 ml buffer and incubated with the array in a Techne bottle at 62°C for 18
h. Following hybridisation, the membranes were rinsed in wash buffer and washed
twice for 30 min at 62°C.
2.9.2.3 Visualisation and analysis of arrays
The arrays were placed on Super resolution (type SR) Phosphor screens for 24 to 48
h in the dark and exposed to a phosphoimager using OptiQuant software. Analysis
of each spot was carried out using ArrayVision software. The change in gene
expression was calculated as intensityt,/intensitya, where b was the sample of higher
ploidy and a was the sample of lower ploidy e.g. 4n and 8n samples (b) were
compared with 2n samples (a). The actual comparisons and samples that were
studied are detailed in Appendix 4. Spots were only included if the intensity was
greater than the intensity of the background, calculated from the immediate area
surrounding the spots and if the variability between duplicates was less than ± log
(0.2) (allowing for the mean variability of duplicates across the whole array). Using
custom written macros in Microsoft Excel, the data was sorted and the clones that
were induced and repressed more or less than 2-fold were checked on the actual
arrays. Three clones; 1) major urinary protein 2 (MUP2), 2) the EST similar to
human Pterin 4a-carbinolamine dehydratase (PCD) and 3) IFNyR, were chosen for
further analysis on the basis that they met the above criteria and appeared on several
different comparisons.
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2.9.3 Qualitative and quantitative PCR
2.9.3.1 Primer design and reverse-transcription PCR
Primers were designed from cDNA sequences and included those of the 3 clones that
were chosen from the microarray analysis, Pten, a gene involved in regulation of cell
size (Huang et al., 1999) and housekeeping genes, G3PDH and (3-actin. P-Actin
primers (kindly donated by Claire Duggan and Shirley O'Dea, amplicon size -100
and 400 bp) were used to assess the quality ofRNA obtained from cells stained with
various fluorescent dyes and cells that had been sorted. All other primer sets were
used for quantitative PCR and were first assessed by reverse-transcription PCR to
determine if the PCR product was the correct size and to check for primer dimers.
Template cDNA was synthesised using lpg of RNA (from whole mouse liver),
RNASEOUT inhibitor (1 pi) Superscript II and Oligo dT primer, according to the
manufacturers instructions. Controls for real-time PCR excluded the Superscript II
enzyme. RNase H (1 pi) was added at 37°C for 20 min to the samples used for real¬
time PCR to degrade template RNA. The primers used in this study are shown in
Table 4. A typical 50 pi PCR reaction for qualitative PCR contained 1 pM of each
primer, 2 pi cDNA, 100 pM dNTPs, 0.1% (w/v) BSA, 0.25 units of Taq polymerase
and 1.5 mM MgC^. The following protocol was used for all reactions: 95°C for 5
min; 35 cycles at 95°C for 3 min, 60°C for 1 min, 72°C for 1.5 min.
The products of the P-actin PCR were analysed by electrophoresis using a 1% (w/v)
agarose gel that separates products between 500 and 10000 bp. Other products were
analysed using a 2% (w/v) agarose gel that enabled the separation of 50 - 2000 bp
products. Gels were stained and visualised as in section 2.9.1.
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Table 4. Primer sequences used for PCR
Primer 5' sequence (5' to 3') 3' sequence (5' to 3') Amplicon
Size (bp)
MUP CAAGAAAGACATGGTCCTGACA AAAGTTCCTTCCCGTAGAACT 131
GA AGCTT
PCD CAGCTGCTTGCAAACCTGAGGG GAAAGACCGGCACATTCATG 216
GG
Pten TTGTGGTCTGCCAGCTAAAGG GATATCACCACACACAGGCA 115
ATG
IFNyR TCGGATCCAACCTGTGAGTTT TACCATAGACTTACGGCTGGC 207





To confirm the changes in gene expression seen in the microarray analysis,
quantitative real-time PCR was carried out using the LightCycler™ on sorted
samples and samples from young and old mice. Standards, made from a pool of all
cDNAs being tested, were serially diluted as in Table 5. Each 20 pi reaction was set
up in glass capillary tubes according to manufacturers instructions and contained 0.5
pmol/pl of each primer, 1 pi cDNA (diluted 1 in 20, 1 in 40 or 1 in 100), 13.4 pi
H2O, 1.6 pi MgCh and 2 pi SYBR green (containing Taq DNA polymerase, reaction
buffer, 10 mM MgCl2, dNTP mix with dUTP instead of dTTP and SYBR green I
dye). The program consisted of four stages: 1) Denaturation at 95°C for 2 min; 2)
amplification and quantification; 3) determination of the melt curve where capillaries
were raised to 95°C, then cooled to 65°C for 10 s at a transition rate of 20°C/s. The
melt curve was then generated by increasing the temperature to 95°C at a
temperature transition rate of 0.2°C/s, measuring fluorescence continuously; 4) the
chamber was cooled to 40°C for 1 min. The optimal amplification and quantification
conditions used for each primer set are given in Table 5.
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Table 5. Optimum conditions for real-time PCR
Primers Annealing Time for Standard Sample Fluorescence
Temp.(°C) Elongation1 Dilutions Dilutions Measurement
for 4 s (s) at 72°C Temp.fC)
MUP 63 7 1:50-1:1600 1:100 82
PCD 65 11 1:50-1:1600 1:100 83
Pten 60 7 1:10-1:320 1:40 80
G3PDH 62 20 1:50-1:1600 1:100 88
Time for elongation step (s) = (size of the product (bps) / 25) + 2-3s.
The measurements of fluorescence were taken at a temperature just below the
melting temperature of each product to ensure specificity. The Real Time
Fluorometer (RTF) was used to set the FL1 gains between 10 and 20 on the most
concentrated standard. Where possible, triplicate samples were analysed and the
experiment was repeated twice.
2.10 Statistics
The majority of the statistical analysis was carried out using GraphPad InStat
Software. Linear regression analysis was carried out using Microsoft Excel
Software. For all tests a p value less than 0.05 was considered significant.
The following comparisons were done using a 1-way ANOVA:
1) PB-treated samples were compared to relevant controls,
2) The proportion of 2n and 8n cells within each ploidy population after
plating, at time 0, after 5 days in culture (Control) and after treatment
with IFNy. Tetraploid cells were compared using a Kruskal-Wallis test as
the difference in SDs between each group varied significantly,
3) The amount ofRNA extracted from 2n, 4n and 8n sorted samples.
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The purity of sorted cells was compared before and after the addition ofDNase I and
PI using a Kruskal-Wallis test. The induction of apoptosis by IFNy and the effect of
IFNy on the incorporation ofBrdU were compared using a Mann-Whitney U test.
The nuclear diameter of the 2n and 4n populations and the volume of the 2n, 2x2n,
4n and 2x4n cells were compared using an unpaired t-test with a Welch correction
for volume. A paired t-test was also used to compare the size of nuclei from the
same cell.
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3 Phenobarbitone-induced polyploidisation occurs
independently of p53
3.1 Objectives
The carcinogenic potential of drugs is of paramount importance in the field of
toxicology. In order to assess drugs quickly, it is necessary to develop transgenic
animal models which can act as short-term carcinogenicity bioassays and can detect
both non-genotoxic and genotoxic drugs (Blain et ah, 1998). The p53 tumour
suppressor gene that is involved in cell cycle arrest, apoptosis, differentiation and
repair (Prives and Hall, 1999) has been found to be mutated in 50% of human
tumours (Greenblatt et ah, 1994). Transgenic models lacking or containing
mutations within this gene are expected to develop tumours more rapidly than wild-
type strains (p53 +/+) (Harvey et ah, 1993). The p53 homozygous (-/-) mice are not
suitable for such studies as they die early in life (Armstrong et ah, 1995) and have a
high incidence of spontaneous tumours within 3-6 month of age (Donehower et ah,
1992). p53 heterozygous (+/-) mice have a much lower incidence of tumours up
until 9 months of age (Donehower, 1996). The p53 +/- mouse model has been found
to be useful in the identification of genotoxic carcinogens (Blain et ah, 1998) but at
present, there is no evidence to suggest that it can identify non-genotoxic carcinogens
such as Sodium phenobarbitone (PB).
Chronic or long-term administration of PB is associated with the development of
hepatocarcinogenesis (Lin et ah, 1989; Manjeshwar et ah, 1994). Of particular
interest to this PhD is the effect of short-term administration of PB on liver ploidy.
Administration of PB for 10 days to mice was found to increase the level ofploidy in
the liver with no affect on the proportion of mononuclear, binuclear or polynuclear
cells (Bohm and Noltemeyer, 1981). Other effects associated with acute
administration of this drug include increases in liver weight, RNA and protein
synthesis, cytochrome P450 enzymes, increased cell proliferation and a decrease in
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the rate of apoptosis (Bohm and Noltemeyer, 1981; Carthew et al., 1998; Lin et al.,
1989; Maier and Schawalder, 1993; Wojcik et al., 1988).
One study showed that PB delays and attenuates the G1 checkpoint response in a
p53-dependent manner (Gonzales et al., 1998). There is also evidence that p53 could
play a role in the control and mechanism of ploidy, although conflicting evidence
exists (Bellamy et al., 1997; Yin et al., 1998). Several studies have shown that
mutations in p53 can result in the formation of polyploid cells after the disruption of
the mitotic spindle (Ciciarello et al., 2001; Gualberto et al., 1998; Minn et al., 1996;
Notterman et al., 1998). Induction of polyploidy in fibroblasts from Li-Fraumeni
syndrome which contain a congenital mutation in one p53 allele, can lead to
aneuploidy through genetic instability and increases the risk of carcinogenesis
(Bischoff et al., 1990; Gualberto et al., 1998; Shackney et al., 1989). The possibility
that polyploidisation induced by PB could be affected by p53 genotype has not
previously been studied. Therefore, the aim of this part of the study was to
determine if p53 was involved in the polyploidisation and proliferation of
hepatocytes induced by PB. This study utilised C57BL/6 p53 +/+, p53 +/- and p53 -
/- male mice and DNA content was measured using flow cytometry. For materials
and methods see chapter 2.
3.2 Results
3.2.1 PB caused an increase in liver weight and liver cell number
PB administration for 21 days resulted in a 39-60% increase in liver weight
expressed as liver/body weight ratio compared to controls (Table 6: p<0.05); no
differences were identified relating to p53 genotype. The number of hepatocytes per
liver also showed a modest increase after PB administration in p53 +/+ and -/- mice
(16% and 21% increase respectively) but not in the p53 +/- group compared to
controls (p<0.05). The proportion of non-parenchymal cells was the same in PB-
treated and control mice for each genotype (Table 6). No histological abnormalities
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were identified in any group and in particular no carcinomas were seen; there was no
evidence of hepatocyte apoptosis.
Table 6. Effect of phenobarbitone on liver weight and cell number
Group +/+ +/- -/-
PB Con PB Con PB Con
Liver 0.078* 0.050 0.075* 0.047 0.077* 0.055
Weight ±0.008 ±0.002 ±0.003 ±0.004 ±0.004 ±0.002
Total Cell 2244* 1940 2034 1848 2315* 1919
No. ±87 ±187 ±300 ±89 ±134 ±166
%NPC 32.78 29.16 33.23 33.42 31.68 28.91
±2.38 ±3.34 ±2.21 ±3.08 ±2.33 ±2.11
Liver weight is expressed per gram of total mouse weight; total cell number is the
total number of hepatocytes per liver (cells per 5mm2 x liver weight); %NPC is the
ratio of non-parenchymal cells to hepatocytes. * Represents a significant increase in
PB-treated v. control mice (p<0.05).
3.2.2 PB caused liver polyploidisation
Administration of PB for 21 days resulted in a striking increase (250-400%) in the
proportion of 8n nuclei compared with control mice (Figure 6), with no differences
noted comparing the three p53 genotypes (Figure 6, p<0.001). A small but
significant reduction in 2n cells was also noted in p53 +/+ and -/- genotypes
(p<0.001). No changes were identified in the 4n population.
3.2.3 PB increased hepatocyte proliferation
All untreated control samples showed similar baseline levels of BrdU positivity with
no differences between p53 genotypes so the controls were combined. The
proportion of BrdU positive nuclei was increased in all 3 genotypes after PB
treatment (Figure 7; p<0.001) with p53 +/+ and -/- mice also showing higher levels
ofBrdU positivity than p53 +/- mice. Separating BrdU positivity according to ploidy



















Figure 6. The effect of PB on ploidy. A. Flow cytometry histograms showing (1)
side scatter (ss log, granularity) vs. forward scatter (fs log, size) and (2) numbers of
events (count, nuclei) vs. ploidy (FL3 (DNA), PI uptake) for control (con) and PB-
treated (pb) mice. Arrows indicate 2n, 4n and 8n nuclei. B. Proportion of diploid,
tetraploid and octoploid nuclei after 21 days administration of PB. Comparison of
proportion of nuclei in each ploidy class in control (con) and PB-treated (pb) groups
of p53 +/+, +/- and -/- mice. * Indicates a significant decrease in cell number in PB-
treated mice compared with controls (p<0.001) ** Indicates a significant increase in
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Figure 7. Brdll positivity after 21 days administration of PB. A. Comparison of
controls with PB-treated p53 +/+, +/- and -/- mice for the total population of nuclei.
Proportion of BrdU positive nuclei in B. 2n, C. 4n and D. 8n ploidy classes. *
Indicates an increase compared with controls (p<0.01); # indicates an increase
compared with p53 +/- mice.
3.3 Discussion
3.3.1 PB induces hepatocyte polyploidisation independently of p53
The results of this study demonstrate that PB induces a large increase in 8n nuclei
with no change in 4n and a slight decrease in 2n nuclei by 21 days. This increase in
ploidy is not affected by p53. Bohm and Noltemeyer, 1981, found that PB caused an
increase in 4n and 8n nuclei with a concomitant reduction in 2n nuclei after 10 days
treatment. The reason for the difference between these two studies is not clear but
could be related to the different strains of mice studied or the length of time of
administration of PB. Age-related polyploidisation varies between strains of mice
(Severin et al., 1984) and it could be possible that the degree of polyploidisation in
response to PB is strain-dependent.
Some chemicals have been found to increase ploidy predominantly in mononuclear,
binuclear cells or both (Melchiorri et al., 1993; Scampini et al., 1993). An increase
in 8n mononuclear cells has been described following the administration of the non-
carcinogenic hepatic mitogen 1,4-dichlorobenzene (Hasmall and Roberts, 1997) and
the peroxisome proliferators WY-14 643 and methylclofenapate (Miller et al., 1996).
Although this study has examined 8n nuclei and not cells, immunostaining of BrdU
in sections from the same cases as this study showed positivity in both mononuclear
and binuclear cells (Orton et al., 1999) indicating that both mononuclear and
binuclear cells respond to PB.
3.3.1.1 p53 and polyploidisation
There is conflicting evidence regarding the role of p53 in polyploidisation. Bellamy
et al., 1997, demonstrated that p53 deficiency in the normal liver did not affect
progression from diploidy to polyploidy with age. Similarly, Gould et al., 2001,
found that in p53 +/+, +/- and -/-mice, the changes in the levels ofEGFR, M6PB and
TGFpi in response to PB were the same in all mice and suggested that p53 did not
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play a role in early phenobarbitone-induced effects. However, Yin et al., 1998,
found that normal polyploidisation associated with age did not occur in p53+/- and -
/- mice. The study by Bellamy et al., 1997, did suggest that abnormal ploidy may
occur in p53 null livers after DNA damage induced by y-irradiation, due to the loss
of Gi and G2 checkpoints. Furthermore, mutations in p53 have been shown to be
involved in polyploidisation after administration of spindle depolarising agents by
overcoming checkpoint controls and allowing the re-replication of DNA following
an incomplete mitosis (Ciciarello et al., 2001; Gualberto et al., 1998; Minn et al.,
1996; Notterman et al., 1998). Therefore it remains a possiblity that p53 may be
involved in polyploidisation in response to DNA-damaging agents or other drugs that
directly affect the cell cycle but may not be involved in age-related polyploidisation
nor involved in ploidy induced by non-genotoxic drugs such as PB.
3.3.2 The induction of proliferation by PB may occur through a p53-
dependent pathway
PB induced an increase in cell number, liver weight and BrdU positivity compared
with controls, confirming PB is mitogenic. The increase in cell number and
proliferation in p53 +/+ and -/- mice and not p53 +/- mice, suggests that p53 may
play a role in the proliferative response to PB. The increase in cell number was not
due to increases in non-parenchymal cells, as PB did not alter the proportion of these
cells.
There was an increase in BrdU positivity in PB-treated mice in comparison with
untreated controls in the 8n population only. The fact that there was not an increase
in BrdU positivity in 2n and 4n nuclei after administration of PB for 21 days
indicates that the continuous exposure of cells to PB does not invoke a constant
proliferative response in all cells. If this had been the case, the BrdU positivity of 2n
and 4n nuclei would also have expected to increase. The increase of BrdU positivity
in the 8n population only, together with the increase in proportion of 8n nuclei and
slight decrease in 2n nuclei suggests that proliferation is accompanied by
polyploidisation with 2n nuclei becoming 8n nuclei by 21 days. Time lapse
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experiments in mouse hepatocytes have demonstrated that polyploidisation occurs in
2 stages: Firstly the mononuclear cells become binuclear cells through a process of
acytokinesis where the cells replicate their DNA, undergo mitosis but do not divide.
The second stage is the formation ofmononuclear polyploid cells which occur when
the nuclei of a binuclear enter mitosis simultaneously, form a common mitotic
spindle and then divide normally, producing two mononuclear cells of a higher
ploidy class (Nadal and Zajdela, 1966; Brodsky and Uryvaeva, 1985b). The fact that
BrdU positivity was evident in both mononuclear and binuclear cells (Orton et al.,
1999) suggests that the transition of 2n nuclei to 8n nuclei could occur through the
formation of intermediary binuclear cells.
3.3.3 The p53 +/- mouse is not a good model for the identification of
the non-genotoxic drug, PB
The study of drug-induced hepatocarcinogenesis is greatly benefited by the
development of transgenic animal models that rapidly develop tumours. The
oncosuppressor gene, p53 is mutated in approximately 50% of human tumours
(Greenblatt et ah, 1994) and p53 transgenic mice have been proposed to be useful
models in short-term carcinogenesis studies. Evidence from the literature suggests
that p53 is involved in polyploidisation in response to direct DNA damage (Bellamy
et ah, 1997) and damage to components of the cell cycle such as the mitotic spindle
(Ciciarello et ah, 2001; Gualberto et ah, 1998; Minn et ah, 1996; Notterman et ah,
1998). However, the results of this study indicate that p53 is not involved in the
induction of polyploidy by PB. There were also no apparent histological
abnormalities in the PB-treated group compared with controls, suggesting that the
p53 +/- mouse model will not be useful in short-term carcinogenesis studies with PB.
Further work may help determine if this model may be useful for longer-term studies
or to determine if this model may be useful in the identification of other non-
genotoxic drugs.
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4 Functional Analysis of Mouse Hepatocytes
Differing in DNA Content: Volume, Receptor
Expression and Effect of IFNy
4.1 Objectives
The reasons for and functions of polyploidy in the liver remain largely unknown but
several hypotheses exist (Chapter 1). The size and volume of polyploid cells is
proportional to DNA content (Danielsen et ah, 1986; Deschenes et ah, 1981;
Watanabe and Tanaka, 1982) and the possibility that increasing cell size may play a
role in the function of polyploid hepatocytes has not until now been explored.
Interestingly, alterations in cell volume in various cell types have been found to
participate in a wide variety of functions including cell proliferation and cell death
(Lang et ah, 1998) and cell size has been implicated in the regulation of the
transcription factor, DBP (Schmidt and Schibler, 1995). Therefore, there is a
possibility that the size of polyploid cells could modulate their function. One method
that increasing size could induce an effect on the cells is by altering the density of
surface receptors. To study this hypothesis, the first aim of this chapter was to
develop a method of accurately measuring the size of each ploidy population and
secondly of determining whether surface receptor expression increased in these cells.
Intercellular adhesion molecule-1 (ICAM-1) and Interferon gamma (IFNy) have
important inflammatory roles in the liver. ICAM-1 is a member of the
immunoglobulin supergene family and is expressed on hepatocytes after dissociation
of cell-to-cell contact (Ohno et ah, 1995) or after induction with pro-inflammatory
cytokines such as tumour necrosis factor-alpha (TNFa) and IFNy (Bumgardner et al.,
1998; Oudar et al., 1998). Expression of this adhesion molecule has been found to
be important in hepatitis and liver graft rejection (Bumgardner et al., 1998; Schroder
et al., 1995). Through the interaction with specific membrane receptors, IFNy
induces G1 cell cycle arrest and apoptosis in hepatocytes (Kano et al., 1997; Morita
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et al., 1995; Shinagawa et al., 1991) and is also thought to play a role in hepatitis in
humans and mice (Gilles et al., 1992; Peters et al., 1991). Therefore, any differential
expression of ICAM-1 or IFNyR on 2n and polyploid hepatocytes could be clinically
important.
There is some evidence that polyploid hepatocytes are more likely to undergo
apoptosis and that extensive polyploidy could lead to organ failure (Gupta et al.,
2000). To study this possibility, this chapter has also determined whether polyploid
hepatocytes are more likely to undergo apoptosis in response to IFNy. For materials
and methods see Chapter 2.
4.2 Results
4.2.1 Determination of ploidy and volume of hepatocytes using
confocal microscopy
Images obtained using confocal microscopy and Imaris imaging software allowed the
accurate determination of nuclear ploidy and absolute cell volume. Due to the
spherical shape of the nuclei and therefore, the consistent measurements of the
nuclei, nuclear diameter was found to be the most accurate determinant of ploidy.
The nuclear diameter of all nuclei measured was plotted as a frequency histogram
and the diameter of 2n ranged from 7.0 to 9.0 pm and 4n ranged from 9.5 to 11.5 pm
(Figure 8). The nuclei falling within each range were found to be significantly
different to each other (p<0.001). There was no significant difference in the nuclear
diameter of nuclei from the same cell. From the 300 nuclei analysed, only one 8n
nuclei was measured and therefore the accurate determination of the diameter of 8n
nuclei was not possible. The proportion of 2n and 4n nuclei plotted on the frequency
histogram was found to be similar to the proportion of these nuclei using flow
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Figure 8. Measurement of nuclear diameter of hepatocytes with different DNA
contents. A. Confocal images of hepatocytes stained with dyes SYTO 16 (nucleic
acid, green) and CTO (protein, orange). B. Frequency histogram of nuclear
diameter measured from confocal images and Imaris imaging software. Arrows
indicate the peaks corresponding to 2n and 4n nuclei.
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The measurement of nuclear ploidy by measurement of their diameter allowed the
subsequent determination of the volume of cells of different ploidy. The volume of 2
x 2n (7035 ± 2391 pm3) and 4n (7352 ± 1650 pm3) cells was 1.7-1.8 fold greater
than 2n cells (4154 ± 1137 pm3, p<0.001) and 2 x 4n cells (14326 ± 4453 pm3) was
1.9-2.0 fold greater than 2 x 2n and 4n cells (p<0.001). There was no significant
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Figure 9. Volume of hepatocytes measured from confocal images and Imaris
imaging software. *Significantly lower than 2 x 2n and 4n, p < 0.05. **Significantly
higher than 2 x 2n and 4n, p < 0.05. Values represent mean ± SD.
4.2.2 The fluorescence intensity of ICAM-1 (CD 54) but not IFNyR,
increases in relation to DNA content
Alterations in cell size could potentially affect the number of receptors on the cell
surface and in turn affect cell signalling and cell function. Two-parameter flow
cytometry was used to measure the expression of ICAM-1 or IFNyR and DNA
content of hepatocytes. Receptor expression was compared to the volume of
^3
hepatocytes with different DNA contents measured by confocal imaging.
Mononuclear and binuclear cells with the same DNA content cannot be distinguished
using flow cytometry. Therefore, the average volume ofmononuclear and binuclear
4n cells (2x2n and 4n) was used. The linear relationship between fluorescence
intensity of ICAM-1 and the average volume of 2n, 4n and 8n cells was highly
significant, demonstrating that expression of ICAM-1 increases in proportion to
volume and DNA content (r2 = 0.907, p < 0.0001) (Figure 10). The fluorescence
intensity of IFNyR was the same as the isotype controls indicating that IFNyR was
not detectable on these cells. Background fluorescence (isotype controls) was low
and increased with increasing DNA content. However, the ratio of fluorescence
intensity of ICAM-1 to background was equal for all cells and was therefore
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Figure 10. Plot of average volume measured by confocal imaging against
fluorescence intensity of ICAM-1 measured by flow cytometry for 2n, 4n and
8n hepatocytes. The values represent mean volume ± SD of 2n, 4n and 8n cells.
Graph show the line of best fit, r2 = 0.907, p < 0.0001.
4.2.3 IFNy induces apoptosis in all ploidy populations equally
To determine whether the cells that undergo IFNy-induced apoptosis are
predominantly diploid or polyploid, the cells that remain alive after treatment with
IFNy were studied using flow cytometry. Feulgen staining was used to determine the
amount of IFNy-induced apoptosis. The results from different experiments were not
combined due to differences in the baseline levels of apoptosis each time the
experiment was performed. Maximal apoptosis occurred 3-4 days after
administration of IFNy (Figure 11). Therefore, 4 days was chosen for ploidy
analysis. At this time-point, between 10 and 22% of hepatocytes had condensed,
fragmented chromatin and were visibly apoptotic (Figure 12).
Figure 11. Time course of induction of apoptosis by IFNy. Graph shows data
from one representative experiment, which was carried out 3 times. Values
represent mean ± SD, n = 4. *Significantly different to control, p = 0.0286.
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Figure 12. Feulgen staining of hepatocytes after 4 days administration of IFNy.
A. Control and B. IFNy-treated. Arrows indicate apoptotic nuclei. Images were
captured using a x40 objective.
To determine if 2n cells were more resistant to apoptosis after 4 days treatment, flow
cytometry was used and showed that the proportion of 2n (8.0 ± 1.6), 4n (65.8 ± 6.0)
and 8n (15.1 ± 2.9) cells was the same as controls (2n 8.2 ± 1.4; 4n 67.1 ± 5.2; 8n
16.3 ± 3.0) (Figure 13). This indicates that IFNy induces apoptosis in all ploidy
populations equally. Interestingly, the control hepatocytes showed a significant
decrease in 4n cells (67.1 ± 5.2 c.f. 76.7 ± 1.9, p<0.001) and increase in 8n cells
(16.3 ± 3.0 c.f. 12.7 ± 2.8, p<0.05) over 5 days in culture, (Figure 13). The














Figure 13. DNA content of cells remaining after IFNy treatment. Proportion of
2n, 4n and 8n cells in culture before treatment (Time 0) and with (IFN-g) or without
(control) IFNy for 4 days. Administration of IFNy does not alter the proportion of 2n,
4n and 8n cells. Over time there is decrease in 4n and increase in 8n hepatocytes.
*Significantly different to time 0, p < 0.05. Values represent mean ± SD, n = 15.
4.2.4 Hepatocytes remaining after IFNy-treatment did not arrest in G1
The proportion of BrdU positive cells increased over time in control and IFNy treated
cultures. Both mononuclear and binuclear cells incorporated BrdU. After 4 days,
IFNy had no significant effect on the proportion of mononuclear and binuclear BrdU
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Figure 14. Effect of IFNy on BrdU incorporation. Hepatocytes were given IFNy
for 4 days in culture and the effect on BrdU incorporation was measured by counting
the proportion of BrdU positive cells after a 3 hour pulse. The histograms shown are
from one representative experiment that was carried out 3 times. A. Total % BrdU
positive cells with IFNy (IFN) and without (Con). B. Proportion of BrdU positive cells
which were mononuclear. C. Proportion of BrdU cells which were binuclear. Values
represent mean + SD, n = 4, *p = 0.0286.
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4.3 Discussion
The reasons for increasing polyploidisation as a function of age or after
administration of toxic chemicals remain largely unknown. This chapter has studied
the differences between 2n, 4n and 8n mouse hepatocytes with respect to cell
volume, receptor expression and response to IFNy to try to determine more about
their function.
4.3.1 Confocal microscopy is a useful method for the measurement of
cell volume of different ploidy populations
Until now, there was no accurate method of determining the volume of live isolated
hepatocytes differing in DNA content. Previous measurements of volume and DNA
content have required fixed cell preparations. Confocal microscopy together with
appropriate imaging software has been used to determine the volume of live
chondrocytes (Bush and Hall, 2001) and can now be applied to hepatocytes. In order
to measure the size or volume of hepatocytes of different ploidy using this technique,
it was necessary to find a way to distinguish the ploidy populations. Due to the
consistently spherical shape of nuclei, nuclear diameter proved to be an accurate
measurement of ploidy. The nuclear diameter of 2n nuclei was found to range
between 7.0 and 9.0 pm and 4n nuclei between 9.5 and 11.5 pm. Nuclei of the same
binuclear cell were also found to be of similar size which has also been demonstrated
in human hepatocytes (Watanabe and Tanaka, 1982). These measurements were
found to be slightly larger than those found by Danielsen et al., 1986 who measured
cells within mouse tissue sections and found the diameter of 2n nuclei ranged
between 6.0 and 7.5 pm and 4n nuclei ranged between 7.5 and 9.0 pm. This
difference would be expected in fixed tissue sections as fixation shrinks tissues and
cells. The advantage of measuring ploidy in this way means that live cells of
different ploidy and nuclearity can be visualised along with other parameters such as
cell volume. The volume of cells approximately doubled with doubling DNA
content and the volume of mononuclear and binuclear cells containing the same
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amount of DNA was found to be equal. Other studies in humans, mice and rats,
utilising methods such as cytophotometry, microspectrophotometry, stereological
image analysis, Coulter counter and sedimentation velocities have shown similar
trends (Deschenes et ah, 1981; Epstein, 1967; Sweeney et ah, 1978a; Watanabe and
Tanaka, 1982). However, such studies have relied on mathematical calculations and
assumptions that cells are spherical in their determination of cell size and volume.
The use of confocal imaging negates these assumptions and calculations and
therefore provides the first accurate measurements ofmouse hepatocyte cell volume.
The only disadvantage is the time required to obtain images using the confocal
system, which limits the number of cells that can be analysed.
4.3.2 Expression of ICAM-1 increases with increasing cell size
Cell volume participates in a wide variety of functions including cell proliferation
and cell death (Lang et ah, 1998) and the possibility that the increase in size of
polyploid cells could be involved in the regulation of these cells has not previously
been studied. Schmidt and Schibler, 1995 suggested that cell size and volume was a
factor controlling the expression of various genes, including the leucine zipper
protein, DBP, although the ubiquitous transcription factors, Octl and NF-Y, were not
regulated by size. This study proposed that one way increasing cell size could
modulate the function or response of hepatocytes to signals was by altering the
expression ofmolecules such as ICAM-1 and IFNyR on the cell surface.
ICAM-1 is expressed on hepatocytes after dissociation of cell-cell contact (Ohno et
ah, 1995) and is important in inflammatory processes, including hepatitis and liver
transplant rejection (Bumgardner et ah, 1998; Schroder et ah, 1995). Therefore cell
volume measurements were used in conjunction with flow cytometry to analyse
ICAM-1 expression on 2n, 4n and 8n cells. The results indicate that the fluorescence
intensity of ICAM-1 increases in proportion to volume and DNA content. As the
volume of hepatocytes approximately doubles with doubling DNA content and the
fluorescence intensity of ICAM-1 increases accordingly, the polyploid cells actually
express a greater number of ICAM-1 molecules. Assuming that fluorescence
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intensity approximately equates to the number of ICAM-1 molecules on the surface,
the density of ICAM-1 is actually greater on polyploid cells, as surface area (sphere
9 • ^
= nr ) does not increase to the same extent as volume (sphere = 4/37ir ). Whether or
not the number or density of receptors on hepatocytes is functionally important,
remains to be seen. There is a possibility that up-regulation of receptors through
perfusion injury or in disease, induces the expression of receptors to an extent that is
not usually attained in vivo. Therefore, it would also be interesting to study receptor
expression in cells of different ploidy in vivo. A comparison of hepatocytes isolated
from prenatal, postnatal and adult rats, found that the number of insulin binding sites
per cell increased constantly, whereas the affinity of plasma membrane receptors for
the hormonal ligand remained unaltered from prenatal to adult hepatocytes (Autuori
et al., 1981).
The expression of IFNyR was of particular interest, as this study has also looked at
the effects of IFNy on cells with different DNA content. Flowever, IFNyR a or p
chains could not be detected. IFNyR is not expressed at detectable levels on normal
human hepatocytes (Volpes et ah, 1991) and this could be the case in the mouse. A
study by LeClaire et ah, 1992, demonstrated by immunocytochemical staining that
the majority of immunologically reactive mouse IFNyR protein is intracellular.
4.3.3 All hepatocytes undergo apoptosis in response to IFNy
Although contradictory evidence exists, several studies have indicated that polyploid
cells are more susceptible to apoptosis (Gupta et ah, 2000; Oren et ah, 1999; Sigal et
ah, 1999). Therefore, this chapter studied the effects of IFNy on the different
populations of hepatocytes. Although IFNyR was not detectable on isolated
hepatocytes, IFNy did induce apoptosis in culture, in agreement with other studies
(Kano et ah, 1997; Morita et ah, 1995; Shinagawa et ah, 1991). The mechanism
through which IFNy exerts its effects is largely unknown, although interferon
regulatory factor 1 (IRF-1) has been shown to be essential in IFNy-induced apoptosis
(Kano et ah, 1999). Although analysis of gene expression in 2n, 4n and 8n
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hepatocytes would have been an interesting way to study the effects of IFNy on these
cells, differences in gene expression would have been undetectable as the majority of
cells, at earlier time points, are unaffected by IFNy. BrdU immunohistochemistry
demonstrated that the hepatocytes that remained alive after treatment with IFNy were
able to incorporate BrdU to a similar extent as control cells and were not arrested in
Gl. In order to determine whether polyploid cells were more susceptible to the
induction of apoptosis by IFNy, flow cytometry was carried out on the cells that
remained alive after treatment. The prolonged effects of IFNy made it necessary to
study cells after 4 days treatment.
The proportions of 2n, 4n and 8n hepatocytes were the same as controls indicating
that all hepatocytes are equally sensitive to IFNy-induced apoptosis in vitro. A study
by Melchiorri et al., 1993, found that after administration of the mitogen, lead nitrate,
the elimination of excess cells by apoptosis did not occur preferentially in the
polyploid population. In contrast, Oren et ah, 1999, found that the rate of apoptosis
was increased in polyploid cells after administration of the potent hepatic mitogen,
triiodothyronine (T3) to rats pre-treated with the cell cycle inhibitor, retrorsine. Sigal
et ah, 1999, suggested that apoptosis accounted for the decrease in the proportion of
8n cells 5 days after a partial hepatectomy. Increased rates of apoptosis have also
been found in the livers of LEC rats where the liver has become populated with
megalocytes, containing enormous nuclei (Gupta et ah, 2000). In the cases where the
cell cycle has been disrupted through administration of cell cycle inhibitors like
retrorsine or in the case of LEC rats, polyploid cells or megalocytes form through a
disruption or block in the cycle. The difference in the susceptibility of polyploid
cells to apoptosis may therefore be related to the type of polyploid cell or to the type
of injury inflicted on the cell. Susceptibility of hepatocytes to apoptosis may also
differ in vivo and in vitro.
There have been reports that polyploid cells are also more susceptible to injury from
toxic compounds. Perivenous hepatocytes found to exhibit greater ploidy than
periportal cells (Schmucker, 1990) were more susceptible to the cytotoxic effects of
carbon tetrachloride and paracetamol (Osypiw et al., 1994). A study by Sancho-
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Tello et al., 1987, on young rats, showed that hepatocytes from the perivenous region
of the liver were more greatly damaged than periportal cells when exposed to alcohol
in vivo. In contrast, the study by Osypiw et al., 1994, found that periportal
hepatocytes were more susceptible to methotrexate and 1-naphthylisothiocyanate.
Therefore the susceptibility of hepatocytes to injury may be due to their zonal
location rather than their degree of ploidy and may be linked to the different function
and/or gene expression within cells of these areas.
4.3.4 Hepatocytes become increasingly polyploid in culture
Although there was no change in the proportion of 2n, 4n and 8n hepatocytes after
administration of IFNy, there was a change in the proportion of polyploid cells over
time in control cultures. The proportion of 8n hepatocytes increased, 4n hepatocytes
decreased and 2n hepatocytes remained the same over 5 days. BrdU
immunohistochemistry showed that both mononuclear and binuclear cells proliferate
in these cultures. Previous studies have shown that polyploidisation and cell fusion
occur in rat hepatocyte cultures (Gomez-Lechon et al., 1981; Mossin et al., 1994).
The reasons why the proportions of 4n and 8n populations alter while 2n cells remain
the same in this study are unknown. Gomez-Lechon et al., 1981, suggested that
polyploid hepatocytes are more unstable in culture. However, this is unlikely to be
the case in this study as the 8n population increases. Alterations in the proportions of
cells are likely to be due to a combination of cell death, proliferation,
polyploidisation and cell fusion and the rate or susceptibility of 2n, 4n and 8n cells to
each of these parameters will have an effect on the proportion of each population.
4.4 Summary
This chapter demonstrates that confocal imaging can be used to accurately determine
the volume and DNA content of isolated live hepatocytes. The volume of
hepatocytes approximately doubles with doubling DNA content and the increase in
volume is accompanied by a proportionate increase in ICAM-1 expression. Whether
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the number of receptors is biologically relevant and whether all the hepatocyte
populations respond equally to the signals from such receptors is unknown. IFNy-
induced apoptosis in all hepatocytes in culture equally although IFNyR was not
detectable on isolated cells. Further analysis of receptor expression and
susceptibility of polyploid cells to apoptosis are required to help determine the
function ofpolyploid hepatocytes.
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5 Comparison of Gene Expression in 2n, 4n and 8n
Mouse Hepatocytes
5.1 Objectives
Analysis of gene expression in cells of different ploidy is one way in which more
information regarding the control and function of polyploidisation in the liver could
be obtained. Given that there is so little information regarding this process in the
liver, the ability to screen thousands of genes using microarray technology, within
cells differing only in DNA content, would provide a vast amount of information that
has not been available before. Such studies have so far only been carried out in
yeast. Galitski et al., 1999, compared haploid to tetraploid strains of Saccharomyces
cerevisiae using microarray technology and found 10 genes that were induced and 7
genes that were repressed. The ability to carry out similar studies in hepatocytes is
dependent on a method that separates pure populations of 2n, 4n and 8n cells.
Hepatocytes separated on the basis of size and density using techniques such as
centrifugal elutriation (Le Rumeur et ah, 1983; Overturf et ah, 1999; Watkins III et
ah, 1992), Percoll gradients (Osypiw et ah, 1994; Rajvanshi et ah, 1998) and velocity
sedimentation (Miller and Phillips, 1969; Sweeney et ah, 1978a; Tulp et ah, 1976)
contain mixed populations of 2n, 4n and 8n cells. Separation of hepatocytes
differing only in DNA is only possible by FACS using DNA dyes such as Hoechst
33342. This technique has been used for the separation of various cell types
including mouse and rat hepatocytes (Davies et ah, 1990; Lydon et ah, 1980;
VanZandt and Fry, 1983; Weglarz et ah, 2000). However, the viability of mouse
hepatocytes post-sort was found to be relatively low (Weglarz et ah, 2000). The aim
of this part of the study was to develop an improved method for separating highly
pure populations of live mouse hepatocytes. So far, gene expression analysis of
sorted cells differing only in DNA content has not been done in mammalian cells.
Therefore, a further aim of this section was to determine if the RNA from sorted
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hepatocytes was suitable for gene expression analysis and to carry out initial
experiments to compare gene expression using microarray technology in hepatocytes
separated on the basis ofDNA content by FACS.
5.2 Results
5.2.1 Separation of Hepatocytes
5.2.1.1 Cell sorting
Sorting was carried out using the conditions that achieved the highest percentage
purity and viability. Figure 15 shows a typical analysis ofmouse hepatocytes stained
with Hoechst 33342. Distinct populations of 2n, 4n and 8n cells can be seen. The
majority of cells are 4n (73%) and the rest are 2n (7%) and 8n (18%). PI positive
(dead cells) made up 30-33% of the total population and were removed from the
analysis.
5.2.1.1.1 Purity and viability of sorted hepatocytes
The purity of each sorted population was determined by flow cytometry ofPi-stained
cells. Purity and viability of sorted cells were affected mainly by doublet gating,
addition of DNase type I and the addition of PI. These parameters affected the sorts
in different ways. Doublet gating was necessary to gate out clumps, which affected
purity greatly. DNase type I was initially added to prevent or reduce cell clumping
by reducing the amount of free DNA released from dead cells and thereby increasing
the yield of cells post-sort. However together with PI, DNase I also increased the
purity of the sorted samples. The purity of all populations increased significantly
with the addition of DNase I and PI (p < 0.05); the 2n population increased from 59
to 93%, the 4n population increased from 72 to 94% and the 8n population increased
from 55 to 82% (Table 7). Figure 16 shows typical flow histograms of pure
populations of hepatocytes sorted using PI and DNase I.
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Figure 15. Histograms used for sorting 2n, 4n and 8n hepatocytes. A.
Histogram of forward scatter (size) v side scatter (granularity). B. Doublet gating,
R3 contains single cells only. C. Histogram of forward scatter v FL2 (PI staining),
R6 contains PI positive cells. D. Histogram of Hoechst area (DNA content) v
counts. M1, M2 and M3 are the sort gates for the 2n, 4n and 8n populations,
respectively.
Table 7. Purity of sorted samples
Doublet Addition of Addition of Av. % Purity of Cells
Gating DNase I PI 2n 4n 8n
Yes No No 59+13.0 72 ± 8.2 55 ±23.8
Yes Yes No 86 ± 0.6 76 ± 1.0 76 ± 5.1
Yes Yes Yes 93 ± 2.8* 94 ±2.6* 82 ±7.1*
Values represent mean ± SD. *Significantly different to the purity of cells before the
addition of DNase I and PI, p < 0.05.
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Figure 16. Purity of sorted cells assessed by PI staining and flow cytometry.
Histograms of FL3 (PI positivity, DNA content) v counts, A. 2n, B. 4n and C. 8n.
Assessment of cell viability post sort using a trypan blue exclusion assay
demonstrated that addition of DNase I as well as doublet gating increased the
proportion of viable cells. Viability increased from an average of 35 % to 84 %. The
addition ofDNase I increased the side scatter of the dead cells (Figure 17).
A. B.
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Figure 17. Increase in side scatter of dead cells with the addition of DNase I.
A. Before addition of DNase I. B. With the addition of DNase I. Arrows indicate dead
cells, which have a higher side scatter.
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5.2.1.1.2 Proportion of mononuclear and binuclear cells in sorted
populations
Cytospins were used to determine the proportions of mononuclear and binuclear cells
within the sorted populations. The purity of the 2n population was >92%. The 4n
and 8n populations were made up predominantly of binuclear cells (70 - 80%) and
20 - 30% mononuclear cells (Figure 18).
A. B. C.
Figure 18. Cytospins of 2n, 4n and 8n cells sorted using PI and DNase I. A.
2n mononuclear cells, B. 4n mononuclear and binuclear cells, C. 8n mononuclear
and binuclear cells.
5.2.1.1.3 Growth capacity and proliferation of sorted cells
In addition to the trypan blue exclusion assay, viability and growth potential of
sorted cells were studied in culture. The ability of cells to attach and spread to the
collagen matrix and their ability to progress through S-Phase was examined. After
24 and 48 hr in culture, dead cells rounded up and detached from the surface and the
live cells attached and spread. At 48 h, 51% of 2n cells were BrdU positive whereas
the 4n population was negative at both time points (Figure 19). Time-lapse
experiments showed that sorted cells were capable of cell division (Appendix 5).
ioq
Figure 19. BrdU incorporation of 2n and 4n cells after 48 h in culture. A. 2n
and B. 4n. BrdU positive cells stain brown. Arrows indicate dead cells that have
rounded up and detached from the culture substratum.
5.2.1.2 Percoll gradients
Percoll gradients were used to determine if mononuclear and binuclear hepatocytes,
which could not be separated using FACS, could be separated on the basis of cell
density. Percoll gradients resulted in the separation of 3-4 distinct bands of cells.
Cytospins of cells from each fraction did not show any enrichment of mononuclear
or binuclear cells. However, flow cytometry showed that there was an enrichment of
diploid and polyploid cells in different fractions. The lower fractions (H3a and H4)
were enriched in polyploid cells (H3a: 4n, 61.8% and 8n, 1.4%; H4: 4n, 53.6% and
8n, 7.3%) compared to the lower fractions (Hla and b) (Hla: 4n, 37.9%, 8n, 0.7%;
Hlb: 4n, 47.3%, 8n, 1.5%, respectively). These fractions also showed a decrease in
the proportion of 2n cells (H3a: 32.1%; H4: 24.2% compared to Hla: 57.3%; Hlb:
40.9%, respectively) (Table 8). Similar trends were seen comparing the separated
fractions with the cells before separation. Altering the concentration of Percoll did
not increase the purity of cells within each fraction with respect to DNA content.
U6
Table 8. DNA content ofcells separated by Percoll gradients.
Mouse / Age Fraction % Cells
2n 4n 8n
C3H / Before separation 41.6 45.0 1.0
1.5 months old Hla 57.3 37.9 0.7
H2a 38.0 51.6 1.8
H3a 32.1 61.8 1.4
C3H / Before separation 19.0 66.6 2.1
2.5 months old Hlb 40.9 47.3 1.5
H2b 34.3 51.0 3.0
H3b 37.0 46.2 3.9
H4 24.2 53.6 7.3
The purity of the separated fractions using Percoll gradients was not suitable for
further gene expression analysis and therefore only cells separated by FACS were
used.
5.2.2 Analysis of RNA quality
5.2.2.1 Sorting using Hoechst 33342 does not affect RNA quality
The RNA from sorted cells stained with Hoechst 33342 was of good quality and two





Figure 20. Quality of RNA extracted from sorted hepatocytes. RNA was
extracted using phenol/chloroform and was electrophoresed on a 1 % agarose gel.
Lane 1. 2n, 2. 4n, 3. 8n, 4. Unsorted cells and 5. Molecular weight marker (Cambio).
Arrows indicate the 28S and 18S ribosomal bands.
Reverse transcription PCR using P-actin primers was not affected by staining with
Hoechst 33342, sorting or fixation as clear bands are visible. However, PI staining
affected the reaction resulting in no product (Figure 21).
1 2 3 4 5 6 7
~ lOObp—►
Figure 21. The effect of fixing, sorting or staining with PI or Hoechst 33342 on
P-actin reverse transcription PCR. Lane 1. PI staining, 2. Fixed in ethanol, 3.
Unstained, unfixed, 4. Hoechst 33342 staining, 5. Sorted cells, 6. Negative control
and 7. Molecular weight marker (25 bp ladder; Life Sciences).
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5.2.3 Gene Expression Analysis
5.2.3.1 The amount of total RNA from sorted cells increases with ploidy
For analysis of gene expression, it is important to know if the amount of RNA
obtained from hepatocytes increases in proportion to DNA content. The results
indicate that the total amount of RNA does increase with increasing DNA content
and the amount obtained from 8n cells (26.18 pg/1 x 106 cells) is approximately 4
times that from 2n cells (6.5 pg/1 x 106 cells) (Figure 22, p < 0.05).
Figure 22. Amount of RNA extracted from sorted hepatocytes. RNA was
extracted using a phenol/chloroform extraction protocol and quantified by the
absorbance reading at 260 nm on a spectrophotometer. *Significantly greater than
2n, p < 0.05.
5.2.3.2 Microarray analysis
Microarray analysis was carried out to screen the expression of over 8500 genes
within the sorted 2n, 4n and 8n populations and within hepatocytes from old and
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young mice. Figure 23 shows a representative area from a 2n, 4n and 8n array.
There are both induced and repressed genes in the 8n sample.
Due to the vast amount of information obtained from microarray analysis, it is
necessary to set criteria that will separate the many thousands of genes analysed from
the genes of interest. In this case, the genes of interest were those that were induced
or repressed more than 2-fold and could therefore not be accounted for by an
increase in DNA content. Table 9 shows which genes were induced or repressed
more than 2-fold in cells of higher ploidy compared with cells of lower ploidy
(details of each comparison are given in Appendix 4). Esterase 31, MUP2 and
IFNyR were induced whereas the ESTs similar to PCD and KIAA1265 protein were
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Figure 23. Images of representative areas of nylon microarrays from A. 2n, B.
4n and C. 8n sorted hepatocytes. Highly expressed genes stain darker due to a
greater incorporation of P33. Arrow 1 represents the MUP gene, which is more
highly expressed in 4n and 8n cells and 2, represents two genes that are repressed
in the hepatocytes with greater DNA content. Each gene is spotted in duplicate.
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ESTs highly sim PCD
ESTs
ESTs, KIAA1265
Torsin Family 2, A
Histocomp. 2, K
Plasminogen Act.Inh. II
DNA Segment, Chr. 10
ESTs, Golgi App.
This tabe illustrates genes that were induced (in blue) and repressed (in red) more
that 2-fold in cells of higher DNA content using microarray analysis. Sorted cells
with the same DNA content were pooled together (Appendix 3) and cDNA probes
prepared using RT-PCR, incorporating p33 were hybridised to known sequences on
nylon membranes. The expression of each gene in the sorted samples was
detected and measured using a phosphoimager and appropriate macros in
Microsoft Excel. ESTs = Expressed Sequence Tags, MUP2 = Major Urinary Protein
2, PCD = Pterin 4a-carbinolamine dehydratase, ZBP1 = Zipcode Binding Protein 1,
Histocomp. 2,K = Histocompatibility 2, K region, Plasminogen Act. Inh. II =
Plasminogen activator inhibitor, type II.
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5.2.3.3 Reverse-transcription and real-time PCR
MUP2, IFNyR and the EST similar to PCD, which were either induced or repressed
in the microarray analysis were chosen for confirmation by real-time PCR analysis.
Pten was also chosen due to its role in the regulation of cell size (Huang et al., 1999;
Goberdhan et al., 1999). The primer sets for each gene were first checked by reverse
transcription PCR on RNA extracted from whole liver to ensure there were no primer
dimers and the PCR products were the correct size. The primers for the IFNyR did
not work in any of the conditions that were tried. There were virtually no primer
dimers and all bands corresponded to products of the correct size (Figure 24).
A. 1 2 3 4 5 6 7
1 2 3 4 5 6 7
Figure 24. Reverse transcription PCR of primers chosen for real-time PCR
analysis. PCR products were electrophoresed on a 2% agarose gel. A. Lane 1.
pGEM molecular weight marker, 2. MUP (131 bp), 3. PCD (216bp), 4. Pten (115bp),
5. IFNyR (207bp), 6. p-Actin (~400bp) and 7. pGEM molecular weight marker. B.
Corresponding controls without the addition of cDNA, run below each sample on the
same gel.
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Real-time PCR confirmed the expression of MUP2, PCD and Pten in samples
extracted from 2n, 4n, 8n sorted cells and in samples from old and young mice;
however, the results were so variable, it was not possible to determine if there were
any differences between samples.
5.3 Discussion
5.3.1 The separation of hepatocytes differing in DNA content
Sorting using Hoechst 33342 allows the separation of cells differing only in DNA
content. This technique has been successfully used in the separation of many cell
types including bone marrow (Vanzandt and Fry, 1983), cell lines (Fried et al.,
1982), lymphocytes (Loken, 1980), mouse hepatocytes (Weglarz et al., 2000) and rat
hepatocytes (Davies et al., 1990). Hoechst 33342 is a DNA-specific dye that binds
reversibly to adenine: thymidine rich regions of the DNA (Durand and Olive, 1982).
Unlike the nucleic acid dye, PI, Hoechst 33342 did not affect the quality of RNA
from sorted cells in these studies. The addition of PI (2 pg/ml) and DNase type 1
(0.1 mg/ml) greatly increased the purity and viability of the sorted populations. The
viability was greater than 80% for 4n and 8n populations. This value is higher than
the viability of cells presented in the study by Weglarz et al., 2000, who did not use
DNase 1. They found that viability was between 50 and 74 %. The addition of
DNase 1 increased the side scatter of the dead cells and possibly increased the
proportion of dead cells gated out of the analysis.
Although Hoechst 33342 binds quantitatively to DNA, the staining of 2n, 4n and 8n
hepatocytes was not linear. On the plot of Hoechst area, the 2n and 4n peaks fall at
approximately 200 and 400 respectively, whereas the 8n peaks falls below 800.
There are several reasons why this could be the case. Firstly, in the analysis of
different types of diploid cells e.g. granulocytes, lymphocytes and macrophages, the
position of the 2n peak varies when they are stained with either Hoechst 33342 or PI
and this is likely to be due to the different conformation of the DNA within the
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nucleus. Therefore, there is a possibility that the conformation of DNA varies in
hepatocytes of different ploidy. Secondly, Hoechst 33342 is a live cell stain and is
continually being pumped out of the cell. The rate that the dye is pumped out could
vary between cell types and affect where the peak will fall.
Other techniques such as centrifugal elutriation (Le Rumeur et al., 1983; Overturf et
al., 1999; Watkins III et al., 1992), velocity sedimentation (Miller and Phillips, 1969;
Sweeney et al., 1978a; Tulp et al., 1976) and Percoll gradients (Osypiw et al., 1994;
Rajvanshi et al., 1995; Rajvanshi et al., 1998) have also been used to separate
different populations of hepatocytes. This study has shown that separation of
hepatocytes by Percoll gradients enriches the 2n or the polyploid populations;
however, separated fractions always contained mixed populations of 2n, 4n and 8n
cells and cells of different nuclearity. This was expected, as there is no means of
separating cell aggregates. A study by Tulp et al., 1976, used velocity sedimentation
to separate mouse and rat hepatocytes on the basis of ploidy. However, they had
limited success separating whole cells and the technique was found to be more useful
for the separation of isolated nuclei. Techniques used in the separation of cells of
different size or density do, however, have other advantages and they have been used
to study the function of cells separated from different zones of the liver (Bengtsson et
al., 1981; Osypiw et al., 1994; Rajvanshi et al., 1998; Sancho-Tello et al., 1987;
Vargas et al., 1987).
5.3.2 Separation of mononuclear and binuclear cells
In adult mice, the majority of hepatocytes are binuclear. Using FACS, mononuclear
and binuclear cells containing the same amount of DNA are sorted together. As
there may be differences in gene expression between these cells, it was desirable to
separate these cells. However, as I have mentioned above, Percoll gradients did not
enrich mononuclear or binuclear cell populations. A combination of centrifugal
elutriation and flow sorting has been used to enrich populations of mononuclear and
binuclear rat hepatocytes (Davies et al., 1990). The purity of the binuclear
populations separated in this way was 81%. This was not much greater than the
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proportions of binuclear cells obtained from sorting alone in this study. Sorting of
mouse hepatocytes resulted in the separation of a predominantly mononuclear 2n
population (> 92%) and binuclear 4n and 8n populations consisting of between 70
and 80% binuclear cells. For the separation ofmouse cells, it is preferable to use just
one technique, as fewer numbers of cells are obtained from a mouse liver compared
with a rat liver and one technique will limit the amount of cell loss. Although it has
not been possible to separate mononuclear and binuclear hepatocytes of the same
ploidy class, information obtained from the comparison ofmononuclear 2n cells with
predominantly binuclear 4n and 8n cells and the comparison of 2n, 4n and 8n cells
themselves will be useful.
5.3.3 Sorted cells were able to grow and proliferate in culture
The growth potential of hepatocytes post-sort was not extensively studied, as the
majority of cells were required for gene expression studies. However, initial
experiments indicated that 2n and 4n cells were able to attach and spread onto
collagen-coated slides. After 48 h, the approximately 50% of 2n cells incorporated
BrdU, whereas the 4n cells were negative at 24h and 48 h. BrdU labelling index has
been found to be inversely correlated with ploidy (Mossin et al., 1994), and it was
therefore expected that the 4n cells would not proliferate at the same time. Although
there were too few cells to study later time-points, there is a possibility that 4n
hepatocytes would have proliferated after 48 h. As well as incorporating BrdU, the
sorted hepatocytes were also able to divide as demonstrated by time-lapse
experiments. Hoechst 33342 is a relatively non-toxic and non-mutagenic dye but has
been shown to be inhibitory to the cell cycle in some cell types (Arndt-Jovin and
Jovin, 1977; Durand and Olive, 1982; Fried et al., 1982; Lydon et al., 1980).
Although not studied in this chapter, cell death was noticed in culture by the presence
of small, rounded, darker staining cells that detached from the slide. This could be
related to effects of the dye or the process of sorting itself. There is also a
possibility that there is some deleterious effect on cells from the laser during sorting.
More extensive studies on the proliferation of sorted cells over longer periods in
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culture as well as assays to quantify cell death would be useful to properly assess the
effects of sorting on hepatocytes.
5.3.4 RNA content increases with DNA content and could affect gene
expression analysis
The amount of RNA from 8n cells was approximately 4 times that of a 2n cell.
Although not significant, the 4n cells contained more RNA than 2n cells and less
than 8n cells. The large standard deviation is likely to be due to experimental error.
In order to avoid protein contamination after the phenol/chloroform extraction, not
all of the RNA can be removed. There are also two RNA precipitation steps in the
protocol that increase the chances of losing some of the extracted RNA. Combining
the RNA from different sorts also introduces some degree of error, as the amount of
RNA extracted will vary each time. In this study, microarray analysis was carried
out by comparing an equal amount ofRNA from each sample (where possible 15 pg)
and an equal amount of cDNA probe. As the amount ofRNA from cells was found
to increase with increasing DNA content, any changes in gene expression are likely
to be much greater when the total amount ofRNA in a cell is taken into account. For
example, a gene which is induced 3-fold in a 4n cell compared with a 2n cell could
express 6 times the amount of that gene if the actual RNA content of the 4n cell was
2-fold greater. Interestingly, a study by Collins, 1978, demonstrated that the rate of
RNA synthesis in 2n, 4n and 8n rat hepatocytes was similar and that the rate ofRNA
synthesis in hepatocytes declines with age. The fact that polyploid cells contain
more RNA but do not have increased rates of RNA synthesis could be in some way
related to the function of hepatocytes. The increase in RNA in polyploid cells may
allow these cells to produce large amounts of protein without expending large
amounts of energy. RNA extracted from sorted hepatocytes was not affected by
sorting and was suitable for gene expression analysis determined by reverse-
transcription PCR.
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5.3.5 Gene expression analysis
Due to the lack of information regarding the genes involved in hepatic
polyploidisation, the best way of obtaining a lot of information quickly is by
screening thousands of genes using microarray technology. Nylon microarrays
combined with P-labeled radioactive probes are sensitive enough to allow small
samples of RNA to be analysed and are therefore suitable for the analysis of flow
sorted cells (Bertucci et ah, 1999). Comparison of the sorted 2n, 4n and 8n
hepatocytes using this technology will provide valuable information about the genes
involved in the function and maintenance of polyploidisation in the liver and is the
first description of this type of analysis in mammalian cells.
Several studies have demonstrated that various genes and proteins are expressed in
proportion to DNA content, including albumin (Le Rumeur et al., 1981), the leucine
zipper protein, DBP (Schmidt and Schibler, 1995), succinate dehydrogenase and
NADPH cytochrome C (Tulp et al., 1976). These studies have also found genes that
are unchanged by increasing ploidy such as the ubiquitous transcription factors,
OCT1 and NF-Y (Schmidt and Schibler, 1995) or altered in a way that can not be
explained by DNA content such as lactate dehydrogenase, of which the activity per
genome was much lower in 2n cells compared with polyploid cells (Tulp et al.,
1976). This study was interested in genes that did not solely change relative to DNA
content, therefore a cut-off greater than 2-fold was used.
The majority of genes studied either did not vary with increasing ploidy or change
relative to DNA content. Several genes were induced or repressed in comparisons of
2n with 4n and 8n cells, unsorted with 8n cells and hepatocytes from young mice
compared with those from old mice. The comparison of unsorted with 8n cells and
the comparisons of young and old mice were included as controls. If cell sorting had
affected gene expression in any way, different gene expression patterns would have
been expected in the control samples. However, this did not appear to be the case.
The proportion of polyploid cells is greater in older mice. Therefore, the pattern of
gene expression in the comparison of young and old mice was also expected to be
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similar to comparisons of 2n with polyploid cells. Indeed, several similar genes were
detected in these comparisons. Comparing hepatocytes that differ only in DNA
content is complicated by the presence of a large proportion of binuclear cells within
the 4n and 8n populations. As I have mentioned previously, it is not possible to
separate mononuclear and binuclear cells with the same DNA content. However, it
was expected that genes important in binucleation as opposed to those involved in
the production of mononuclear polyploid cells would also be detected in the
comparisons of 2n with 4n and 8n cells, as 2n cells are mononuclear and 4n and 8n
cells are predominantly binuclear.
5.3.5.1 Identification of genes involved in the function or maintenance of
polyploidy
Three of the genes that appeared on several of the comparisons were of particular
interest. The first of these was IFNyR, which was induced in polyploid cells. One of
the aims in a previous chapter of this thesis was to determine whether the increase in
size of polyploid cells could affect the expression of ICAM-1 or IFNyR. Using flow
cytometry it was demonstrated that the fluorescent intensity of ICAM-1 increased in
proportion to DNA content. However, IFNyR was not detectable using this
technique and it was suggested that IFNyR was mainly intracellular. Microarray
analysis suggests polyploid hepatocytes express more IFNyR. However, it is not
possible to determine whether polyploid cells translate all IFNyR mRNA into protein
or whether polyploid cells just store a larger amount of IFNyR mRNA.
The second gene of interest was the MUP2, also found to be induced in polyploid
hepatocytes. The literature regarding the major urinary proteins reveals some
striking similarities between MUPs and ploidy. MUP gene expression is first
detected in the liver between 2 to 4 weeks of age (Held et al., 1989), at the same time
as polyploid cells appear in the liver (Brodsky and Uryvaeva, 1977; Carriere, 1967;
Nadal and Zajdela, 1966). MUPs, like ploidy are under complex hormonal control.
The synthesis ofMUPs is sex-dependent under the influence of androgens and other
hormones such as growth hormone, thyroid hormone, the glucocorticoids and insulin
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are required for the normal MUP synthesis (Knopf et al., 1983). As described in
Chapter 1, the regulation ofploidy is also under the control of hormones with thyroid
hormone playing a major role (Torres et ah, 1999). The degree of polyploidisation
varies between male and female mice with female mice showing higher levels of
ploidy than male mice of the same age (Epstein, 1967; Steele et ah, 1981a).
Similarly, the liver of female mice contains different MUP products and different
levels ofMUPs to that of the male (Knopf et ah, 1983).
MUP gene expression was found to be critical to normal liver development.
Suppression ofMUP mRNAs in the liver through the expression of a MUP/SV40 T
antigen transgene in mice was shown to result in the development of liver
hyperplasia and tumours. The livers of these transgenic mice enlarged by 4 weeks of
age and the nuclei were found to be irregular in size and shape (Held et ah, 1989).
Cavaggioni and Mucignat-Caretta, 2000, have recently provided a comprehensive
review regarding the function, control and genetics of the MUPs. The multigene
family consists of approximately 35 genes per haploid genome, which are clustered
on chromosome 4 and encode small monomelic proteins with Mr of about 18000
(Cavaggioni and Mucignat-Caretta, 2000; Mcintosh and Bishop, 1989). The group 1
genes are expressed highly in the liver with MUP mRNA constituting approximately
5% of the total (Shaw et ah, 1983). So far, the only known function ofMUPs seems
to be in chemosensory signalling in rodents. MUPs are secreted in the urine and act
as odorant carriers as well as proteins that prime endocrine reactions in females
(Cavaggioni and Mucignat-Caretta, 2000). The importance ofMUP gene expression
in liver development and the striking similarities in hormonal control, expression of
MUP and initiation of ploidy make the role of MUP gene expression in
polyploidisation worthy of further study.
The third gene of interest was the EST similar to pterin-4a-carbinolamine
dehydratase (PCD) that was mainly found to be repressed in polyploid hepatocytes.
PCD is also known as phenylalanine hydroxylase-stimulating protein (PHS) and has
been found to be identical in structure to a protein of the cell nucleus called
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dimerization co-factor of hepatocyte nuclear factor 1 alpha, reported to be involved
in transcription (Hauer et al., 1993; Mendel et al., 1991). Another function of PCD is
in the cytosol where it is required for efficient tetrahydrobiopterin regeneration after
phenylalanine hydroxylase activity (Thony et al., 1998). The fact that this gene
seems to be repressed in cells of higher ploidy suggests that it could play some role
in the polyploidisation in the liver. However, further studies will be necessary to
determine if this is the case.
The level of induction or repression varied between comparisons. This is most likely
to be due to inter-animal variation, spotting of the membranes, variability in probe
preparation, background variation or the accuracy in the determination of the spot
intensity. Therefore, this study did not utilise microarray technology for quantitative
analysis but found it particularly useful for screening genes that may otherwise not
be associated with ploidy. Quantitative analysis was attempted using real-time PCR.
This technique was able to confirm the expression of MUP2, IFNyR and PCD.
However, the variation between samples was too great to determine any differences
between the 2n, 4n and 8n populations. Real-time PCR uses fluorescence to detect
the changes in gene expression and is not as sensitive as radio-labelling used in the
microarray analysis.
5.3.5.2 Genes involved in the control of polyploidisation
The only previous attempt to study gene expression in cells of different ploidy using
microarray technology was done in yeast. Galitski et al., 1999, compared haploid
and tetraploid strains of S. cerevisiae in exponential growth and found that 10 genes
were induced and 7 genes were repressed greater than 10-fold in the cells of higher
ploidy. One of the genes that was repressed, CLN1, was found be highly
homologous to human cyclin A. Other studies in yeast, megakaryocytes and various
cell lines have found that many cell cycle regulators such as cyclin A (Bortner and
Rosenberg, 1995; Datta et al., 1998), p21 (Datta et al., 1998; Kikuchi et al., 1997;
Sheikh et al., 1995) and genes of the Aurora family (Kawasaki et al., 2001;
Schumacher et al., 1998) are involved in the control of polyploidisation. This
chapter has focused on the comparison of gene expression within static populations
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of hepatocytes and has not looked at the expression of hepatocytes in exponential
growth. Therefore genes involved in the cell cycle and others involved in the control
of polyploidisation were not expected to vary in the microarray analysis. Studies
into the control of polyploidisation in hepatocytes would be of great interest.
However, this is much more difficult to do in hepatocytes compared with yeast.
There is a possibility that 2n, 4n and 8n hepatocytes could be sorted after the
induction of polyploidisation in mice by mitogenic drugs such as PB or peroxisome
proliferators. However, the interpretation of the results would be complicated, as
there is a possibility that drugs will induce polyploidisation through different
pathways or induce the expression of genes not usually associated with normal
polyploidisation or proliferation. A study by Chevalier et al., 2000, demonstrated
that the protein expression profiles induced by the peroxisome proliferator,
nafenopin, were different to those induced by the mitogen, EGF. Another option that
would allow the analysis of hepatocytes in exponential growth would be to grow
sorted 2n, 4n and 8n cells in culture and extract the RNA when each population is
actively proliferating. Further characterisation of the effect of sorting and Hoechst
33342 on hepatocytes would be necessary to determine whether this approach would
be suitable.
5.3.5.3 Gene expression in cells of different ploidy and cells in different zonal
locations in the liver
This PhD has not studied the ploidy of hepatocytes in situ. However, this area would
be interesting to pursue in further studies as the relationship between gene expression
within cells of different ploidy and cells in different zones of the liver is unclear. As
mentioned earlier, the cell size and degree of ploidy varies in different regions of the
liver, with the perivenous cells exhibiting greater polyploidy and the periportal cells
less ploidy (Rajvanshi et al., 1998; Schmucker, 1990). There are a number of genes
that vary in expression between the different regions of the liver and relate to the
different functions of these two zones. The cells within the periportal region (zone I)
are involved in gluconeogenesis, ureagenesis and amino acid uptake and degradation,
whereas the cells in the perivenous area (zone III) are involved in glycolysis and
glutamine synthesis (Feldmann, 1992; Jungermann and Kietzmann, 1996; Sigal et
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al., 1992). Perivenous cells express glutamine synthetase, GLUT-1, alcohol
dehydrogenase, cytochrome P450, whereas serum albumin, ceruloplasmin and the
glucose transporter, GLUT-2 are expressed in hepatocytes throughout the liver lobule
(Bilir et al., 1993; Ingelman-Sundberg et al., 1988; Osypiw et al., 1994; Rajvanshi et
al., 1998; Yamauchi et al., 1988). As this study has demonstrated, expression of
genes such as IFNyR, MUP2 and PCD vary within hepatocytes of different ploidy.
Whether the expression of these genes is related to the function of cells within the
different zones or whether they are involved more specifically in the function of
polyploid cells is unknown. Analysis of 2n, 4n and 8n hepatocytes from different
zones of the liver may help determine if this is the case.
This study has demonstrated that microarray technology is a useful method for
screening gene expression in sorted 2n, 4n and 8n hepatocytes. The genes induced or
repressed more than 2-fold including IFNyR, MUP2 and PCD may play a role in the
function or maintenance of polyploidisation. However, further confirmatory studies
such as biological assays would be necessary to determine if this is the case. In time,
this technique may also be useful in determining which genes are involved in the




As well as having developed novel techniques, this thesis describes some important
findings regarding polyploidisation in the rodent liver. One area of particular interest
is the significance of polyploidisation in the liver, especially as contradictory
hypotheses exist. A review by Gupta et al., 2000, concludes that polyploidisation is
an advancement towards terminal differentiation and senescence, with increasing risk
of apoptosis, organ failure and hepatocarcinogenesis. In contrast, previous studies
suggest that polyploidisation is in fact a protective response (Brodsky and Uryvaeva,
1977; Cascales et al., 1994; Schwarzc ct al., 1984; Uryvaeva, 1981). Another area of
importance is the control of polyploidisation and many studies have been carried out
in various cell types to determine what genetic mechanisms are involved. This
chapter discusses the results of this thesis with particular regard to the significance
and control ofpolyploidisation.
6.1 The Significance of Polyploidisation
6.1.1 A protective mechanism?
This study found that administration of PB for 21 days increased the proportion and
proliferation of 8n nuclei without affecting the proportion of binuclear cells. The
increase in ploidy associated with the administration of PB or cocaine has been
suggested to enable hepatocytes to carry out their function whilst coping with the
intensive stress induced by the drugs (Bohm and Noltemeyer, 1981; Cascales et al.,
1994). Other studies suggest that by avoiding mitosis, polyploid cells limit the
development of chromosomal abnormalities, which could lead to transformation and
cell death (Medvedev, 1986; Uryvaeva, 1981). Whether these suggestions can
explain why there is an increase in 8n nuclei after administration of PB is not known.
The degree of ploidy has been shown to return to normal after the removal of PB
(Bohm and Noltemeyer, 1981). This may indicate that drug-induced
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polyploidisation could be a method of coping with drug-induced stress.
Administration of PB was not associated with any histological abnormalities and,
over this relatively short period, did not induce any signs of disease or apoptosis.
Therefore, the induction of polyploidisation did not appear to be deleterious to the
cell. Interestingly, the development of carcinogenesis after the administration of
many drugs has been associated with long-term rather than short-term administration
(Melnick, 1992). Therefore, before any conclusions can be drawn, it would be useful
to study the long-term effects ofPB on ploidy and disease.
6.1.2 Susceptibility to apoptosis?
There are several conflicting findings regarding the susceptibility of polyploid
hepatocytes to apoptosis. Apoptosis occurs in association with increasing polyploidy
in rats pre-treated with the cell cycle inhibitor, retrorsine and given T3 (Oren et al.,
1999). The formation of 'giant' polyploid cells in the livers of LEC rats associated
with increasing copper accumulation also results in cell death through apoptosis
(Yamada et al., 1998). Disruption of cell cycle checkpoints through the deletion,
mutation or upregulation of specific genes also results in polyploidy and subsequent
apoptosis. Examples include the downregulation of the zinc finger protein, KRC
(Allen and Wu, 2000) and transfection of p21Wafl (Sheikh et al., 1995). The livers of
Trident (the winged helix transcription factor) and ERCC-1 (involved in NER)
knock-out mice show extensive polyploidy with reduced binucleation and the mice
die before weaning due to liver failure (Korver et al., 1998; McWhir et al., 1993;
Nunez et al., 2000; Weeda et al., 1997). Examination of the polyploid cells in each
of the above cases revealed that the nuclei, in the main, were grossly abnormal.
These studies certainly provide evidence to link increasing polyploidy with
apoptosis. However, can the development of 'giant' or abnormal polyploid cells be
related to polyploidy which occurs in normal development or polyploidy induced by
the short-term administration of drugs such as PB? Melchiorri et al., 1993, found
that polyploid cells induced by administration of Lead nitrate were not preferentially
eliminated. Similarly, results form this thesis demonstrated that cultured polyploid
cells were equally susceptible to apoptosis induced by IFNy. As mentioned above,
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polyploid cells induced by PB showed no histological abnormalities. These findings
may therefore suggest that the susceptibility of polyploid cells to apoptosis may be
associated with the degree of polyploidy or induction of 'abnormal' polyploid cells
and may depend on whether or not the cell cycle is disrupted. Further studies are
necessary to determine whether the abnormal polyploid cells are an advancement of
normal polyploidy or whether they occur through different mechanisms.
The increase in polyploidy in the ERCC-1 deficient mice is said to contribute to the
progression of severe aneuploidy by 3 weeks (McWhir et al., 1993). Obviously,
increasing polyploidy and therefore aneuploidy in this case is likely to lead to an
increased risk of hepatocarcinogenesis. Disruption of other cell cycle genes also
results in aneuploidy. Mutations or deletions in genes involved in the mitotic spindle
checkpoint such as Babl (Bernard et al., 1998) and ZwlO and Rod (Basto et al.,
2000; Chan et al., 2000) result in aneuploidy through the misseggregation of
chromosomes during anaphase. There is no information at present to indicate that
polyploid cells occurring during normal development progress to aneuploidy.
However, it would be interesting to determine whether 'normal' polyploid cells
contain copies of all chromosomes.
6.1.3 Size, ploidy and receptor expression
Could cell size play a role in the function ofpolyploid hepatocytes? Large polyploid
cells function as a protective barrier in the urinary bladder (Hicks, 1975) and the
increasing size ofmegakaryocytes is important in the production ofplatelets (Baatout
et al., 1998a). Cell size has also been shown to play important roles in various
processes including proliferation and apoptosis (Lang et al., 1998). Unlike
megakaryocytes and urinary epithelial cells, there is no obvious role of increasing
cell size in hepatocellular function. However, differences could be subtle. Increases
in volume has the potential to result in a dilution of genes and proteins within the cell
and increasing surface area could alter the expression of molecules on the surface.
Such changes could lead to alterations in signalling events. On isolated hepatocytes,
ICAM-1 expression increased in proportion to cell size and ploidy. Whether or not
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all receptors or surface molecules are altered by increasing size or ploidy and
whether differences in receptor expression is functionally important remains to be
seen.
6.2 The Control of Polyploidisation
Studies in yeast, Drosophila, Xenopus, C.elegans and megakaryocytes have revealed
many genes that are important in maintaining ploidy (chapter 1). Overexpression,
mutation, deletion or abnormal phosphorylation events of genes involved in the
Gl/S, G2/M and the mitotic spindle checkpoint can result in the formation of
polyploid cells. The regulatory genes involved in polyploidisation in hepatocytes
remain unknown. The role of the oncosuppressor gene, p53 in Gl/S and G2/M
checkpoints (Stewart et al., 1995) and in the mitotic spindle checkpoint (Ciciarello et
al., 2001) suggests a possible role for this gene in the control of polyploidisation.
The role of p53 in the control of polyploidisation in normal ageing hepatocytes is
however contradictory (Bellamy et al., 1997; Yin et al., 1998). In agreement with the
study by Bellamy et al., 1997, polyploidisation induced by PB occurred
independently of p53. There is however, evidence that p53 plays a role in
polyploidisation after mitotic spindle damage (Casenghi et al., 1999; Minn et al.,
1996; Notterman et al., 1998), which may suggest that regulation of ploidy may
occur through different mechanisms under different circumstances. The mechanisms
controlling ploidy in normal ageing hepatocytes may therefore differ from those
involved in polyploidisation after cellular or genetic damage.
A valuable technique in the study of genetic regulation in polyploid cells is
microarray technology. Galitski et al., 1999, used this technique to determine which
genes are involved in the polyploidisation of yeast. A similar study was carried out
on sorted hepatocytes in this thesis. However, the cells were not in exponential
growth and genes involved in the control of polyploidisation were therefore not
expected to change. The genes that were upregulated or repressed in the polyploid
cells may however, be important to the function or maintenance of ploidy in
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hepatocytes. Biological assays are required to determine if this is the case.
Mononuclear and binuclear hepatocytes containing the same DNA content were not
possible to separate in this study. Whether binuclear cells are purely an intermediary
stage in the formation ofpolyploid cells is unknown and needs to be examined.
6.3 Future Work
Whether polyploidisation is a protective mechanism or whether it is an advancement
of terminal differentiation and senescence resulting in a higher susceptibility to
apoptosis requires further study. In either case, understanding the regulation of this
process is vital in the control, prevention and treatment of disease. The use of sorting
and microarray technology to study hepatocytes in exponential growth will require
some characterisation but will provide vital information into the genes involved in
polyploidisation. Confocal microscopy and image analysis can be used to visualise
genes involved in the process in different hepatocyte populations. The use of
biological assays will help to determine the function or role of MUP2, Pterin and
IFNyR in polyploid cells.
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Packard Instruments Company Inc., II USA
OptiQuant software
Phosphoimager
Super resolution (type SR) Phosphor screens
Pharmingen, San Diego, CA
FITC hamster a-IgG, group 1 antibody
Hamster a-mouse CD54 (ICAM-1) antibody
Purified rat IgG2a, k antibody









Santa Cruz Biotechnology, Inc., CA, USA
Normal rabbit IgG
Rat a mouse IFNyR P chain antibody
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FITC-sheep a rabbit IgG antibody
FITC-rabbit a rat IgG2a antibody
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Boric Acid (For molecular biology) BSA
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Carbodiimide
Collagen type 1 (From rat tail)
Collagenase type 4
Chee's modified medium
Chloroform (For molecular biology)
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Buffers and solutions are listed in the order they are used in Materials and Methods
(Chapter 2). PBS was made in distilled water from tablets obtained from Sigma.
TISSUE CULTURE
Stock Solutions:










Add 0.6 ml /100 ml sterile H20.
Dissolve 19.5 mg in 100 ml sterile H20.
Dissolve 10 mg of collagen type 1 (from rat-tail) in 50 ml
0.1M Acetic acid (0.02% w/v). Sterilise solution by adding 5
ml chloroform and leave at 4°C overnight.
Dissolve 1 mg in 1ml absolute ethanol and 1 ml PBS (0.04
mg/ml). Store @ -20°C in 500 pi aliquots.
Dissolve 100 mg in 5 ml sterile H20 (20 mg/ml). Store @ -
20°C in 500 pi aliquots.
Dissolve 100 pg in 4 ml of Chee's modified medium (25
pg/ml). Store @ -20°C in 500 pi aliquots.
Dissolve in 5 ml sterile H20. Store @ -20°C in 500 pi
aliquots.
Dissolve 500 mg in 5 ml sterile H20. To 5 ml Chee's
modified medium, add 250 pi (5 mg/ml). Store @ -20°C in
500 pi aliquots.
Add 2.2 ml Hanks' buffered saline to 20 ml Percoll.
Media:
Amount of Stock (in 500 ml) /Final Concentration
Liver Perfusion Medium
Gentamicin 500 (0.1 / 0.1 mg/ml
Hanks' Buffered Salt Solution (Digestion medium)
Gentamicin As above
DMEM F12 (Incl. Hepes), pH 7.4 (Plating medium)
Gentamicin As above
L-Glutamine 10 ml / 4 mM
Dexamethasone 500 (ol / 0.04 (og/ml
ITS 500 [ol
lMNaOH 1ml





EGF 500 |ol / 0.025 |og/ml
1M NaOH As above
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Collagen Coating of Slides and Plates
Add 2 volumes carbodiimide solution to 1 volume of collagen solution and coat
plates using the following volumes:
Slide/Plate Surface area (cm ) Volume of Carbodiimide/collagen
per well (mis)
8-well glass slides 0.69 0.2
6-well plates 9.6 1.0
Small petri dishes 21.5 1.8
FLOW CYTOMETRY







Dissolve in 800 ml
distilled H20, adjust pH
and make up to 1 1.
Stock solution, pH 7.6
Tri-Sodium citrate 2 g
Tris 121 mg
Spermine tetrahydrochloride 1.044 g
Nonidet P40 2 ml
Dissolve in 1.8 1
distilled water, adjust pH
and make up to 2 1.
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Solution A, pH 7.6
Trypsin 15mg Dissolve in 500 ml stock solution.
Store at -20°C in 10 ml aliquots, bring to room temperature before use.
Solution B, pH 7.6
Trypsin inhibitor 250 mg Dissolve in 500 ml stock solution.
RNase A 50 mg Store as for solution A.
Solution C, pH 7.6
PI 208 mg Dissolve in 500 ml stock
Spermine tetrahydrochloride 500 mg soln. Store as for solution A.
Bring to 0°C before use.
MOLECULAR TECHNIQUES
Buffers:
Church and Gilbert Hybridisation Buffer (100 ml)
1 M Sodium phosphate, pH 7.2 20 ml
0.5 M EDTA 0.2 ml
BSA 1 g
20% SDS 33 ml
deionised formamide 15 ml
H20 32 ml
Array Wash Buffer (500 ml)
1 M Sodium phosphate, pH 7.2 20 ml
0.5 M EDTA 1.25 ml
20% SDS 25 ml
H20 Up to 500 ml
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RNA Extraction Buffer (500 ml), pH 7.0
Guanidine isothiocyanate
0.75 M Sodium citrate
5% n-lauroylsarcosine
P-mercaptoethanol
23.63 g -i Dissolve in 300 ml mQ
0.37 g H20, adjust pH, make
0.25 g _ up to 500 ml.
360 pi /50 ml Soln. Add prior to use.
50x TAE Buffer (500 ml), pH 8-8.2
Tris 121 g
Glacial acetic acid 28.6 ml
0.5 M EDTA (pH 8) 50 ml
Dissolve in 300 ml mQ
H20, adjust pH, make
up to 500 ml.
TBE Buffer (500 ml)
Tris 54.45 g
Boric acid 24.35 g
EDTA 5.0 g
Dissolve in 300 ml mQ
H20, make up to 500 ml.
OTHER SOLUTIONS
Bourn's fixative (500 ml)
Methanol 425 ml
Glacial acetic acid 25 ml
40% Formalin 50 ml
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APPENDIX 3
SAMPLES USED FOR GENE EXPRESSION ANALYSIS
Purity and proportion of mononuclear and binuclear cells in samples
Sample Sample % Purity % Mono¬ % Binuclear No. of Sorted
(Date) No. (Gated nuclear cells cells Events/No. of
Events) cells
2n (12/10/00) 1 90.0 93.1 6.9 262610
2n (17/10/00) 1 92.6 95.1 4.9 355582
2n (8/11/00) 1 97.8 98.0 2.0 381662
2n (10/11/00) 1 95.0 - - 302081
2n (27/11/00) 2 93.0 97.0 3.0 157309*
2n (30/11/00) 2 91.0 98.0 2.0 43789*
4n (10/10/00) 3 95.0 26.0 74.0 533898
4n (12/10/00) 3 91.3 26.7 73.3 366506
4n (17/10/00) 3 97.1 24.3 75.7 989562
4n (1/11/00) 3 93.5 24.1 75.6 2354231
4n (8/11/00) 4 94.7 32.0 68.2 800334
4n (10/11/00) 4 95.5 20.8 79.0 730062
4n (20/11/00) 4 91.8 18.0 82.0 2417843
4n (22/11/00) 5 90.1 23.0 77.0 162413*
4n (27/11/00) 5 97.0 - - 300045*
4n (30/11/00) 5 95.0 20.0 80.0 207851*
4n (12/12/00) 5 98.4 21.0 79.0 330028*
8n (10/10/00) 6 78.6 17.9 79.3 162987
8n (17/10/00) 6 69.7 10.8 88.3 571553
8n (1/11/00) 6 82.3 6.8 87.8 733876
8n (8/11/00) 7 89.1 9.3 89.7 458180
8n (10/11/00) 7 84.2 4.4 85.6 627953













8 14 66 20 28.2 71.8
Total Young (3/2/01)
3 weeks
9 38 35 0.6 41.6 58.2
Total Old (20/11/00)
17 weeks
10 17 72 8 25 75
* Cells in S-phase not included
















1. 2n 93.8 ±3.3 95.4 ±2.5 4.6 ±2.5 5.6 1301935
2. 2n 92.0+1.4 97.5 ±0.7 2.5 ±0.7 9.8 201098*
3. 4n 94.2 ± 2.4 25.3 ± 1.3 74.6 ± 1.2 53.1 4244297
4. 4n 94.0 ± 1.9 23.6 ±7.4 76.4 ±7.3 49.8 3948239
5. 4n 95.1 ±3.6 21.3 ± 1.5 78.7 ± 1.5 40.7 1000337*
6. 8n 76.9 ±6.5 11.8 ± 5.6 85.1 ±5.1 25.2 1468416




COMPARISONS CARRIED OUT USING MICROARRAY ANALYSIS
Comparison Sample No.
(See Appendix 3)
Sample Type Date ofAnalysis
1 N/A Unsorted v 8n 21/8/00
2 1 v4 2n v 4n 22/01/01
3 1 v7 2n v 8n 22/01/01
4 2 v 5 2n v 4n 19/02/01
5 3 v 6 4n v 8n 19/02/01
6 lOv 11 TYvTO 19/02/01
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Polyploidy and binuclearity are characteristics of the mammalian liver. Increasing
polyploidisation occurs with age and after administration of various drugs and
chemicals. This study was designed to examine the function of ploidy by addres¬
sing several questions: (1) Does the increase in size of polyploid hepatocytes have
any physiological function by altering surface receptor expression such as inter¬
cellular adhesion molecule-1 (ICAM-1, CD54) or IFNyR? and (2) Do polyploid
cells respond differently to inflammatory cytokines such as interferon gamma
(IFNy)? We have developed a method to accurately measure the volume of live
isolated hepatocytes using confocal microscopy and image analysis. Using flow
cytometry, we have shown that the expression of ICAM-1 increases with increas¬
ing DNA content and IFNyR is not detectable on isolated mouse hepatocytes.
Diploid (2n), tetraploid (4n) and octoploid (8n) hepatocytes were found to be
equally susceptible to IFNy-induced apoptosis in vitro. Although the function of
polyploidy remains unanswered, we have described some of the characteristics of
polyploidy in isolated hepatocytes and in vitro. J. Cell. Physiol. 191: 138-144,
2002. © 2002 Wiley-liss, Inc.
The mammalian liver consists of hepatocytes with
different DNA content or ploidy (Alfert and Geshwind,
1958; Carriere, 1967; Schulte-Hermann, 1974; Brodsky
and Uryvaeva, 1977). Polyploid cells can be mono¬
nuclear or binuclear and it is important to distinguish
between them. In this study, the term polyploid refers to
cells with an increase in DNA content and includes both
mononuclear and binuclear cells. However, where we
have been able to separate mononuclear from binuclear
cells, we make this distinction. In C3H male mice of
16 weeks of age, the majority ofparenchymal cells are 4n
(70%) and 80% are binuclear. Diploid and 8n cells make
up 20% and 9.5% of the parenchymal population, res¬
pectively. The degree of polyploidisation varies among
mammals. The human liver is predominantly 2n with
polyploid hepatocytes occurring in later life (Kudryavt-
sev et al., 1993). Polyploidisation also increases after
partial hepatectomy and after administration ofvarious
drugs and chemicals (Steele et al., 1981;Melchiorri et al.,
1993; Hasmall and Roberts, 1997; Sigal et al., 1999;
Martin et al., 2001).
There is no evidence to suggest why polyploidisation
occurs in the liver and conflicting theories exist. One
hypothesis suggests that it could be a protective res¬
ponse; cells containingmore than the normal number of
chromosomes may be protected from dominant expres¬
sion ofmutated oncogenes (Schwarzeetal., 1984). Other
theories suggest that polyploidisation is purely a ter¬
minal differential state associated with ageing (Sigal
et al., 1995). A review by Gupta (2000) concluded that
polyploid cells might be more susceptible to apoptosis,
which could lead to organ failure and oncogenesis.
To test these theories, we have examined some of the
features of diploid and polyploid mouse hepatocytes,
including cell volume, receptor expression and response
to IFNy.
Cell size and volume have previously been examined
in mouse, rat and human livers using various methods
including cytophotometry and microspectrophotometry
(Epstein, 1967; Watanabe and Tanaka, 1982), stereo-
logical image analysis (Danielsen et al., 1986) and
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Coulter counter and sedimentation velocities (Sweeney
et al., 1979; Deschenes et al., 1981). In all of these
studies, there is evidence that increasing cell size is
proportional to increasing DNA content. Alterations in
cell volume participate in a wide variety of functions
including cell proliferation and cell death (Lang et al.,
1998). We have used confocal microscopy and image
analysis to investigate whether the increase in size of
polyploid cells could provide any physiological function
by reducing the density of receptors i.e., ICAM-1 or
IFNyR on the surface and preventing or reducing injury
or cell death.
ICAM-1 is a member of the immunoglobulin super-
gene family, which is expressed on hepatocytes after
dissociation of cell-to-cell contact (Ohno et al., 1995), or
after induction with pro-inflammatory cytokines such as
tumour necrosis factor-alpha (TNFoO and IFNy (Bum-
gardner et al., 1998; Oudar et al., 1998). Expression of
this adhesion molecule has been found to be important in
certain inflammatory processes in the liver, including
hepatitis and liver graft rejection (Schroder et al., 1995;
Bumgardner et al., 1998). Therefore, any differential
expression of ICAM-1 on 2n and polyploid cells could be
clinically important.
IFNy is thought to play a role in hepatitis in humans
and mice (Peters et al., 1991; Gilles et al., 1992) and is
known to cause G1 cell cycle arrest and apoptosis in
hepatocytes (Shinagawaetal., 1991;Moritaetal., 1995;
Kano et al., 1997). IFNy exerts its effects by first inter¬
acting with specific membrane receptors (Rubinstein
et al., 1987; Langer and Pestka, 1988). Therefore, in
addition to ICAM-1 expression, we have looked at the
expression of the IFNyR subunits, a and (1 on 2n, 4n
and 8n hepatocytes. We have studied whether the cells
that undergo IFNy-induced apoptosis are predomi¬
nantly diploid or polyploid by examining the cells that
remain alive after treatment with IFNy using flow
cytometry.
The aim of this study was to determine if polyploidy
could provide a protective role either by altering the
density of surface receptors or by responding differently
to IFNy. We have also developed a method to accurately
measure the volume of live isolated hepatocytes of
different ploidy and nuclearity.
MATERIALS AND METHODS
Isolation of hepatocytes and cell culture
Primary hepatocytes from C3H male, 6—12 weeks old,
were isolated using a retrograde two-step liver perfusion
procedure and purified by centrifugation through
Percoll (Amersham Pharmacia Biotech, Little Chalfont,
UK) (Bellamy et al., 1997). The hepatocytes were plat¬
ed onto collagen-coated 8-well glass slides and 6-well
culture plates (Life Technologies, Paisley, UK) in
Dulbecco's Modified Eagle's Medium/Nutrient Mixture
F12 Ham (DMEM F12; Life Technologies) containing
2% FCS, gentamicin (50 mg/ml, Life Technologies),
L-glutamine (4 mM; Life Technologies), dexametha-
sone (0.04 gg/'ml; Sigma, Poole, UK), insulin-transfer-
rin-Sodium selenite media supplement (ITS; Sigma).
Cells were plated at a density of 0.3—0.4 x 10'Vcm2.
After 24 h, media was replaced with Chee's modified
medium (Sigma) containing gentamicin, L-glutamine,
dexamethasone, ITS and EGF (0.025 pg/ml; Sigma). IFNy
(100 U/ml) was administered in Chee's medium for
4 days. Controls were set up without IFNy. Experiments
were set up in 5 wells per condition and repeated three
times. Each experiment showed the same trend and
were combined. Values are given as mean ± standard
deviation (S.D.).
Feulgen's staining for apoptosis
Apoptotic cells can be distinguished from necrotic cells
by their distinct morphology. To determine the amount
of apoptosis at each time-point, slides were fixed in
Bouin's fixative (methanol (85%), acetic acid (5%),
formalin (10% of 40% solution)) overnight at 4"C. After
denaturing with 5N HC1 for 45 min at room tempera¬
ture, slides were stained in Schiffs reagent (Sigma) for
1 h and counterstained in light green (0.1%, Merck,
Lutterworth, UK). A minimum of 500 cells was counted
and the results were expressed as the percentage of
apoptotic cells.
BrdU immunohistoehemistry
Hepatocytes cultured on 8-well slides were given
BrdU (1 pl/ml, Amersham) for 3 h prior to fixation in 80%
ethanol. Slides were incubated in 5N HC1 for 45 min
at room temperature. Rat a-BrdU (Harlan Sera-labs,
Loughborough, UK) diluted 1 in 100 in blocking solution
(PBS, NRS (20%), Tween 20 (0.05%)) was added for 1 h.
Negative controls omitted this antibody. Peroxidase-
conjugated rabbit a-rat (Sigma) pre-absorbed with
normal mouse serum (50%) and diluted 1 in 100 in
blocking solution, was added for 30 min. Positive cells
were visualised using DAB chromagen. Cells were coun¬
terstained with haematoxylin and light green. The re¬
sults are expressed as the percentage of BrdU positive
cells. A minimum of 500 cells was counted.
Hepatocyte DNA content
The DNA content of hepatocytes treated with IFNy
and controls was determined by flow cytometry. Isolated
hepatocytes were compared with cells plated for 24 h to
determine the plating efficiency of the different ploidy
populations. Hepatocytes for analysis were fixed after
the perfusion or were removed from culture plates
using a trypsin (0.12%)/EI.)TA (0.02%) solution and cell
scraper. Cells were fixed in cold 70% ethanol overnight
at 4 C and stained with propidium iodide (PI, 20 pg/ml;
Sigma), RNase (0.2 mg/ml; Sigma) and Triton X-100
(0.1%; Sigma) in phosphate buffered saline (PBS) for
15 min at 37"C. Flow cytometric analysis was carried
out using a COULTER EPICS'" XL Flow Cytometer
(Beckman-Coulter Electronics, Luton, UK). PI was
excited at 488 nm and the red fluorescence emitted
was detected at 620 nm. A minimum of 5,000 cells was
counted. Mononuclear and binuclear cells with the same
DNA content fell within the same gate and were not
distinguished in this analysis.
Confocal imaging to measure cell volume
Isolated hepatocytes were plated on collagen-coated
glass coverslips (in 6-well plates) in Chees's medium
containing 2% FCS for V2 h at 37 C. The nucleic acid
stain, SYTO 16 (5 pM; Molecular Probes, Cambridge
Bioscience, Cambridge, UK) and CellTracker Orange
(CTO; 5 pM) (Molecular Probes) were added in fresh
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media for V2 h at 37 C. Glass coverslips were transferred
to small petri dishes and covered in fresh media for
confocal imaging. Confocal microscopy and calibration
of the system for volume determination was carried out
as previously described (Bush and Hall, 2001). Confocal
images were acquired with the Leica TCS NT confocal
system (Leica Microsystems, Heidelberg GmbH, Heidel¬
berg, Germany). A 63x water immersion lens, fitted to
the upright Leica DMRE microscope was used to collect
quantitative fluorescent images ofhepatocytes in optical
Z-steps of ~1 pm. SYTO 16 was excited at 488 nm and
CTO at 568 nm. A minimum of 300 measurements was
taken for nuclear diameter analysis and 70 measure¬
ments for cell volume analysis. For the calibration of
diameter, images of Flouresbrite Microspheres (mean
10 |im ± 0.1; Polysciences, Warrington, PA) were taken
using the same procedure.
Measurement of nuclear diameter
and cell volume
Image analysis was performed on a Silicon Graphics
O2 workstation (Silicon Graphics Inc., Mountain View,
CA) running Bitplane (Bitplane Inc., Zurich, Switzer¬
land), Imaris and VoxelShopPro Software. Volume mea¬
surements were carried out as previously described
using an intensity threshold technique (Bush and Hall,
2001). The study util ised GalceinAM as the cytoplasmic
fluorosphere. Due to the similar spectral response of
Syto 16 to Calcein AM, our study utilised the red shifted
dye, CTO. To check the validity of CTO, hepatocytes
were co-loaded with CTO and Calcein AM and volume
analysis was performed. Cell volumes obtained were
consistent (r2 = 0.78, P > 0.05). However, CTO derived
volumes were an order of magnitude smaller (1.7x ±
0.25). Hence, volume measurements were amended to
account for this. Nuclear diameter was measured using
the same confocal images and software. Measurements
were taken at the central plane of each image. Using
this technique, the diameter of the 10 pm beads was
9.41 pm ± 0.65. Therefore, there was no need to adjust
the nuclear measurements.
Receptor expression
ICAM-1 (CD54) expression was studied on isolated
hepatocytes by staining cells with a FITC-conjugated,
hamster a-mouse CD54 antibody (0.5 mg/ml; Pharmin-
gen, San Diego, CA) diluted 1 in 10 in PBS with 0.1%
sodium azide and 1% BSA for 1 h at 4°C. Isotype controls
were included in analysis (FITC hamster a-IgG, group 1;
Pharmingen). IFNyR expression was determined using
an indirect method. Isolated hepatocytes were stained
with purified rat a-mouse CD 119 (IFNyR a chain,
0.5 mg/ml; Pharmingen) or rabbit a-mouse IFNyR (3
chain (200 pg/ml; Santa Cruz Biotechnology, Inc., Santa
Cruz, CA) after blockingwith appropriate serum in PBS
with 0.1% sodium azide and 1% BSA for 10 min. Cells
were incubated for 1 h at 4"C. Isotype controls were
included (purified rat IgG2a, k; Pharmingen and normal
rabbit IgG; Santa Cruz). Undiluted FITC conjugated
secondary antibodies (FITC-a rat IgG2a and FITC-a
rabbit IgG; Serotec, Oxford, UK) were incubated with
cells for 30 min at 4°C. To determine the DNA content,
cells were fixed in 70% ethanol and stained with PI,
RNase and Triton X-100, as above. Receptor expression
and DNA content was measured by flow cytometry using
a BD FACS Calibur (Becton Dickinson, Oxford, UK). PI
and FITC were both exited at 488 nm; the red
fluorescence emitted by PI was detected at 620 nm and
the green fluorescence emitted by FITC was detected at
525 nm. A minimum of 5,000 cells was counted and each
experiment was carried out in triplicate. The data was
normalised by making the intensity of fluorescence of2n
cells equal to 1 and calculating the intensity for 4n and
8n cells accordingly. Values of fluorescence intensity for
2n, 4n and 8n cells were plotted against average cell
volume, determined by confocal imaging.
Statistics
GraphPad InStat Software (GraphPad Software Inc.,
Redfern, CA) was used for the following statistical
analyses: The proportion of 2n and 8n cells within each
ploidy population at time 0, after 5 days in culture
(Control), after treatment with IFNy (IFN-g) and before
and after plating was compared using a one-way
ANOVA. The proportion of 4n cells was compared using
a Kruskal—Wallis test. The nuclear diameter of the 2n
and 4n populations and the volume of the 2n, 2 x 2n, 4n
and 2 x 4n cells were compared using an unpaired t-test
with a Welch correction for volume. A paired t-test was
used to compare the diameter of nuclei from the same
cell. Linear regression analysis was carried out using
Microsoft Excel Software (Microsoft Corporation, Red-
fern, CA).
RESULTS
Determination of ploidy and volume of
hepatocytes using confocal microscopy
Images obtained using confocalmicroscopy and Imaris
imaging software allowed the accurate determination of
nuclear ploidy and absolute cell volume. The nuclear
diameter of all nuclei measured was plotted as a fre¬
quency histogram and the diameter of 2n ranged from
7.0 to 9.0 pm and 4n ranged from 9.5 to 11.5 pm (Fig. 1).
The nuclei falling within each range were found to be
significantly different to each other (P < 0.001). There
was no significant difference in the nuclear diameter of
nuclei from the same cell. From the 300 nuclei analysed,
only one 8n nuclei was measured and therefore, the
accurate determination of the diameter of8n nuclei was
not possible. The proportion of 2n and 4n nuclei plotted
on the frequency histogram was found to be similar to
the proportion of 2n and 4n nuclei analysed by flow
cytometry (data not shown).
The volume of binuclear 2n cells (2 x 2n; 7035 ± 2391
pm3) and mononuclear 4n cells (4n; 7352 ±1650 pm3)
was 1.7-1.8-fold greater than mononuclear 2n cells (2n;
4154± 1137 pm3,P< 0.001).The volume ofbinuclear 4n
cells (2 x 4n; 14326 ±4453 pm3) was 1.9-2.0-fold
greater than 2 x 2n and 4n cells (P < 0.001). There was
no significant difference in the volume of 2 x 2n and 4n
cells (Fig. 2).
Fluorescence intensity of ICAM-1 (CD 54),
but not of IFNyR, increases in
relation to DNA content
Two-parameter flow cytometry was used to measure
the expression of ICAM-1 or IFNyR and DNA content of
hepatocytes. This was compared with the volume of
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Fig. 1. Measurement of nuclear diameter of hepatocytes with dif¬
ferent I)NA contents. A: Confocal images of hepatocytes stained with
dyes CTO (protein) and SYTO 16 (nucleic acid). B: Frequency histo¬
gram of nuclear diameter measured from confocal images and Imaris
imaging software. Arrows indicate the peaks corresponding to 2n and
4n nuclei.
hepatocytes with different DNA contents measured by
confocal imaging. Mononuclear and binuclear cells with
the same DNA content cannot be distinguished using
flow cytometry. Therefore, the volume of binuclear 2n
(2 x 2n) and mononuclear 4n cells was combined. The
linear relationship between fluorescence intensity of
ICAM-1 and average volume of 2n, 4n (2 x 2n and 4n)
and 8n (2 x 4n) cells was highly significant, demonstrat¬
ing that expression of ICAM-1 increases in proportion to
volume and DNAcontent (r2 = 0.907, P < O.OOOlMFig. 3).
The fluorescence intensity of IFNyR was the same as
22000
Fig. 2. Volume of hepatocytes measured from confocal images and
Imaris imaging software. *Significantly lower than 2 x 2n and 4n,
P< 0.05. "Significantly higher than 2 x 2n and 4n, P < 0.05. Values
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Fig. 3. Plot of average volume measured by confocal imaging against
fluorescence intensity of ICAM-1 measured by flow cytometry for 2n,
4n and 8n hepatocytes. The values represent mean volume ± SD of 2n,
4n (2 x 2n and 4n) and 8n (2 x 4n) cells. Graph shows the line of best
fit, r2 = 0.907, P< 0.0001.
isotype controls. Background fluorescence (isotype con¬
trols) was low and increased with increasing DNA
content. However, the ratio of fluorescence intensity of
ICAM-1 to background was equal for all cells and was
therefore, excluded from the analysis.
IFNy induces apoptosis in all ploidy
populations equally
Feulgen stainingwas used to determine the amount of
IFNy-induced apoptosis. After 4 days administration of
IFNy, 30%-40% of hepatocytes had condensed frag¬
mented chromatin and were visibly apoptotic (Fig. 4).
Analysis of the hepatocytes that were alive after 4 days
treatment using flow cytometry showed that the
proportion of 2n (8.0 ±1.6), 4n (65.8 ±6.0) and 8n
(15.1 ± 2.9) cells was the same as controls (2n 8.2 ± 1.4;
4n 67..1 ± 5.2; 8n 16.3 ± 3.0) (Fig. 5). This indicates that
IFNy induces apoptosis in all ploidy populations equally.
The control hepatocytes showed a significant decrease in
4n cells (67.1 ± 5.2 c.f. 76.7 ± 1.9,P < 0.001) and increase
in 8n cells (16.3 ± 3.0 c.f. 12.7 ± 2.8, P < 0.05) over 5 days
in culture, (Fig. 5). BrdU positivity was apparent in
mononuclear (13% ± 0.5) and binuclear cells (11% ± 2.8)
after 4 days in culture. The proportion of 2n, 4n and 8n
cell did not change after plating.
DISCUSSION
The reasons for increasing polyploidisation as a func¬
tion of age or after the administration of toxic chemicals
remain largely unknown. We have studied the different
ploidy populations in the mouse liver to try and deter¬
mine the differences between 2n, 4n and 8n cells with
respect to cell volume, receptor expression and response
to IFNy.
We found that the volume of cells approximately
doubled with doubling DNA content, that the volume of
mononuclear and binuclear cells containing the same
amount of DNA was the same and that the nuclei of
binuclear cells were the same size. Other studies in
humans, mice and rats, utilising methods such as
cytophotometry and microspectrophotometry, stereolo-
gical image analysis and coulter counter and sedi¬
mentation velocities have shown similar trends
(Epstein, 1967; Sweeney et al., 1979; Deschenes et al.,
1981; Watanabe and Tanaka, 1982). Such studies have














Fig. 4. Induction of apoptosis by IFNy. Feulgen staining of hepatocytes, arrows indicate apoptotic nuclei.
A: Control and (B) IFNy-treated. Images were captured using a 40 x objective.
relied on mathematical calculations and assumptions
that cells are spherical in their calculation of cell size
and volume. However, the use of confocal microscopy
and image analysis negates these assumptions and
calculations and therefore, this study provides the first
accurate measurements of mouse hepatocyte cell
volume. The actual measurements of nuclear diameter
were slightly larger than those described by Danielsen
et al. (1986) who measured cells within tissue sections
and found the diameter of 2n mouse hepatocytes ranged
between 6.0 and 7.5 pm and the diameter of 4n cells was
between 7.5 and 9.0 gm. This was expected due to the
shrinkage of cells during fixation.
Cell volume participates in a wide variety of functions
including cell proliferation and cell death (Lang et al.,
1998) and the possibility that the increase in size of
polyploid cells could be involved in the regulation of
these cells has not been studied. Schmidt and Schibler
(1995) suggested that cell size and volume was a factor
controlling the expression of various genes, including
the leucine zipper protein, DBF although the ubiquitous
transcription factors, Octl and NF-Ywere not regulated
90
2n 4n 8n
Fig. 5. DNA content of cells remaining after IFNy treatment.
Proportion of 2n, 4n and 8n cells in culture before treatment (Time
0) and with (IFN-g) or without (Control) IFNy for 4 days. Values
represent mean ± SD, n — 15. *Significantly different to Time 0,
P < 0.05.
by size. A study by Le Rumeur et al. (1981) found 4n
hepatocytes produced twice asmuch albumin as 2n cells.
Similarly, the production of succinate dehydrogenase
and NADPH cytochrome C were found to be the same.
However, the activity of lactate dehydrogenase was
much lower in 2n cells (Tulp et al., 1976). This study
proposed that one way increasing cell size could modu¬
late the function or response of hepatocytes to signals
was by altering the expression of molecules such as
ICAM-1 and IFNyR on the cell surface.
ICAM-1 is expressed on hepatocytes after dissociation
of cell-cell contact (Ohno et al., 1995) and is important
in inflammatory processes, including hepatitis and liver
transplant rejection (Schroder et al., 1995; Bumgardner
et al., 1998). Therefore, cell volume measurements were
used in conjunction with flow cytometry to analyse
ICAM-1 expression on 2n, 4n and 8n cells. Our results
indicate that the fluorescence intensity of ICAM-1
increases in proportion to DNA content. As the volume
of hepatocytes approximately doubles with doubling
DNA content and the fluorescence intensity of ICAM-1
increases accordingly, the polyploid cells actually ex¬
press a greater number of ICAM-1 molecules. Assuming
that fluorescence intensity approximately equates to the
number of ICAM-1 molecules on the surface, the density
of ICAM-1 is actually greater on the polyploid cells, as
surface area (sphere = rcr2) does not increase to the same
extent as volume (sphere 4/37rr'h- Whether or not the
receptor density or actual number of receptors on hepa¬
tocytes is functionally important remains to be seen.
The expression of IFNyR was of particular interest
as we were also studying the effects of IFNy on dif¬
ferent populations of hepatocytes. However, IFNyR a or
P chains could not be detected in this study. IFNyR is not
expressed at detectable levels on normal human hepato¬
cytes (Volpes et al., 1991) and this could also be the case
in the mouse. A study by LeClaire et al. (1992) demon¬
strated by immunocytochemical staining that the
majority of immunologically reactive mouse IFNyR
protein is intracellular.
Although IFNyR was not detectable on isolated
hepatocytes, IFNy did induce apoptosis in culture, in
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agreement with other studies (Shinagawa et al., 1991;
Morita et al., 1995; Kano et al., 1997). The mechanism
through which IFNy exerts its effects is largely un¬
known, although interferon regulatory factor-1 (IRF-1)
has been shown to be essential in IFNy-induced
apoptosis (Kano et al., 1999). Analysis of gene expres¬
sion in 2n, 4n and 8n cells would have been an interest¬
ing way to study the effect of IFNy on these cells.
However, the time course of effects following IFN7 is
quite prolonged and the majority of cells at earlier time
points are unaffected by IFNy. Changes in gene ex¬
pression before 72 h would be very small or undetect¬
able. Therefore, we have examined the cells that remain
alive after treatment with IFNy for 4 days, to determine
if polyploid cells are more susceptible to apoptosis.
The proportion of 2n, 4n or 8n cells was not altered by
treatment with IFNy for 4 days in culture. Therefore, it
appears that 2n, 4n and 8n hepatocytes are equally
sensitive to IFNy-induced apoptosis in vitro: There is
conflicting evidence regarding the susceptibility of poly¬
ploid cells to apoptosis and injury. A study by Melchiorri
et al. (1993) found that after administration of the mito¬
gen, lead nitrate, the elimination of excess cells by
apoptosis did not occur preferentially in the polyploid
population. In contrast, Oren et al. (1999) found that the
rate of apoptosis was increased in polyploid cells after
administration of the potent hepatic mitogen, triiodo¬
thyronine (T3) to rats pre-treated with the cell cycle
inhibitor, retrorsine. Sigal et al. (1999) suggested that
apoptosis accounted for the decrease in the proportion of
8n cells 5 days after a partial hepatectomy. Increased
rates of apoptosis have also been found in the livers of
Long-Evans Cinnamon (LEC) rats, where the liver has
become populated with megalocytes, containing enor¬
mous nuclei (Gupta, 2000). The difference in the sus¬
ceptibility of polyploid cells to apoptosis may be related
to the type of polyploid cell or to the type of injury
inflicted on the cell.
The plating efficiency of all hepatocytes was equal.
However, after 5 days in culture the proportion of 4n
cells decreased, the 8n cells increased and there was no
change in the 2n population. BrdU immunohistochem-
istry showed that both mononuclear and binuclear cells
proliferate in these cultures and time-lapse experiments
demonstrated that the cells were capable of dividing
(data not shown). Rat hepatocytes have been shown to
undergo polyploidisation (Mossin et al., 1994) and cell
fusion (Gomez-Lechon et al., 1981) in culture. Why the
proportions of 4n and 811 cells alter while 2n cells
remains the same in this study is unknown. However, it
is likely that the proportions are altered through a
combination ofcell death, proliferation, polyploidisation
and cell fusion and the change in each cell population
will depend on the susceptibility of cells to each of these
processes.
This work illustrates that the volume of hepatocytes
approximately doubles with doubling DNA content and
this increase in volume is accompanied by a propor¬
tionate increase in ICAM-1 expression. Whether the
number of receptors is biologically relevant and whether
all the hepatocyte populations respond equally to the
signals received from such receptors is unknown. IFNy-
induced apoptosis in all hepatocytes in culture equally
although IFNyR was not detectable on isolated cells.
Further analysis ofreceptor expression and responses to
cytokines such as IFNy are required to help determine
the function of polyploid hepatocytes and to determine
whether polyploidisation is a protective response.
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Abstract
Liver polyploidisation, characterised by accumulation of tetraploid and octaploid cells, is found with increasing age
and after administration of various drugs. The significance and mechanisms controlling polyploidisation are not
understood but p53 is a candidate gene to be involved. We have investigated the effect of p53 on sodium
phenobarbitone (PB)-induced liver proliferation and polyploidisation. Using p53 wild type ( + / + ), heterozygous
( + / — ) and homozygous ( — / — ) C57BL/6J mice, we measured ploidy and proliferation (BrdU incorporation) after
21 days oral administration of PB. Administration of PB caused a striking ploidy change compared with untreated
controls, with an increase in 8n cells, and no difference noted comparing the p53 genotypes. BrdU positivity also
increased significantly compared with controls, with the increase in BrdU positivity occurring in 8n cells. Our results
confirm that PB is a hepatic mitogen that causes liver polyploidisation with a striking increase in 8n cells within the
liver. p53 status does not appear to have any effect on this PB-induced ploidy change. © 2001 Elsevier Science Ireland
Ltd. All rights reserved.
Keywords: Ploidy; DNA content: Phenobarbitone; p53
I. Introduction
Increasing ploidy with age characterised by ac¬
cumulation of tetraploid and octaploid cells is
found in both rodent and human liver (Schulte-
Hermann, 1974; Brodsky and Uryvaeva, 1977;
* Corresponding author. Tel.: + 44-131-6502880; fax: + 44-
131-6506528.
E-mail address: angus.mcgregor@ed.ac.uk (A.H. McGre¬
gor).
Gahan and Middleton, 1984). Toxic injury caused
by various chemicals and partial hepatectonry also
induce an increase in ploidy, usually associated
with extensive but transient proliferation (Gerlyng
et ah, 1993; Melchiorri et ah, 1993; Styles, 1993).
Furthermore, polyploidisation has been associ¬
ated with the development of hepatocellular car¬
cinoma although its precise role and significance
is uncertain. In some situations polyploidisation
may provide protection against the dominant ex¬
pression of mutated oncogenes (Schwarze et ah,
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1984) and therefore, protect against tumour for¬
mation. However, the mechanisms regulating
polyploidisation are not known and are only now
beginning to be investigated in yeasts (Galitski et
al., 1999). p53 has well-recognised roles in cell
cycle control, mitotic spindle organisation and
apoptosis and is a candidate gene to be involved
in the control of polyploidisation although confl¬
icting evidence exists regarding the role of p53 in
polyploidisation in rodent liver (Bellamy et al.,
1997; Yin et al., 1998).
Sodium phenobarbitone (PB) is a hepatic mito¬
gen in rodents that causes liver enlargement by a
combination of mitosis, an increase in cell size
and an increase in ploidy (Bohm and Noltemeyer,
1981; Lin et al., 1989; Carthew et al., 1998). PB is
also a non-genotoxic hepatocarcinogen (Whysner
et al., 1996) causing development of hepatocellu¬
lar carcinomas in male and to a lesser degree in
female C57BL/10J mice (Jones, personal commu¬
nication). However, while PB is a liver mitogen in
C57BL/6 mice it is not carcinogenic (Evans et al.,
1992) suggesting that the carcinogenic effect is
strain dependent and occurs separately from mito-
genesis. In vitro exposure of hepatocytes to PB
delays and attenuates the G1 checkpoint response
in a p53-dependent manner (Gonzales et al., 1998)
suggesting that p53 may be one intracellular path¬
way through which PB acts (Yin et al., 1998).
We have studied PB-induced liver ploidy
changes and proliferation in C57BL/6 wild type
( + / + ), p53 heterozygous ( + / — ) and p53 ho¬
mozygous ( — / — ) male mice.
2. Materials and methods
2.1. Animals and animal procedures
All animal work was carried out by Zeneca
Pharmaceuticals. Briefly, 5-6-week-old male
C57BL/6 p53 + / + , + / — and — / — mice were
purchased from Taconic Farms, Germantown,
New York and acclimatised for 2 weeks prior to
dosing. Animals were housed five per cage under
appropriate conditions of temperature and hu¬
midity and with a 12-h artificial light cycle. Mice
were fed powdered irradiated R and M Nol
(modified) diet (Special Diet Services) containing
PB (Sigma, UK; 1000 ppm) for 21 days; this
regimen was chosen based on previous data (not
shown). Control groups were fed a similar diet
without PB. Food and water were available ad
libitum. BrdU was administered continuously in
drinking water (0.8 mg/ml) for 72 h before
termination.
2.2. Preparation of liver cells
Mice were euthanised by inhalation of
halothane (FLUOTHANE™, Zeneca Pharmaceu¬
ticals). The mouse body and liver weights were
noted. A representative portion of liver tissue was
removed from the right lobe, fixed in methacarn
overnight and processed to paraffin for histologi¬
cal examination. Fine needle aspirates (FNA)
were then taken using a 20-g needle and making
at least six passes to include each lobe of the liver;
cells were aspirated into citrate buffer (8.6% Su¬
crose, 1.2% trisodium citrate, 5% dimethyl sulfox¬
ide (DMSO) in distilled water, pH 7.6). This
technique yielded similar amounts of tissue from
each case. FNA were stored at — 70°C prior to
use for the determination of ploidy and BrdU
incorporation; samples were stable for several
months.
For ploidy analysis, nuclei were prepared using
the method of Vindelov (Vindelov et al.,
1983a,b,c). The Vindelov technique is a robust
and reliable method of measuring ploidy using
isolated nuclei rather than intact cells; distinguish¬
ing mononuclear or binuclear cells is, therefore,
not possible.
For assessment of proliferation, cells were dou¬
ble-labelled with propidium iodide (PI) and
FITC-labelled anti-BrdU antibody. Fine needle
aspirates were centrifuged at 300 x g for 5 min
and the supernatant was removed. Absolute etha-
nol was added for 20 min and samples were
centrifuged, as before. The samples were washed
twice with phosphate buffered saline (PBS).
Pepsin (Sigma, UK; 0.2 mg/ml in 2 N hydrochlo¬
ric acid) was added for 20 min and samples were
washed twice with PBS and centrifuged at
1000 x g for 10 min. Samples were transferred to
a round-bottomed 96-well plate (NUNC™, Den-
N.C. Martin et al. / Toxicology Letters 119 (2001) 109-115 111
mark), washed in PBS and spun at 1200 x g for
10 min. Rat monoclonal anti-BrdU antibody
(Harlan Sera-lab, UK; diluted 1:100 in PBS, 0.5%
Tween and 0.5% normal rabbit serum (NRS)) was
added and the sample incubated overnight at 4°C.
Samples were washed twice as above and resus-
pended in FITC-labelled rabbit anti-rat antibody
(Serotec, UK; diluted 1:100 with PBS, Tween and
NRS) for 30 min at room temperature. After two
washes with PBS, PI (100 pg/ml; Sigma, UK) and
RNase (0.04%; Sigma, UK) were added to sam¬
ples on ice for 15 min.
2.3. Flow cytometry
DNA content and proliferation were evaluated
using a COULTER®EPICS®XL Flow Cytometer.
PI and F1TC were both excited at 488 nm; the red
fluorescence emitted by PI was detected at 620 nm
and the green fluorescence emitted by FITC was
detected at 525 nm. A minimum of 10 000 nuclei
was counted to determine ploidy and BrdU
profiles.
2.4. Histological assessment
Sections (4 pm) of liver were stained with
haematoxylin and eosin and examined to detect
any histopathological abnormalities. The number
of cells was calculated, counting the total number
of hepatocytes and non-parenchymal cells in ten
high power fields (0.5 mm2 per field). The number
of hepatocytes was then multiplied by the liver
weight to obtain the total number of hepatocytes
for each liver (expressed in arbitrary units = hepa¬
tocytes per 5mm2 x liver weight/mouse weight).
Table I
Effect of PB on liver weight and cell number0
2.5. Statistical analysis
PB-treated samples were compared with rele¬
vant controls using one-way ANOVA. A P-value
of less than 0.05 was considered significant.
3. Results
3.1. PB caused an increase in liver weight and
liver cell number
Phenobarbitone administration for 21 days re¬
sulted in a 39-60% increase in liver weight ex¬
pressed as liver/body weight ratio compared with
controls (Table 1; P < 0.05); no differences were
identified relating to p53 genotype. The number of
hepatocytes per liver also showed a modest in¬
crease after PB administration in p53 + / + and
—/ — mice (16 and 21% increase, respectively)
but not in the p53 + / — group compared with
controls (Z3 < 0.05). The proportion of non-par¬
enchymal cells was the same in PB-treated and
control mice for each genotype (Table 1). No
histological abnormalities were identified in any
group and in particular no carcinomas were seen;
there was no evidence of hepatocyte apoptosis.
3.2. PB caused liver polyploidiscition
Administration of PB for 21 days resulted in a
striking increase (250-400%) in the proportion of
octaploid nuclei compared with control mice (Fig.
1A), with no differences noted comparing the
three p53 genotypes (Fig. IB; P < 0.05). A small
Group +/+ +/— —/ —
PB Control PB Control PB Control
Liver weight 0.078* ± 0.008 0.050 ± 0.002 0.075* ± 0.003 0.047 ± 0.004 0.077* ± 0.004 0.055 ± 0.002
Total cell number 2244* ± 87 1940 ±187 2034 ± 300 1848 + 89 2315* ±134 1919 ±166
% NPC 32.78 ±2.38 29.16±3.34 33.23 ±2.21 33.42 ± 3.08 31.68 ± 2.33 28.91 ±2.11
" Liver weight is expressed per gram of total mouse weight; total cell number is the total number of hepatocytes per liver (cells
per 5 mm2 x liver weight); % NPC is the ratio of non-parenchymal cells to hepalocytes.* Represents a significant increase in
PB-treated vs. control mice (P<0.05).
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Fig. 1. (A) Flow cytometry histogram showing (1) side scatter (ss log, granularity) vs. forward scatter (fs log, size) and (2) numbers
of events (count, nuclei) vs. ploidy (FL3 (DNA), PI uptake) for control (con) and PB-treated (pb) mice. Arrows indicate 2n, 4n,and
8n nuclei. (B) Proportion of diploid, tetraploid and octaploid nuclei after 21 days administration of PB. Comparison of proportion
of nuclei in each ploidy class in control (con) and PB-treated (pb) groups of p53 + / + , + / — and — / — mice. * Indicates a
significant decrease in cell number in PB-treated mice compared with controls (P < 0.05) ** Indicates a significant increase in cell
number in PB-treated mice compared with controls (P < 0.05).
but significant reduction in 2n nuclei was also
noted in all three genotypes (Z'<0.05). No
changes were identified in the tetraploid
population.
3.3. PB increased hepatocyte proliferation
All untreated control samples showed similar
baseline levels of BrdU positivity with no differ¬
ences between p53 genotypes so the controls were
combined. The proportion of BrdU positive nu¬
clei was increased in all three genotypes after PB
treatment (Fig. 2; P < 0.05) with p53 + / + and
—/— mice also showing higher levels of BrdU
positivity than p53 +/— mice. Separating BrdU
positivity according to ploidy showed increased
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positivity in 8n cells only for all three p53 geno¬
types (Fig. 3; P < 0.05).
4. Discussion
We have shown that administration of PB for
21 days results in a striking change in liver ploidy
with 250-400% increase in octaploid nuclei with a
small reduction in 2n nuclei and no change te-
traploid nuclei. No difference was noted whether
p53 was present or not. Previous studies in mouse
liver showed that PB caused an increase in te-
traploid and octaploid cells with a concomitant
reduction in diploid cells after 20 days (Bohm and
Noltemeyer, 1981). This differs from our findings
although the reason for this is not clear, possibly
relating to the different strains of mice studied.
While our ploidy data for PB relates specifically
to octaploid nuclei rather than cells, an increase in
mononuclear octaploid cells has been described
following administration of a variety of other
drugs including the non-carcinogenic hepatic mi¬
togen 1,4-dichlorobenzene (Hasmall and Roberts,
1997), and the peroxisome proliferators WY-
14 643 and methylclofenapate (Miller et al.,
1996). Nuclearity of cells may also be important
as other chemicals cause an increase in ploidy
predominantly in binuclear or multinuclear cells
(Melchiorri et al., 1993; Scampini et al., 1993) and






Con pb +/+ pb +/-
Tetraploid
pb -/-
Con pb +/+ pb +/- pb -/-
Octaploid
Con pb +/+ pb +/- pb -/-
Fig. 3. Proportion of BrdU positive nuclei by ploidy class.
Comparison of control and PB-treated mice from different p53
genotypes. * Indicates an increase compared with controls
(P < 0.05).
con +/+ +/-
Fig. 2. Proportion of BrdU positive cells after 21 days admin¬
istration of PB. Comparison of controls with PB-treated p53
+ / + . +/— and — /— mice. * Indicates an increase com¬
pared with controls (P < 0.05): # Indicates an increase com¬
pared with p53 + / — mice.
diate stage in the formation of mononuclear poly¬
ploid cells (Alfert and Geschwind, 1958).
Conflicting evidence exists regarding the effects of
PB on hepatocyte nuclearity (Bohm and Nolte¬
meyer, 1981; Maier and Schawalder, 1993).
Our data confirm that PB is mitogenic, causing
an increase in liver weight and total liver cell
number and a marked increase in BrdU positivity.
Our results suggest that proliferation may be
greater in p53 + / + and — / — than + / — mice,
with the increase in BrdU positivity occurring
only in 8n nuclei. Similar differences in BrdU
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positivity in cells of different ploidy have been
described in other models, administration of DCB
in rats showing most proliferation in mononuclear
octaploid cells (Hasmall and Roberts, 1997). Im-
munostaining for BrdU in sections from the same
cases as our study shows positivity in both
mononuclear and binuclear hepatocytes (Orton et
al. 1999) suggesting that both mononuclear and
binuclear cells are responding to PB.
p53 knockout mice have been shown previously
to have reduced age-dependent polyploidisation
compared with wild type controls (Yin et al.,
1998) while other data has shown that polyploidi¬
sation with age is p53-independent (Bellamy et al.,
1997). Furthermore, mutations in p53 may con¬
trol polyploidisation after administration of spin¬
dle depolarising agents (Gualberto et al., 1998).
However, the role of p53 in polyploidisation in¬
duced by non-genotoxic agents is not known.
Since the ploidy profile in our study was the same
for the three groups of mice, we suggest that p53
is not a critical element in PB-induced liver poly¬
ploidisation for this strain of mouse. The mecha¬
nisms controlling polyploidisation are complex
and it is probable that different pathways to
polyploidy exist (for example, age-dependent vs.
drug-induced) where different stimuli may acti¬
vate different intracellular pathways.
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